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Abstract: A straightforward procedure for the synthesis of 
enantiopure polysubstituted piperidines is reported. It 
consists of the direct generation of chiral non-racemic 
oxazolo[3,2-a]piperidone lactams that already incorporate 
carbon substituents on the heterocyclic ring, and the 
subsequent removal of the chiral auxiliary. The key step is a 
cyclocondensation reaction of (R)-phenylglycinol, or other 
aminoalcohols, with racemic or prochiral -oxo(di)acid 
derivatives, in highly stereoselective processes involving 
dynamic kinetic resolution and / or desymmetrization of 
diastereotopic or enantiotopic ester groups. 
 
Abstract in Spanish: Se describe un procedimiento directo 
para la síntesis enantioselectiva de piperidinas 
polisustituidas. Consiste en la generación directa de 
oxazolo[3,2-a]piperidonas quirales no racémicas que ya 
incorporan sustituyentes carbonados en las diferentes 
posiciones del heterociclo, y en la posterior eliminación del 
auxiliar quiral. La etapa clave es una reacción de 
ciclocondensación entre el (R)-fenilglicinol, u otros 
aminoalcoholes quirales, con derivados de -oxoácidos 
racémicos o proquirales, en procesos altamente 
estereoselectivos que implican una resolución cinética 
dinámica y/o la desimetrización de grupos diastereotópicos o 
enantiotópicos. 
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Introduction 
The development of new and efficient methodologies for the 
generation or two or more stereogenic centers with high 
diastereo- and enantioselectivity in a single synthetic step 
is one of the most challenging subjects in organic synthesis, 
particularly in the field of bioactive natural or synthetic 
products. The preparation of a single enantiomer from a 
racemate may be achieved via a conventional resolution or by 
exploiting the differences in reactivity (kinetic 
resolution). Although enzyme-catalyzed kinetic resolution of 
racemates has become a classical approach for the synthesis 
of enantiopure compounds,
[1]
 it suffers, like conventional 
resolution processes, from the drawback that the maximum 
yield of one enantiomer is always limited to 50%. This 
situation dramatically changes when the racemic substrate or 
the two diastereomers resulting from the initial reaction 
with a chiral reagent have a chirally labile stereogenic 
center capable of undergoing in situ racemization
[2]
 or 
epimerization during the reaction to form a chirally stable 
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enantiopure product in up to 100% chemical yield (dynamic 
kinetic resolution).
[3]
 Although these processes represent a 
viable and useful tool for preparing enantiopure chiral 
compounds, they have been scarcely used in synthetic 
sequences due to the structural restrictions imposed by the 
substrate. When the reaction involves the generation of 
additional stereogenic centers, this methodology can convert 
a racemic compound into one of several possible enantiopure 
stereoisomers. 
On  the other hand, although enzyme-mediated 
desymmetrizations of prochiral or meso substrates, generally 
diesters, also constitute classical approaches for the 
synthesis of enantiopure compounds and have become powerful 
synthetic tools,
[4]
 the chemical, non-enzymatic, 
differentiation of two enantiotopic functional groups is 
still little developed in spite of the impressive advances in 
this field over the last years. 
Since the piperidine ring is the central structure of many 
biologically active alkaloid natural products
[5]
 and 
therapeutic agents, much effort has been devoted to the 
development of general methods and strategies for the 
enantioselective synthesis of piperidine derivatives.
[6]
 In 
this context, cyclocondensation reactions of -oxoacid 
derivatives with chiral nonracemic aminoalcohols have 
received considerable attention,
[7]
 since the resulting 
oxazolopiperidone lactams have proven to be versatile 
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building blocks for the enantioselective synthesis of 
piperidine-containing derivatives.
[8]
 In particular, in 
previous work we have demonstrated that simple 
phenylglycinol-derived bicyclic lactams trans-2, cis-2, and 
their enantiomers allow the stereocontrolled formation of C-C 
bonds at the different positions of the nitrogen 
heterocycle.
[7d,f-h,j]
 Our approach consists of three phases: 
(i) a cyclocondensation reaction of (R)- or (S)-
phenylglycinol with methyl 5-oxopentanoate (1a) to generate 
the required bicyclic lactam, (ii) successive stereoselective 
introduction of the ring substituents taking advantage of the 
functionalization and conformational rigidity of the bicyclic 
lactam system, and (iii) reductive removal of the chiral 
auxiliary (Scheme 1). Although this approach gives excellent 
results from the stereoselective and diversity points of 
view, leading to enantiopure piperidines with a variety of 
substitution patterns, it has the inconvenience that the 
substituents have to be introduced step by step. 
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In this paper we report a more straightforward procedure 
for the synthesis of enantiopure polysubstituted piperidines. 
It consists of the direct generation of chiral nonracemic 
oxazolopiperidone lactams A that already incorporate the 
carbon substituents on the heterocyclic ring, and the 
subsequent reductive removal of the chiral auxiliary (Scheme 
2). The key step is a cyclocondensation reaction of (R)-
phenylglycinol, or other aminoalcohols, with racemic or 
prochiral -oxo(di)acid derivatives, in processes involving 
dynamic kinetic resolution (DKR) and/or desymmetrization of 
enantiotopic or diastereotopic ester groups.
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Results and Discussion 
 
Phenylglycinol-Derived Lactams. The efficiency of the 
approach depicted in Scheme 2 for the generation of 2-
substituted piperidines from lactams bearing a substituent at 
the angular 8a-position relies on the stereocontrol in the 
reductive opening of the oxazolidine ring.
[9]
 To study the 
stereoselectivity of this process from an 8a-aryl substituted 
lactam we prepared lactam 3b, which was readily obtained in 
90% yield as a single stereoisomer by cyclocondensation of  
(R)-phenylglycinol with 5-phenyl-5-oxopentanoic acid (1b, 
Scheme 3). 
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Interestingly, treatment of lactam 3b with Red-Al gave 2-
phenylpiperidine 4b (54%) as the only stereoisomer detectable 
by spectroscopic methods. In contrast, 9-BBN reduction of 3b 
stereoselectively provided 2-phenylpiperidine 5b (75%), 
resulting from an inversion of the configuration at C-8a 
(5b:4b ratio 97:3). However, reduction of 3b with AlH3 or BH3 
showed poor stereoselectivity, affording mixtures of 4b and 
5b in which the former was the major stereoisomer (~7:3 
ratio). Removal of the chiral inductor of 4b and 5b by 
hydrogenolysis using Pd/C as the catalyst gave (S)-2-
phenylpiperidine (6b) and (R)-2-phenylpiperidine (ent-6b), 
respectively. The above three-step sequence opens a short 
enantiodivergent route to 2-arylpiperidines from easily 
available achiral -oxoacids. 
The remarkable difference in the stereoselectivity of the 
above reductions can be explained in terms of the reactive 
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intermediates B and C (R1 = C6H5, R
2
 = H) as depicted in Scheme 
4. Thus, the stereoselectivity in the Red-Al reduction of 3b, 
leading to 2-substituted piperidine 4b with retention of 
configuration, also observed in the reduction of related 8a-
alkyl substituted lactams,
[8g,10]
 can be rationalized by 
considering that, after the reduction  of the carbonyl 
lactam, the reductive cleavage of the oxazolidine ring takes 
place through complexation of the oxygen with the reductant, 
followed by delivery of the hydride from the same face of the 
C-O bond (B). The opposite stereochemical result observed in 
the reduction with 9-BBN suggests that, in this case, the 
reaction takes place via the ion paired intermediate C. The 
intramolecular delivery of the hydride under stereoelectronic 
control from the preferred conformation C’ accounts for the 
stereoselective formation of isomer 5b. Due to steric 
interactions, the 9-BBN reduction of intermediate B is slower 
than the formation of the iminium salt C. Moreover, the 
presence of the 8a-phenyl group (R
1
 = C6H5) contributes to the 
stabilization of this intermediate C, making the C-O bond 
more prone to undergo cleavage than in related 8a-alkyl 
lactams. 
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To further illustrate the potential of the 
cyclodehydration-stereocontrolled reduction sequence here 
developed, we undertook the synthesis of the tobacco alkaloid 
(–)-anabasine.[11] The required bicyclic lactam 3c was 
obtained as a single stereoisomer by cyclocondensation of 
keto-acid 1c with (R)-phenylglycinol in refluxing toluene. 
Although treatment of 3c with Red-Al or BH3 afforded complex 
mixtures resulting from partial reduction of the 
heteroaromatic ring, more satisfactorily, reduction with 9-
BBN in refluxing THF provided (73%) a 37:63 mixture of 
isomers 4c and 5c, respectively. The lower stereoselectivity 
of this reduction as compared with the 9-BBN reduction of the 
related phenyl substituted lactam 3b probably reflects the 
lesser ability of pyridine, a -deficient heterocycle, to 
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stabilize the intermediate iminium ion C in comparison with a 
phenyl group. In this series, the best result regarding 
stereoselectivity was obtained when 3c was treated with an 
excess of LiAlH4. The desired piperidine 4c was obtained in 
78% yield along with only minor amounts (6%) of its epimer 
5c. Hydrogenolysis of pure isomer 4c over Pearlman’s catalyst 
afforded (–)-anabasine (6c). 
We then examined the stereochemical outcome of 
cyclocondensations of (R)-phenylglycinol with racemic -alkyl 
-oxoacid derivatives, both aldehydes and ketones, which 
incorporate a chirally labile stereogenic center capable of 
undergoing in situ racemization or epimerization during 
reaction.
[12]
 Cyclocondensation reactions from aldehyde esters 
1d-1f, bearing an alkyl substituent at the -position of the 
aldehyde carbonyl group, took place in good chemical yield 
and stereoselectivity, leading to the enantiopure 
oxazolopiperidone 3-H/8a-H cis lactams 7d-7f, respectively, 
as the major products
[13]
 (Table 1), thus indicating that a 
dynamic kinetic resolution had occurred.
[14]
 Minor amounts of 
the corresponding diastereoisomeric 3-H/8a-H trans lactams 8 
were also formed (approximate 7/8 ratio, 4-5:1). Similar 
stereoselective cyclodehydrations occurred from -alkyl 
substituted ketones 1g-i, including both dialkyl (non-cyclic 
and cyclic) and alkyl aryl ketones, although in all these 
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cases the respective 3-H/8a-R
1
 trans lactams 8g-i were the 
major products (approximate 7/8 ratio, 1:4).[15] 
 
 
Table 1. Cyclocondensation reactions from 
racemic -substituted -oxoacid derivatives. 
 
 R R1 R2 yield 
(%) 
7/8  
ratio 
d Me H Et 79 4:1 
e Me H (CH2)2 C
S
S
CH3  
71 6:1 
f Me H CH2CH=CH2 71 7:1 
g H C6H5 Et 50 1
a
:4 
h H Me Et 60 1:4 
i H -(CH2)4- 70 1:5
b 
j Me H OTBDMS 50 
c 
k Me H OAc 45 
d 
l H CH2OBn OMEM 74 
e 
     
 
a
 The minor stereoisomer was the C8a-epimer of 7g. 
b 
The relative stereochemistry of 8i was confirmed by 
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X-ray crystallography. c Lactam 7j, its C8-epimer 
(3:2 ratio), and minor amounts of 8j (undetermined 
stereochemistry at C8). 
dLactams 7k, 8a-epi-7k, and 
8a-epi-8k in a 5:2:2 ratio. e 8l and its C8-epimer 
in a 3:2 ratio, and minor amounts of 7l. 
 
These results can be accounted for by considering that the 
two diastereoisomeric imines initially formed in the reaction 
of (R)-phenylglycinol with racemic oxoesters 1d-i are in 
equilibrium via an enamine and, consequently, that a mixture 
of four equilibrating oxazolidines is formed.
[16,17]
 Subsequent 
irreversible lactamization takes place faster from the 
diastereoisomer that allows a less hindered approach of the 
ester group to the nitrogen atom, via a transition state in 
which the alkyl substituent in the incipient chair-like six-
membered lactam is equatorial (Scheme 5; A = C6H5, B = R
3
 = H, 
R
1
 = H, alkyl or aryl, R
2
 = alkyl). 
 
In contrast, cyclocondensation of -oxoacid derivatives (1j-
l) bearing a protected hydroxyl group at the -position of 
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the aldehyde or ketone carbonyl group took place with low 
stereoselectivity, thus indicating that the presence of an 
oxygenated substituent on the epimerizable stereocenter 
inhibits DKR.
[18]
 
To study enantioselective desymmetrizations of prochiral -
oxodiesters with (R)-phenylglycinol, we selected the glutaric 
and pimelic acid derivatives 1m,n and 1r, respectively. 
Interestingly, cyclocondensation of aldehyde diester 1m and 
ketodiester 1n with (R)-phenylglycinol stereoselectively 
afforded the respective lactams 9m (3-H/8a-H cis) and 10n (3-
H/8a-R
1
 trans), as the major products, together with minor 
amounts (approximate 4:1 ratio) of a second diastereoisomer, 
10m and 9n, respectively (Table 2). Similarly, 
cyclocondensation of the prochiral aldehyde diester 1r gave 
lactam 9r (3-H/8a-H cis) in very high stereoselectivity 
(ratio 9r/10r, 9:1). It is worth mentioning that again 
cyclocondensations involving aldehydes lead to lactams with a 
cis 3-H/8a-H relationship whereas in the case of ketones the 
preferential formation of the 3-H/8a-R
1
 trans isomeric 
lactams is observed. 
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Table 2. Cyclocondensation reactions of (R)-
phenylglycinol with prochiral or racemic -
oxodiesters. 
 
 R’ R1 R2 yield 
(%) 
9/10 
ratio 
m Me H H 95 4:1 
n Et Me H 77
a 
1:4
b 
o Et H Et 77 4:1 
p Et Me n-Pr 55
c 1:9 
q Me Me Et 81
c 1:5 
r - - H 67 9:1 
s - - Et 50 9:1
d 
      
aUsing p-TsOH as a catalyst. bThe relative 
stereochemistry of 10n was confirmed by X-ray 
crystallography. cUsing glacial AcOH as a 
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catalyst. dIsomers 9s and 10s were isolated 
accompanied by their respective C8 epimers 
(9s’ and 10s’; 1:1 mixtures). 
 
 
The above results can be rationalized by taking into 
account that, after the formation of the corresponding 
oxazolidines, lactamization occurs faster through a chairlike 
transition state in which the diastereotopic acetate (R
3
 in 
Scheme 5) or propionate chain (R
2
 in Scheme 5) that does not 
undergo cyclization is equatorial. In accordance with this 
interpretation, the presence of an ethyl substituent at the 
prochiral carbon atom in 1s (R2 = Et) suppresses the 
discrimination between the two propionate chains, and lactams 
9s and 10s (9:1 ratio) were formed among with equimolecular 
amounts of their respective C-8 epimers 9s’ and 10s’[19] In 
this case, either the ethyl substituent or one of the 
propionate chains is axially oriented. 
As could be expected from the above results, treatment of 
racemic -oxodiesters 1o-q with (R)-phenylglycinol under the 
usual conditions predominantly afforded one of the eight 
possible stereoisomeric lactams, 9o (3-H/8a-H cis in the 
aldehyde series), 10p, and 10q (3-H/8a-R1 trans in the ketone 
series), respectively. Three stereogenic centers with a well-
defined absolute configuration have been generated in a 
single synthetic step. These reactions involve DKR, with 
epimerization of the configurationally labile stereocenter in 
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the substrate, and differentiation of the two diastereotopic 
acetate chains via a transition state in which the 
substituents R
2
 and R
3
 of the incipient chairlike six-membered 
lactam are equatorial (Scheme 5). 
The substituted chiral lactams 7-10 are immediate 
precursors of a variety of diversely substituted enantiopure 
piperidine derivatives, including 4-piperidineacetates. 
Starting from the 8a-phenyl substituted bicyclic lactam 8g, 
the best stereoselectivities in the reductive opening of the 
oxazolidine ring were obtained, as in the reduction of the 
deethyl analog 3b, with Red-Al (retention of the 
configuration at C-8a) and 9-BBN (inversion), to give 
piperidines cis-11a (56%) and trans-11a (86%), respectively, 
as single stereoisomers detectable by spectroscopic methods 
(Scheme 6). Reduction of 8g with AlH3 and BH3 showed the same 
level of stereoselectivity we had observed in the reduction 
of 3b, thus revealing that the C-8 substituent has no 
influence on the stereoselectivity of the reduction (see 
Scheme 4; R
1
 = C6H5, R
2
 = Et). Removal of the benzylic N-
substituent of the epimeric piperidines 11a by hydrogenolysis 
over palladium afforded piperidines cis-11b (70%) and trans-
11b (60%), respectively. In this way, starting from easily 
available racemic -substituted -oxoacids, the above three-
step sequence provides a stereodivergent entry to enantiopure 
cis- and trans-3-alkyl-2-arylpiperidines. 
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The phenyl substituent at the angular 8a-position has a 
dramatic influence on the stereoselectivity of the above 
reductions with 9-BBN because 9-BBN reduction of lactam 8h, 
bearing a 8a-methyl substituent, led to a 9:1 mixture (55%) 
of cis-piperidine 12a (retention of the configuration at C-
8a) and its C-2 epimer. As expected, reduction of 8h with 
Red-Al or AlH3 afforded cis-piperidine 12a as a single 
stereoisomer (60% and 84% yield, respectively), thus 
providing an efficient entry to enantiopure cis-2,3-
dialkylpiperidines. Hydrogenolysis of 12a over Pearlman’s 
catalyst in the presence of (Boc)2O afforded cis-2-methyl-3-
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ethylpiperidine 12c (82%). Similarly, tricyclic lactam 8i was 
stereoselectively reduced (70%) with AlH3 and then 
debenzylated in good yields to the enantiopure cis-
perhydroquinoline 13b, either directly or via the N-Boc 
derivative 13c.  
The reductive opening of the oxazolidine ring from lactams 
bearing an ester function was chemoselectively accomplished 
with borane. Thus, lactams 9o and 9r were efficiently 
converted to trans-3-ethyl-4-piperidineacetate 14b (70%) and 
3-piperidinepropionate 16b (91%), respectively, by treatment 
with BH3-THF followed by debenzylation of the resulting 
piperidines 14a and 16a. Alternatively, hydrogenolysis of the 
C-N bond of 9o with Ca in liquid NH3, followed by treatment 
of the resulting oxylactams with Et3SiH in TFA, afforded the 
6-oxo derivative 15b (48%), the enantiomer of a crucial 
intermediate in the synthesis of benzo[a]- and indolo[2,3-
a]quinolizidine alkaloids.
[20]
 Reductions using borane were 
also highly stereoselective (retention of configuration) for 
8a-methyl substituted lactams 10n and 10q, leading to the 
respective piperidineacetate derivatives 17a (55%; the C-2 
epimer was isolated in 19% yield) and 18a (66%), which were 
debenzylated to give 17b (or 17c) and 18b in excellent yield. 
A similar two-step sequence from the minor lactam 9n led to 
ent-17b and ent-17c. 
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The above results make evident that substituted 
phenylglycinol-derived lactams 7-10, easily accessible by 
cyclocondensation reaction of (R)-phenylglycinol with racemic 
or prochiral -oxoacid derivatives, are useful chiral 
synthons that allow the straightforward preparation of a 
variety of diversely substituted enantiopure piperidines.  
 
Other Aminoalcohol-Derived Lactams. With the aim of 
improving the diastereoselectivity of the above 
phenylglycinol-induced cyclocondensations, we undertook a 
study of the behavior of other aminoalcohols in similar 
cyclocondensation reactions involving DKR and/or 
differentiation of enantiotopic or diastereotopic ester 
groups. For this purpose we selected several 1,3- and 1,2-
aminoalcohols
[21]
 (19-23) and a variety of -oxoacid 
derivatives including unbranched aldehydes (1a) and ketones 
(1t), simple racemic aldehydes (1d) and ketones (1h and 1u), 
prochiral aldehydo- (1m and 1r) and ketone- (1n) diesters 
bearing enantiotopic ester groups, and racemic aldehydo- (1v) 
and ketone- (1q) diesters bearing diastereotopic ester 
groups. The results are summarized in Table 3.
[22] 
We initially explored the use of 1,3-aminoalcohols 19 and 
20.[23] Although aminoalcohol rac-19, the higher homolog of 
phenylglycinol, underwent cyclodehydration with aldehyde 
esters 1a and 1d to give the corresponding bicyclic lactams 
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rac-24a,b and rac-25a,b, no reaction was observed with 
ketones 1t and 1u. Taking into account furthermore that the 
stereoselectivity of the above reactions with aldehydes was 
low, no additional studies were performed with 19. 
 
 
Table 3. Cyclocondensation reactions of aminoalcohols with 
racemic or prochiral -oxoacid derivatives. 
 
starting 
materials 
products R1 R2 R3 
yiel
d 
a:b 
ratio 
 
1a + rac-19 
1d + rac-19 
N O
C6H5
O
R2
N O
C6H5
O
R29
a b  
 
rac-24 
rac-25 
 
__ 
__ 
 
H 
Et 
 
__ 
__ 
 
68%a 
70%a 
 
7:3 
4b:3 
 
1a + rac-20 
1d + rac-20 
1t + rac-20 
1h + rac-20 
1u + rac-20e 
1n + rac-20e 
N O
CH3
O
R2
R1
N O
CH3
O
R2
R1
a b
R3 R3
 
 
 
rac-26c 
rac-27 
rac-28c 
rac-29 
rac-30 
rac-31 
 
H 
H 
CH3 
CH3 
CH3 
CH3 
 
H 
Et 
H 
Et 
C6H5 
H 
 
H 
H 
H 
H 
H 
CH2CO2Et 
 
90% 
80% 
80% 
45% 
42% 
38% 
 
__d 
1:1d 
__d 
9:1d 
9:1d 
3:2d 
 
1a + 21 
1d + 21 
1m + 21 
1t + 21 
 
 
32 
33 
34 
35 
 
H 
H 
H 
CH3 
CH3 
 
H 
Et 
H 
H 
Et 
 
H 
H 
CH2CO2Me 
H 
H 
 
70% 
87% 
78% 
99% 
74% 
 
4:1 
7:5:3f 
4:1 
1:10 
1:8g 
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1h + 21 
1u + 21 
1n + 21h 
1q + 21 
NO
R2
O
H H
R1
NO
R2
O
H H
R1
a b
R3 R3
 
 
36 
37c 
38 
39 
CH3 
CH3 
CH3 
C6H5 
H 
Et 
H 
CH2CO2Et 
CH2CO2Me 
86% 
64% 
68% 
1:13g 
5:9 
2:3 
 
1d + 22 
1m + 22 
1r + 22 
1v + 22 
1h + 22 
1q + 22h 
 
NO O
R1
NO O
R1
R3 R3a b
C6H5C6H5 OCHPh2OCHPh2
R2R2
 
 
40 
41 
42 
43 
44 
45 
 
H 
H 
H 
H 
CH3 
CH3 
 
Et 
H 
(CH2)2CO2 
Et 
Et 
Et 
 
H 
CH2CO2Me 
H 
CH2CO2Me 
H 
CH2CO2Me 
 
78% 
86% 
80% 
77% 
81% 
58%j 
 
1:9 
1:14 
1:20 
1:15 i 
3:2 
5:2k 
 
1v + 23 
 
 
NO O NO O
a b
C6H5C6H5 MeOMeO
MeO2C MeO2C  
 
46 
 
 
__ 
 
 
__ 
 
 
__ 
 
 
70% 
 
 
2:1l 
 
aThe initially formed cis-oxazine, which has not undergone lactamization, was 
isolated in ~10% yield. b1:1 mixture of C-9 epimers. cThe relative stereochemistry of 
rac-26, rac-28, and 37b was confirmed by X-ray crystallography. dTrace amounts of the 
epimer at the piperidine -position were also detected. eIn the presence of a 
catalytic amount of p-TsOH. fa:b:c ratio (c is the epimer of b at the piperidine -
position). gTrace amounts of the epimer at the piperidine -position were also 
detected. hIn the presence of a catalytic amount of glacial AcOH. iMinor amounts of 
the epimer at the piperidine -position were also isolated.  j Based on consumed 1q. k 
Minor amounts of a third diastereomer were formed. l Other stereoisomers (about 15%) 
were also formed. 
 
In contrast, aminophenol rac-20 reacted with both aldehydes 
(1a and 1d) and ketones (1h,1n,1t,1u). Although no 
stereoselectivity was observed from racemic aldehyde 1d or 
from prochiral ketone 1n, reaction with racemic ketones 1h 
and 1u gave the respective tricyclic lactams rac-29 and rac-
30 in good stereoselectivity (a/b diastereomeric ratios 9:1) 
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but only moderate chemical yield.
[24]
 The isolation of 
considerable amounts of 2-vinylphenol can account for the low 
yield of the above reactions. 
More successful results were obtained when using cis-1-
amino-2-indanol 21,[25] a conformationally rigid analog of 
phenylglycinol.
[24]
 Thus, although no DKR was observed from 
racemic aldehyde 1d, enantioselective desymmetrization of two 
enantiotopic ester groups was produced in the 
cyclocondensation of 21 with aldehyde 1m, which took place in 
good chemical yield with a stereoselectivity similar to that 
previously observed when using phenylglycinol. Lactam 34a was 
isolated in about 60% yield as the major product (a/b 
diastereomeric ratio 4:1). Similarly, cyclocondensation of 21 
with racemic ketones (1h and 1u) took place in excellent 
chemical yield and even better stereoselectivity than when 
using phenylglycinol. Enantiopure tetracyclic lactams 36b and 
37b were isolated in 61% and 77% yield, respectively, after 
column chromatography, thus making evident that dynamic 
kinetic resolution, with epimerization of the stereocenter  
to the ketone carbonyl, had occurred to a considerable 
extent. However, only moderate stereoselectivities were 
observed in cyclocondensations involving desymmetrization of 
acetate chains from ketodiesters 1n and 1q. The higher 
stereoselectivities observed from racemic ketones 1h and 1u 
as compared with racemic aldehyde 1d in the above 
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cyclocondensations with aminoalcohols rac-20 and 21 could be 
explained by considering that lactamization of the 
intermediate oxazine or oxazolidine, both of them bearing an 
additional fused ring, occurs more slowly in the case of the 
ketones due to steric effects. Consequently, the oxazolidine-
enamine equilibrium induces DKR. 
The best results in terms of chemical yield and 
stereoselectivity in cyclocondensation reactions with 
aldehydes were obtained when using aminoalcohol 22.[26] Thus, 
22 reacted with racemic aldehyde 1d to give a 9:1 
stereoisomeric mixture of lactams 40 in 78% yield, which 
clearly indicated that a DKR had again occurred. Similarly, 
prochiral aldehydo-diesters 1m and 1r underwent highly 
enantioselective desymmetrizations during cyclocondensation 
with 22 to give 14:1 and 20:1 stereoisomeric mixtures of the 
respective lactam esters 41 and 42 in excellent yield. The 
major isomers b were isolated in 80% and 76% yield, 
respectively. Finally, racemic oxodiester 1v on reaction with 
aminoalcohol 22 stereoselectively provided enantiopure lactam 
43b, which was isolated in 66% yield, in a highly 
stereoselective process that involves a tandem DKR-
desymmetrization of two diastereotopic acetate chains, with 
generation of three stereogenic centers in a single synthetic 
step. In contrast with the above satisfactory results, 
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similar cyclocondensations from racemic ketones 1h and 1q 
occurred with low stereoselectivity. 
The higher stereoselectivities observed in 
cyclocondensations promoted by aminoalcohols 21 (from 
ketones) and 22 (from aldehydes) as compared with 
phenylglycinol can be rationalized taking into account that 
the substituents at the 4 and 5 ring positions in the 
intermediate oxazolidine (A and B in Scheme 5) are on the 
same face of the ring, thus making the opposite face more 
easily accessible. In agreement with this interpretation, and 
in sharp contrast with the above result from erythro 
aminoalcohol 22, cyclocondensation of threo aminoalcohol 
23[27] with racemic diester 1v took place with low 
stereoselectivity to give a 2:1 diastereomeric mixture of 
lactams 46a and 46b, among with other stereoisomers. 
Finally, to fully illustrate the synthetic usefulness of 
aminoalcohols 21 and 22 as chiral auxiliaries in the above 
cyclocondensation reactions, lactams 37b and 43b were 
converted into the corresponding enantiopure piperidines 48 
and 50 by a two-step sequence involving borane reduction, 
followed by removal of the auxiliary by catalytic 
hydrogenation from the resulting N-substituted piperidines 47 
and 49, respectively (Scheme 7). 
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Conclusion 
Cyclocondensation reactions of phenylglycinol with racemic 
or prochiral -oxo(di)acid derivatives in processes involving 
dynamic kinetic resolution and/or desymmetrization of 
diastereotopic or enantiotopic ester groups take place with 
consistently good to excellent stereoselectivity 
(diastereoisomeric ratios 4-9:1). As both enantiomers of 
phenylglycinol are commercially available, this aminoalcohol 
provides easy access to enantiopure piperidines in both 
enantiomeric series. On the other hand, although aminoindanol 
21 and protected aminopropanodiol 22 also promote highly 
stereoselective cyclocondensation reactions, their usefulness 
as chiral inductors is less general. Thus, whereas 
aminoindanol, whose two enantiomers are also commercially 
available, gives excellent stereoselectivities 
(diastereoisomeric ratios 8-13:1) in cyclocondensations from 
racemic ketones involving DKR, the less accessible alcohol 22 
works with exceptionally high stereoselectivities 
(diastereoisomeric ratios 9-20:1) in cyclocondensations from 
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aldehydes involving either DKR or desymmetrization of ester 
chains. 
The highly enantioselective processes reported herein, 
leading to a variety of (poly)substituted lactams in a single 
synthetic step, represent a conceptual extension of the 
potential of oxazolopiperidone lactams as chiral synthons for 
the enantioselective synthesis of diversely substituted 
piperidine derivatives. 
 
Experimental Section 
 
General Procedure for Cyclocondensation Reactions. A 
solution of aminoalcohol (1.2 equiv) and 1,5-dicarbonyl 
compound (1 equiv) in anhydrous toluene containing molecular 
sieves (4Å) was heated at reflux for 1266 h, with azeotropic 
removal of water produced by a Dean-Stark apparatus. The 
resulting suspension was filtered through Celite, the 
filtrate was concentrated, and the residue was taken up with 
EtOAc, dried, and concentrated. The resulting residue was 
chromatographed to afford the desired lactams. The epimeric 
ratios were determined by using HPLC and/or 
1
H NMR. 
(3R,8aR)-5-Oxo-3,8a-diphenyl-2,3,6,7,8,8a-hexahydro-5H-
oxazolo[3,2-a]pyridine (3b). Operating as in the above 
general procedure, from (R)-phenylglycinol (1.7 g, 12.4 mmol) 
and 5-phenyl-5-oxopentanoic acid (1b; 2 g, 10.4 mmol) in 
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anhydrous toluene (21 mL) for 25 h, lactam 3b (2.7 g, 90%) 
was obtained as a white solid after flash chromatography 
(SiO2 previously washed with hexane-Et3N; gradient 7:3 
hexaneEtOAc to EtOAc): m.p. 119122 oC (THFhexane); []22D 
+9.2 (c 1.0, MeOH), []22D +20.4 (c 0.63, CHCl3); 
1
H NMR 
(CDCl
3
, 300 MHz, COSY, HETCOR):  = 1.60 (m, 1H, H-7), 1.74 
(m, 1H, H-7), 1.95 (ddd, J = 14.0, 12.6, 3.9 Hz, 1H, H-8), 
2.23 (ddd, J = 12.6, 3.9, 0.9 Hz, 1H, H-8), 2.45 (ddd, J 
=18.6, 10.5, 7.8 Hz, 1H, H-6), 2.63 (ddd, J = 18.6, 7.8, 0.9 
Hz, 1H, H-6), 3.62 (t, J = 9.0 Hz, 1H, H-2), 4.39 (dd, J = 
9.0, 7.8 Hz, 1H, H-2), 5.28 (t, J = 9.0 Hz, 1H, H-3), 
7.087.20 (m, 5H, ArH), 7.317.39 (m, 3H, ArH), 7.467.49 (m, 
2H, ArH); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 15.3 (CH2), 30.7 
(CH2), 36.8 (CH2), 60.4 (CH), 69.2 (CH2), 97.1 (C), 126.6 
(CH), 127.6 (CH), 127.2 (CH), 128.3 (CH), 127.9 (CH), 137.8 
(C), 141.2 (C), 170.8 (C); IR (film):  = 1650 cm-1; elemental 
analysis calcd (%) for C19H19NO2: C, 77.79; H, 6.53; N, 4.77; 
found: C, 77.83; H, 6.51; N, 4.76. 
(3R,8aR)-5-Oxo-3-phenyl-8a-(3-pyridyl)-2,3,6,7,8,8a-
hexahydro-5H-oxazolo[3,2-a]pyridine (3c). Operating as in the 
above general procedure, from (R)-phenylglycinol (1.26 g, 
9.12 mmol) and 5-oxo-5-(3-pyridyl)pentanoic acid
[28] 
(1c; 1.48 
g, 7.6 mmol) in toluene (15 mL) for 24 h lactam 3c (1.2 g, 
58%) was obtained after flash chromatography (95:5 
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Et2OEt2NH): m.p. 103106 
o
C (Et2O); []
22
D + 4.3 (c 1.0, 
EtOH); 
1
H NMR (CDCl3, 300 MHz, HETCOR):  = 1.58 (m, 1H, H-7), 
1.83 (m, 1H, H-7), 1.98 (td, J = 12.9, 3.9 Hz, 1H, H-8), 2.23 
(dt, J = 12.9, 3.9 Hz, 1H, H-8), 2.51 (ddd, J = 18.6, 10.5, 
6.4 Hz, 1H, H-6), 2.68 (dd, J = 18.6, 8.1 Hz, 1H, H-6), 3.65 
(t, J = 9.3 Hz, 1H, H-2), 4.46 (dd, J = 9.3, 8.1 Hz, 1H, H-
2), 5.35 (t, J = 8.1 Hz, 1H, H-3), 7.067.21 (m, 5H, ArH), 
7.30 (ddd, J = 8.1, 4.8, 1.8 Hz, 1H, H-5pyr), 7.77 (dt, J = 
8.1, 2.4 Hz, 1H, H-4pyr), 8.60 (dd, J = 4.8, 1.8 Hz, 1H, H-
6pyr), 8.76 (dd, J = 2.4, 0.9 Hz, 1H, H-2pyr); 
13
C NMR (CDCl3, 
75.4 MHz):  = 15.2 (CH2), 30.7 (CH2), 36.7 (CH2), 60.2 (CH), 
69.3 (CH2), 95.9 (C), 122.9 (CH), 127.2 (CH), 127.5 (CH), 
128.3 (CH), 134.5 (CH), 136.9 (C), 137.6 (C), 148.4 (CH), 
149.8 (CH), 170.8 (C); IR (KBr):  = 1653 cm-1; elemental 
analysis calcd (%) for C18H18N202: C, 73.45; H, 6.16; N, 9.52; 
found: C, 73.51; H, 6.25; N, 9.64. 
General Procedure for Reduction Reactions. Method A. A 
mixture of 9-BBN (0.5M in THF, 1–10 equiv) and lactam (1 
equiv) was heated at reflux for 5–8 h. Then, the crude 
mixture was cooled at 0 ºC, a 1:1 solution of aqueous 2N NaOH 
and 30% H2O2 was slowly added, and the stirring was continued 
at 0 ºC for 30 min. Brine was added at 0 ºC, the aqueous 
phase was extracted with EtOAc, the combined organic extracts 
were dried and concentrated, and the residue was 
chromatographed.  
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Method B. Red-Al (0.1M in THF, 2.5–5 equiv) was added to a 
solution of lactam (1 equiv) in anhydrous THF, and the 
mixture was heated at reflux for 8 h. The crude mixture was 
diluted with EtOAc and ice–H2O, and the aqueous layer was 
extracted with EtOAc. The combined organic extracts were 
washed with brine, dried and concentrated, and the residue 
was chromatographed. 
Method C. LiAlH4 (3.2–6.6 equiv) was slowly added to a 
cooled (0 ºC) suspension of AlCl3 (1.4–4.4 equiv) in 
anhydrous THF, and the mixture was stirred at room 
temperature for 30 min. The temperature was lowered to –78 
ºC, the corresponding lactam (1 equiv) was added, and the 
resulting suspension was stirred at –78 ºC for 90 min and at 
room temperature for 2 h. The mixture was cooled to 0 ºC, and 
the reaction was quenched with H2O. The aqueous layer was 
extracted with CH2Cl2, the combined organic extracts were 
dried and concentrated, and the residue was chromatographed.  
Method D. BH3 (1M THF, 3 equiv) was added to a solution of 
lactam (1 equiv) in anhydrous THF at –78 ºC. The mixture was 
stirred at 0 ºC for 2 h and at room temperature for 3 h, 
poured into saturated aqueous 0.2N NaOH and extracted with 
EtOAc. The combined organic extracts were dried and 
concentrated, and the residue was chromatographed. 
(2S)-1-[(1R)-2-Hydroxy-1-phenylethyl]-2-phenylpiperidine 
(4b). Operating as described in the above Method B, from 
lactam 3b (100 mg, 0.34 mmol) and Red-Al (0.1M in THF, 17 mL, 
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1.7 mmol) in anhydrous THF (2 mL) for 8 h, piperidine 4b 
(51.5 mg, 54%) was obtained after flash chromatography 
(hexane): m.p. 61–62 oC (hexane) (lit[29] 60.9 oC); []22D –
165.1 (c 0.95, CHCl3) (lit
[29]
 []20D –165.9 (c 1.0, CHCl3)); 
1
H 
NMR (CDCl
3
, 300 MHz, COSY, HETCOR):  = 1.12–1.26 (m, 1H, H-
4), 1.53–1.76 (m, 5H, 2H-3, H-4, 2H-5), 1.91 (td, J = 12.0, 
2.1 Hz, 1H, H-6), 3.12 (dm, J = 12.0 Hz, 1H, H-6), 3.29 (dd, 
J = 10.8, 3.0 Hz, 1H, H-2), 3.38 (dd, J = 9.0, 3.9 Hz, 1H, H-
1’), 3.54 (bs, 1H, OH), 4.00 (dd, J = 11.3, 3.9 Hz, 1H, H-
2’), 4.03 (dd, J = 11.3, 9.0 Hz, 1H, H-2’), 6.99–7.06 (m, 2H, 
ArH), 7.25–7.44 (m, 8H, ArH); 13C NMR (CDCl
3
, 75.4 MHz):  = 
24.9 (CH2), 26.3 (CH2), 37.8 (CH2), 45.7 (CH2), 59.3 (CH2), 
61.8 (CH), 65.4 (CH), 127.1 (CH), 127.6 (CH), 127.8 (CH), 
127.9 (CH), 128.7 (CH), 129.3 (CH), 134.4 (CH), 144.0 (C); IR 
(film):  = 3441 cm-1; elemental analysis calcd (%) for 
C19H23NO: C, 81.10; H, 8.24; N, 4.98; found: C, 80.86; H, 
8.33; N, 4.91.  
(2R)-1-[(1R)-2-Hydroxy-1-phenylethyl]-2-phenylpiperidine 
(5b). Operating as in the above Method A, from lactam 3b (1 
g, 3.4 mmol) and 9-BBN (0.5M in THF, 68.2 mL, 34 mmol) in THF 
(40 mL) for 8 h, piperidine 5b (720 mg, 75%) was obtained 
after flash chromatography (hexane, 7:3 hexane–EtOAc): m.p. 
77–78 oC (Et2O–hexane), (lit
[27]
 78 
o
C); []22D –30.2 (c 1.1, 
CHCl3), (lit
[29]
 []20D –30.3 (c 1.08, CHCl3)); 
1
H NMR (CDCl
3
, 
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300 MHz, COSY, HETCOR):  = 1.25–1.80 (m, 7H, 2H-3, 2H-4, 2H-
5, OH), 2.51 (td, J = 11.3, 2.7 Hz, 1H, H-6), 2.95 (dm, J = 
11.3 Hz, 1H, H-6), 3.76 (dd, J = 9.9, 2.7 Hz, 1H, H-2), 3.83 
(t, J = 6.6 Hz, 1H, H-1’), 4.04 (m, 2H, 2H-2’), 7.20–7.42 (m, 
10H, ArH); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 25.1 (CH2), 26.4 
(CH2), 37.0 (CH2), 47.6 (CH2), 59.7 (CH2), 62.7 (CH), 65.8 
(CH), 126.6 (CH), 127.0 (CH), 128.0 (CH), 127.6 (CH), 128.5 
(CH), 140.1 (C), 144.8 (C); IR (film):  = 3405 cm-1; 
elemental analysis calcd (%) for C19H23NO: C, 81.10; H, 8.24; 
N, 4.98; found: C, 80.90; H, 8.37; N, 4.95. 
(2S)- and (2R)-1-[(1R)-2-Hydroxy-1-phenylethyl]-2-
pyridylpiperidine (4c and 5c). Lactam 3c (100 mg, 0.34 mmol) 
was slowly added to a suspension of LiAlH4 (129 mg, 3.4 mmol) 
in anhydrous THF (6 mL) at room temperature. The resulting 
mixture was stirred for 15 h and cooled to 0 ºC. The reaction 
was quenched with H2O. The aqueous layer was extracted with 
EtOAc, and the combined organic extracts were dried and 
concentrated. Flash chromatography (EtOAc) afforded 
piperidines 4c (70 mg, 78%) and 5c (5 mg, 6%). 4c: []22D –
120.0 (c 1.3, CHCl3), (lit
[30]
: []22D –123.1 (c 1.3, 
CHCl3));.
1
H NMR (CDCl3, 300MHz):  = 1.18–1.25 (m, 1H), 1.55–
1.77 (m, 5H), 1.96 (td, J = 12.0, 2.4 Hz, 1H), 3.13 (dm, J = 
12.0 Hz, 1H), 3.34 (dd, J = 10.8, 2.4 Hz, 1H), 3.41 (dd, J = 
11.0, 5.4 Hz, 1H), 3.87 (dd, J = 11.0, 5.4 Hz, 1H), 4.05 (t, 
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J = 11.0 Hz, 1H), 6.97–7.00 (m, 2H), 7.31–7.34 (m, 3H), 7.37 
(dd, J = 8.1, 4.8 Hz, 1H), 7.78 (dt, J = 8.1, 2.1 Hz, 1H), 
8.56–8.59 (m, 2H); 13C NMR (CDCl3, 75.4 MHz):  = 24.7 (CH2), 
26.2 (CH2), 37.8 (CH2), 45.7 (CH2), 59.5 (CH2), 62.4 (CH), 
62.6 (CH), 123.9 (CH), 127.9 (CH), 128.0 (CH), 129.2 (CH), 
133.9 (C), 135.2 (CH), 139.4 (C), 148.8 (CH), 149.7 (CH); IR 
(film):  = 3408 cm-1; 5c: []22D –22.7 (c 1.0, CHCl3); 
1
H NMR 
(CDCl3, 300MHz):  = 1.41–1.88 (m, 6H), 2.55 (td, J = 11.4, 
2.7 Hz, 1H), 2.92 (dm, J = 11.4 Hz, 1H), 3.78 (t, J = 6.6 Hz, 
1H), 3.93 (dd, J = 11.1, 2.7 Hz, 1H), 4.03 (dd, J = 11.1, 6.6 
Hz, 1H), 4.12 (dd, J = 11.1, 6.6 Hz, 1H), 7.16–7.38 (m, 6H), 
7.79 (dt, J = 7.8, 1.8 Hz, 1H), 8.28 (dd, J = 4.5, 1.8 Hz, 
1H), 8.52 (d, J = 1.8 Hz, 1H); 
13
C NMR (CDCl3, 75.4 MHz):  = 
24.9 (CH2), 26.2 (CH2), 37.0 (CH2), 46.9 (CH2), 59.8 (CH2), 
62.6 (CH), 63.0 (CH), 123.6 (CH), 126.6 (CH), 127.8 (CH), 
128.0 (CH), 135.2 (CH), 140.1 (C), 140.4 (C), 147.9 (CH), 
149.1 (CH); IR (film):  = 3355 cm-1. 
(2R,3R)-3-Ethyl-1-[(1R)-2-hydroxy-1-phenylethyl]-2-
methylpiperidine (12a). Operating as in the above Method C, 
from lactam 8h (200 mg, 0.77 mmol), AlCl3 (154 mg, 1.1 mmol), 
and LiAlH4 (191 mg, 5.1 mmol) in anhydrous THF (15 mL), 
piperidine 12a (160 mg, 84%) was obtained after flash 
chromatography (1:1 hexane–EtOAc): []22D –15.2 (c 1.36, 
MeOH); 
1
H NMR (CDCl3, 300 MHz, COSY):  = 0.79 (t, J = 7.5 Hz, 
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3H, CH3), 0.85 (d, J = 7.0 Hz, 3H, CH3), 1.19 (q, J = 7.0 Hz, 
2H, CH2), 1.29–1.54 (m, 4H, H-3, 2H-4, H-5), 1.61 (m, 1H, H-
5), 2.45 (m, 1H, H-6), 2.66 (dd, J = 9.0, 3.6 Hz, 1H, H-6), 
2.78 (ddd, J = 13.5, 6.6, 3.6 Hz, 1H, H-2), 3.78 (m, 3H, H-
1', H-2'), 7.24–7.35 (m, 5H, ArH); 13C NMR (CDCl3, 75.4 MHz): 
 = 9.9 (CH3), 11.8 (CH3), 23.5 (CH2), 24.5 (CH2), 25.4 (CH2), 
42.4 (CH), 44.0 (CH2), 53.7 (CH), 62.0 (CH2), 64.7 (CH), 127.4 
(CH), 128.2 (CH), 128.3 (CH), 139.2 (C); IR (film):  = 3414 
cm
-1
; elemental analysis calcd (%) for C16H25NO: C, 76.68; H, 
10.19; N, 5.66; found: C, 76.39; H, 10.12; N, 5.51. 
Ethyl (3S,4S)-3-Ethyl-1-[(1R)-2-hydroxy-1-
phenylethyl]piperidine-4-acetate (14a). Operating as in the 
above Method D, from lactam 9o (175 mg, 0.52 mmol) and BH3 
(1M in THF, 1.58 mL, 1.58 mmol) in THF (8 mL), piperidine 14a 
was obtained (103 mg, 61%) after flash chromatography (8:2 
EtOAc–hexane to EtOAc): []22D –53.0 (c 0.5, MeOH); 
1
H NMR 
(CDCl3, 300 MHz, COSY, HETCOR):  = J = 7.2 Hz, 3H, 
CH3), 1.13 (m, 1H, CH2), 1.22 (t, J = 7.2 Hz, 3H, CH3), 1.23–
1.43 (m, 3H, H-3, H-4, H-5), 1.49 (m, 1H, CH2), 1.74 (m, 2H, 
H-5, H-6ax), 2.01 (dd, J = 14.7, 8.7 Hz, 1H, CH2), 2.02 (t, J 
= 10.5 Hz, 1H, H-2ax), 2.49 (dd, J = 14.7, 4.0 Hz, 1H, CH2), 
2.85 (m, 2H, H-2eq, H-6eq), 3.62 (dd, J = 10.0, 5.2 Hz, 1H, 
H-2'), 3.72 (dd, J = 10.0, 5.2 Hz, 1H, H-1'), 3.97 (t, J = 
10.0 Hz, 1H, H-2'), 4.08 (q, J = 7.2 Hz, 2H, CH2), 7.15–7.35 
(m, 5H, ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 11.1 
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(CH3), 14.2 (CH3), 23.6 (CH2), 31.7 (CH2), 37.1 (CH), 38.4 
(CH2), 42.6 (CH), 46.0 (CH2), 56.9 (CH2), 60.0 (CH2), 60.2 
(CH2), 70.0 (CH), 127.8 (CH), 128.1 (CH), 1.28.8 (CH), 135.2 
(C), 173.0 (C); IR (film):  = 3440, 1732 cm-1; elemental 
analysis calcd (%) for C19H29NO3: C, 71.44; H, 9.16; N, 4.38; 
found: C, 71.38; H, 9.32; N, 4.36. 
General Procedure for Hydrogenolysis Reactions. A solution 
of the piperidine (1 equiv) in MeOH or EtOAc containing Pd-C 
or Pd(OH)2-C was hydrogenated at 25 ºC until disappearance of 
starting material was observed by TLC. The catalyst was 
removed by filtration and washed with hot MeOH, and the 
solution was concentrated to give the substituted piperidines 
after flash chromatography. 
(S)-2-Phenylpiperidine (6b). Following the above general 
procedure, from piperidine 4b (150 mg, 0.53 mmol) and Pd-C 
(10 %, 37.5 mg) in MeOH (25 mL) was obtained piperidine 6b 
(50 mg, 58 %) as a transparent oil after flash chromatography 
(CH2Cl2): []
22
D –26.9 (c 1.0, MeOH), []
22
D –63.8 (c 0.5, 
CHCl3), (lit
[29]
 []20D –27.0 (c 0.43, MeOH)); 
1
H NMR (CDCl
3
, 300 
MHz):  = 1.43–1.93 (m, 6H), 2.78 (td, J = 11.6, 3.1 Hz, 1H), 
3.19 (dm, J = 11.6 Hz 1H), 3.58 (dd, J = 10.4, 2.4 Hz, 1H), 
7.19–7.38 (m, 5H); 13C NMR (CDCl
3
, 75.4 MHz)  = 25.4 (CH2), 
25.9 (CH2), 34.9 (CH2), 47.8 (CH2), 62.3 (CH), 126.5 (CH), 
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126.9 (CH), 128.2 (CH), 145.4 (C); IR (film):  = 3420 cm-1; 
HMRS calcd for C11H15N 161.1199; found 161.1204. 
(S)-3-(2-Piperidyl)pyridine [(–)-S-Anabasine] (6c). 
Following the above general procedure, from piperidine 4c 
(150 mg, 0.53 mmol) and 10% Pd(OH)2-C (40 mg) in MeOH (12 mL) 
was obtained pure anabasine (6c, 70 mg, 81%) as a transparent 
oil after flash chromatography (95:5 EtOAc–EtOH): []22D –74.7 
(c 0.1, CHCl3), (lit
[30]
: []23D –75.5 (c 0.1, CHCl3)); []
22
D –
77.04 (c 0.5, MeOH); (lit
[31]
: []24D –79.2 (c 0.5, MeOH)); 
1
H 
NMR (CDCl3, 300MHz):  = 1.50–2.0 (m, 6H), 2.80 (td, J = 
11.4, 3.0 Hz, 1H), 3.20 (dm, J = 11.4 Hz, 1H), 3.64 (dd, J = 
10.2, 2.7 Hz, 1H), 7.24 (dd, J = 7.8, 4.8 Hz, 1H), 7.72 (dt, 
J = 7.8, 1.5 Hz, 1H), 8.48 (dd, J = 4.8, 1.5 Hz, 1H), 8.58 
(d, J = 1.5 Hz, 1H); 
13
C NMR (CDCl3, 75.4 MHz):  = 25.2 
(CH2), 25.6 (CH2), 34.7 (CH2), 47.6 (CH2), 59.8 (CH), 123.4 
(CH), 134.1 (CH), 140.4 (C), 148.5 (CH), 148.6 (CH). 
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Legends 
Scheme 1. Synthetic Strategy. First Generation 
Oxazolopiperidone Lactams. 
Scheme 2. Synthetic Strategy. Second Generation 
Oxazolopiperidone Lactams. 
Scheme 3. Enantiodivergent Synthesis of 2-Arylpiperidines. 
Enantioselective Synthesis of (–)-Anabasine. 
Scheme 4. Stereoselective Reduction of 8a-Substituted 
Lactams. 
Scheme 5. Lactamization Step during Cyclocondensation of -
Oxoacid Derivatives with 1,2-Aminoalcohols. 
Scheme 6. Synthesis of Diversely Substituted Enantiopure 
Piperidines.  
Scheme 7. Removal of the Chiral Auxiliary. 
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Tables 
 
Table 1. Cyclocondensation reactions from 
racemic -substituted -oxoacid derivatives. 
 
Insert here Figure of Table 1 
 
 R R
1
 R
2
 yield 
(%) 
7/8  
ratio 
d Me H Et 79 4:1 
e Me H (CH2)2 C
S
S
CH3  
71 6:1 
f Me H CH2CH=CH2 71 7:1 
g H C6H5 Et 50 1
[a]
:4 
h H Me Et 60 1:4 
i H -(CH2)4- 70 1:5
[b] 
j Me H OTBDMS 50 
[c] 
k Me H OAc 45 
[d] 
l H CH2OBn OMEM 74 
[e] 
     
 
[a]The minor stereoisomer was the C8a-epimer of 7g.  
[b]The relative stereochemistry of 8i was confirmed 
by X-ray crystallography. [c]Lactam 7j, its C8-
epimer (3:2 ratio), and minor amounts of 8j 
(undetermined stereochemistry at C8). 
[d]Lactams 7k, 
8a-epi-7k, and 8a-epi-8k in a 5:2:2 ratio. [e]8l and 
its C8-epimer in a 3:2 ratio, and minor amounts of 
7l. 
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Table 2. Cyclocondensation reactions of (R)-
phenylglycinol with prochiral or racemic -oxodiesters. 
 
Insert here Figure of Table 2 
 
 R’ R1 R2 yield 
(%) 
9/10 
ratio 
m Me H H 95 4:1 
n Et Me H 77
[a] 
1:4
[b] 
o Et H Et 77 4:1 
p Et Me nPr 55
[c] 
1:9 
q Me Me Et 81
[c] 
1:5 
r - - H 67 9:1 
s - - Et 50 9:1
[d] 
      
[a]Using p-TsOH as a catalyst. [b]The relative 
stereochemistry of 10n was confirmed by X-ray 
crystallography. [c]Using glacial AcOH as a 
catalyst. [d]Isomers 9s and 10s were isolated 
accompanied by their respective C8 epimers 
(9s’ and 10s’; 1:1 mixtures). 
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Table 3. Cyclocondensation reactions of aminoalcohols with 
racemic or prochiral -oxoacid derivatives. 
 
Insert here Figure of Table 3 
 
starting 
materials 
products R1 R2 R3 yield 
a:b 
ratio 
 
1a + rac-19 
1d + rac-19 
N O
C6H5
O
R2
N O
C6H5
O
R29
a b  
 
rac-24 
rac-25 
 
__ 
__ 
 
H 
Et 
 
__ 
__ 
 
68%[a] 
70%[a] 
 
7:3 
4[b]:3 
 
1a + rac-20 
1d + rac-20 
1t + rac-20 
1h + rac-20 
1u + rac-20[e] 
1n + rac-20[e] 
N O
CH3
O
R2
R1
N O
CH3
O
R2
R1
a b
R3 R3
 
 
 
rac-26[c] 
rac-27 
rac-28[c] 
rac-29 
rac-30 
rac-31 
 
H 
H 
CH3 
CH3 
CH3 
CH3 
 
H 
Et 
H 
Et 
C6H5 
H 
 
H 
H 
H 
H 
H 
CH2CO2Et 
 
90% 
80% 
80% 
45% 
42% 
38% 
 
__[d] 
1:1[d] 
__[d] 
9:1[d] 
9:1[d] 
3:2[d] 
 
1a + 21 
1d + 21 
1m + 21 
1t + 21 
1h + 21 
1u + 21 
1n + 21[h] 
1q + 21 
 
NO
R2
O
H H
R1
NO
R2
O
H H
R1
a b
R3 R3
 
 
 
32 
33 
34 
35 
36 
37[c] 
38 
39 
 
H 
H 
H 
CH3 
CH3 
CH3 
CH3 
CH3 
 
H 
Et 
H 
H 
Et 
C6H5 
H 
Et 
 
H 
H 
CH2CO2Me 
H 
H 
H 
CH2CO2Et 
CH2CO2Me 
 
70% 
87% 
78% 
99% 
74% 
86% 
64% 
68% 
 
4:1 
7:5:3[f] 
4:1 
1:10 
1:8[g] 
1:13[g] 
5:9 
2:3 
 
1d + 22 
1m + 22 
1r + 22 
1v + 22 
1h + 22 
1q + 22[h] 
 
NO O
R1
NO O
R1
R3 R3a b
C6H5C6H5 OCHPh2OCHPh2
R2R2
 
 
40 
41 
42 
43 
44 
45 
 
H 
H 
H 
H 
CH3 
CH3 
 
Et 
H 
(CH2)2CO2 
Et 
Et 
Et 
 
H 
CH2CO2Me 
H 
CH2CO2Me 
H 
CH2CO2Me 
 
78% 
86% 
80% 
77% 
81% 
58%[j] 
 
1:9 
1:14 
1:20 
1:15[i] 
3:2 
5:2[k] 
 
1v + 23 
 
 
NO O NO O
a b
C6H5C6H5 MeOMeO
MeO2C MeO2C
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__ 
 
 
__ 
 
 
__ 
 
 
70% 
 
 
2:1[l] 
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[a]The initially formed cis-oxazine, which has not undergone lactamization, was 
isolated in ~10% yield. [b]1:1 mixture of C-9 epimers. [c]The relative stereochemistry 
of rac-26, rac-28, and 37b was confirmed by X-ray crystallography. [d]Trace amounts of 
the epimer at the piperidine -position were also detected. [e]In the presence of a 
catalytic amount of p-TsOH. [f]a:b:c ratio (c is the epimer of b at the piperidine -
position). [g]Trace amounts of the epimer at the piperidine -position were also 
detected. [h]In the presence of a catalytic amount of glacial AcOH. [i]Minor amounts of 
the epimer at the piperidine -position were also isolated. [j] Based on consumed 1q. 
[k] Minor amounts of a third diastereomer were formed. [l] Other stereoisomers (about 
15%) were also formed. 
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Text for the Table of Contents 
 
 
As many as three stereogenic centers can be generated in high 
chemical yield and excellent stereoselectivity in a single 
synthetic step by a cyclocondensation reaction between a 
chiral non-racemic aminoalcohol and a racemic -oxodiester in 
a process involving a tanden dynamic kinetic resolution-
diastereoselective differentiation of two acetate chains. 
This is the key step of a straightforward procedure for the 
enantioselective synthesis of diversely substituted 
piperidines. 
 
Keywords: Asymmetric synthesis, Cyclocondensation, Chiral 
auxiliaries, Dynamic Kinetic Resolution, Enantiopure 
piperidines. 
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MeO2C CHO
N OO
C6H5
NH2
OH
C6H5
+
1. Cyclocondensation
Amidoalkylation
Nucleophilic
alkylation
Enolate
alkylation
2. Introduction
    of substituents
N
R1
R2
3. Removal of the 
    chiral auxiliary
R
1a
trans-2
Enantiopure piperidines
Diels-Alder and conjugate addition 
to an unsaturated lactam
Scheme 1
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Scheme 2
N O
A B
R1
R2
R3
O
R'O2C
R2
R3
O R1
B
A
NH2
OH
1  Racemic or prochiral 
-oxo(di)acid derivatives
Enantiopure
piperidinesSubstituted chiral
nonracemic lactams
A
8a
H
N R1
R2
R3
+
Cyclocondensation Removal of the
 chiral auxiliary
** * *
DKR and / or
Desymmetrization
 
 53 
Scheme 3
b Ar = C6H5
c Ar = 3-C5H4N
HOOC
ArO
N OO
Ar
N Ar
C6H5
OH
H
N Ar
N Ar
C6H5
OH
H
N C6H5
NH2
OH
C6H5
1
3
4 6
5
ent-6b
R
9-BBN
H2, cat
H2, cat
from 5b
Red-Al (from 3b)
LiAlH4 (from 3c)C6H5
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Scheme 4
N
O
R1
H
C6H5
M
H 
+X
N
R2
O
H
M
H
N
R2
R2= H or Et
C' C''
3b
4b 5b
N
R2
R1
O
M
H
C6H5
R2
OM
H
H
B
retention
C
inversion
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Figure of Table 1
ROOC
O N OO
C6H5
1d-l, racemates
R1
R2 R2
N OO
C6H5
R2
7 8
+R1 R18
OH
NH2
C6H5
3
8a
8
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Scheme 5
N
CO2R
O
R1
R2
R3
H
H
H
A
B
N
O
H
A
B
CO2R
R3
H
H
R2
R1
NO O
R1
NO O
R1
R3
R3
A B
A B
R2
R2
From ketones
From aldehydes
R1 = alkyl or aryl
R1 = H
3-H/8a-H cis
3
8a
3-H/8a-R1 trans
8a
 
 
 57 
Figure of Table 2
R'O2C
O
N OO
C6H5
R1
R2 R2
N OO
C6H5
R2
9m-q 10m-q
+R1 R1
CO2R' CO2R' CO2R'
MeO2C CO2Me
O H
R2
N OO
C6H5
R2
CO2Me
N OO
C6H5
R2
CO2Me
+
9r,s 10r,s
1m-q
1r,s
8
8a
3
 
 58 
Scheme 6
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Dynamic Kinetic Resolution and Desymmetrization 
Processes: A Straightforward Methodology for the 
Enantioselective Synthesis of Piperidines 
 
Mercedes Amat,*[a] Oriol Bassas,[a] Núria Llor,[a] Margalida 
Cantó,[a] Maria Pérez,[a] Elies Molins,[b] and Joan Bosch,*[a] 
 
Cyclocondensation Reactions 
(3R,8S,8aR)- and (3R,8R,8aS)-8-Ethyl-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (7d and 8d). 
Method A. Operating as in the general procedure, from methyl 
4-formylhexanoate
[1]
 (1d; 1.2 g, 7.6 mmol) and (R)-
phenylglycinol (1.2 g, 9.1 mmol) in toluene (25 mL) for 18 h, 
compounds 7d (1.23 g, 64%) and 8d (310 mg, 16%) were obtained 
after flash chromatography (EtOAc). 7d (higher Rf): m.p. 97
100
 o
C (Et2Ohexane); []
22
D –23.5 (c 1.0, EtOH); 
1
H NMR (CDCl
3
, 
300 MHz, HETCOR):  = 1.05 (t, J = 7.4 Hz, 3H, CH3), 1.341.50 
(m, 2H, H-7, CH2), 1.701.91 (m, 2H, H-8, CH2), 2.05 (m, 1H, 
H-7), 2.35 (ddd, J = 18.0, 11.2, 7.0 Hz, 1H, H-6), 2.42 (ddd, 
J = 18.0, 7.2, 2.5 Hz, 1H, H-6), 4.00 (d, J = 9.0 Hz, 1H, H-
2), 4.13 (dd, J = 9.0, 6.7 Hz, 1H, H-2), 4.52 (d, J = 8.8 Hz, 
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1H, H-8a), 4.92 (d, J = 6.7 Hz, 1H, H-3), 7.217.35 (m, 5H, 
ArH); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 10.8 (CH3), 23.6 (CH2), 
24.0 (CH2), 31.2 (CH2), 40.7 (CH), 58.7 (CH), 73.6 (CH2), 92.4 
(CH), 126.1 (CH), 128.3 (CH), 127.2 (CH), 141.4 (C), 167.1 
(C); IR (KBr):  = 1655 cm-1; elemental analysis calcd (%) for 
C15H19NO2: C, 73.44; H, 7.80; N, 5.70; found: C, 73.59; H, 
7.89; N, 5.81. 8d (lower Rf): m.p. 7780
 o
C (Et2O); []
22
D –
103.5 (c 1.1, EtOH);
 1
H NMR (CDCl
3
, 300 MHz, HETCOR):  = 1.03 
(t, J = 7.4 Hz, 3H, CH3), 1.37 (m, 1H CH2), 1.51 (m, 2H, H-7, 
H-8), 1.80 (m, 1H, CH2), 1.96 (m, 1H, H-7), 2.36 (ddd, J = 
18.5, 11.3, 6.5 Hz, 1H, H-6), 2.57 (dd, J = 18.0, 5.0 Hz 1H, 
H-6), 3.74 (dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.47 (dd, J = 9.0, 
7.8 Hz, 1H, H-2), 4.67 (d, J = 7.8 Hz, 1H, H-8a), 5.24 (t, J 
= 7.8 Hz, 1H, H-3), 7.257.34 (m, 5H, ArH); 13C NMR (CDCl
3
, 
75.4 MHz):  = 10.9 (CH3), 22.7 (CH2), 24.5 (CH2), 31.3 (CH2), 
41.1 (CH), 58.1 (CH), 72.3 (CH2), 92.6 (CH), 125.9 (CH), 
128.6 (CH), 127.3 (CH), 139.4 (C), 168.7 (C); IR (KBr):  = 
1660 cm
-1
; elemental analysis calcd (%) for C15H19NO2: C, 
73.44; H, 7.80; N, 5.70; found: C, 73.04; H, 7.71; N, 5.51. 
Method B. A mixture of racemic methyl 4-formylhexanoate
[1]
 
(1d; 3.8 g, 24.4 mmol), (R)-phenylglycinol (3.3 g, 24.4 
mmol), and anhydrous Na2SO4 (13.5 g, 95 mmol) in Et2O (80 mL) 
was stirred at 0 ºC for 1 h. The resulting suspension was 
filtered, and the filtrate was concentrated under reduced 
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pressure. The residue was heated at 70 ºC for 2 h under 
vacuum (10-15 mm Hg). Column chromatography (SiO2 previously 
washed with 8:2 hexaneEt3N; 1:1 hexaneEtOAc as eluent) of 
the residue successively afforded lactams 7d (4.3 g, 71%) and 
8d (444 mg, 8%). 
 (3R,8R,8aR)- and (3R,8S,8aS)-8-[2-(2-Methyl-1,3-dithian-2-
yl)ethyl]-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-
oxazolo[3,2-a]pyridine (7e and 8e). Method A. Operating as in 
the general procedure, from methyl 4-formyl-6-(2-methyl-1,3-
dithian-2-yl)hexanoate
[2] 
(1e; 200 mg, 0.7 mmol) and (R)-
phenylglycinol (115 mg, 0.84 mmol) in toluene (2 mL)  for 14 
h, lactams 8e (21.3 mg, 10%) and 7e (124.8 mg, 61%) were 
obtained after flash chromatography (1:1 hexaneEtOAc). 7e 
(lower Rf): []
22
D +10.4 (c 0.65, MeOH); 
1
H NMR (CDCl
3
, 300 
MHz):  = 1.471.60 (m, 2H), 1.64 (s, 3H), 1.802.25 (m, 7H), 
2.282.45 (m, 2H), 2.832.88 (m, 4H), 4.01 (dd, J = 9.0, 1.5 
Hz, 1H), 4.12 (dd, J = 9.0, 5.7, 1H), 4.55 (d, J = 9.0 Hz, 
1H), 4.92 (d, J = 5.7 Hz, 1H), 7.217.30 (m, 5H); 13C NMR 
(CDCl
3
, 75.4 MHz):  = 24.5 (CH2), 25.0 (CH2), 26.3 (2 CH2), 
26.6 (CH2), 27.6 (CH3), 31.2 (CH2), 38.3 (CH2), 39.2 (CH), 
48.8 (C), 58.6 (CH), 73.6 (CH2), 92.5 (CH), 126.0 (CH), 127.2 
(CH), 128.2 (CH), 141.2 (C), 166.8 (C); IR (film):  = 1651 
cm
-1
; elemental analysis calcd (%) for C20H27NO2S2: C, 63.62; H, 
7.21; N, 3.71; found: C, 63.73; H, 7.32; N, 3.67. 8e (higher 
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Rf): m.p. 170172 
o
C (THFEt2O); []
22
D –73.8 (c 0.5, MeOH); 
1
H 
NMR (CDCl
3
, 300 MHz):  = 1.581.60 (m, 3H), 1.62 (s, 3H), 
1.932.07 (m, 6H), 2.40 (m, 1H), 2.59 (dd, J = 19.5, 4.8 Hz, 
1H), 2.832.87 (m, 4H), 3.74 (dd, J = 8.7, 7.8 Hz, 1H), 4.48 
(dd, J = 8.7, 7.8 Hz, 1H), 4.71 (d, J = 6.9 Hz, 1H), 5.24 (t, 
J = 7.8 Hz, 1H), 7.257.31 (m, 5H); 13C NMR (CDCl
3
, 75.4 MHz): 
 = 23.8 (CH2), 25.3 (CH2), 26.5 (2 CH2), 27.3 (CH2), 27.8 
(CH3), 31.5 (CH2), 38.6 (CH2), 39.9 (CH), 49.0 (C), 58.2 (CH), 
72.5 (CH2), 92.9 (CH), 126.0 (CH), 127.5 (CH), 128.7 (CH), 
139.4 (C), 168.5 (C); IR (film):  = 1657 cm-1; elemental 
analysis calcd (%) for C20H27NO2S2: C, 63.62, H, 7.21; N, 3.71; 
found: C, 63.67; H, 7.42; N, 3.77. 
Method B. Operating as in the above Method B, from methyl 
4-formyl-6-(2-methyl-1,3-dithian-2-yl)hexanoate
[2]
 (1e; 200 
mg, 0.7 mmol), (R)-phenylglycinol (3.3 g, 24.4 mmol), and 
anhydrous Na2SO4 (13.5 g, 95 mmol) in Et2O (80 mL), lactams 8e 
(16.7 mg, 8%) and 7e (99.3 mg, 45%) were obtained after 
column chromatography (SiO2 previously washed with 8:2 
hexaneEt3N; 1:1 hexaneEtOAc as eluent). 
(3R,8R,8aR)- and (3R,8S,8aS)-8-Allyl-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (7f and 8f). 
Operating as in the above Method B, from methyl 4-formyl-6-
heptenoate
[3]
 (1f; 4.6 g, 29 mmol), (R)-phenylglycinol (3.97 
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g, 29 mmol), and anhydrous Na2SO4 (17 g) in Et2O (115 mL), 
lactams 7f (5.3 g, 71%) and 8f (753 mg, 10%) were obtained 
after column chromatography (3:1 hexaneEtOAc to EtOAc). 7f: 
[]22D 32,8 (c 1.0, EtOH); 
1
H NMR (CDCl3, 300 MHz, COSY, 
HETCOR):  = 1.45 (dddd, J = 13.8, 13.8, 12.0, 7.2 Hz, 1H, H-
7), 2.02 (m, 3H, H-7, H-8, CH2), 2.30 (ddd, J = 18.0, 12.0, 
6.6 Hz, 1H, H-6), 2.42 (ddd, J = 18.0, 7.2, 1.8 Hz, 1H, H-6), 
2.62 (m, 1H, CH2), 4.02 (dd, J = 9.0, 1.2 Hz, 1H, H-2), 4.10 
(dd, J = 9.0, 6.9 Hz, 1H, H-2), 4.54 (d, J = 8.7 Hz, 1H, H-
8a), 4.92 (d, J = 6.6 Hz, 1H, H-3), 5.12 (m, 2H, CH2), 5.86 
(dddd, J = 16.5, 10.2, 7.8, 6.0 Hz, 1H, CH), 7.207.30 (m, 
5H, ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  23.5 (CH), 31.1 
(CH =2), 35.3 (CH2), 38.9 (CH), 58.8 (CH), 73.5 (CH2), 91.7 
(CH), 117.2 (CH2), 126.0 (CH), 128.2 (CH), 127.1 (CH), 134.4 
(CH), 141.2 (C), 166.9 (C); IR (film):  = 1655 cm-1; 
elemental analysis calcd (%) for C16H19NO2·1/4 H2O: C, 73.40, 
H, 7.51, N, 5.35; found: C, 73.71, H, 7.25, N, 5.41. 8f: 
[]22D 59.9 (c 1.06, EtOH); 
1
H NMR (CDCl3, 300 MHz, COSY, 
HETCOR):  = 1.53 (m, 1H, H-7), 1.66 (m, 1H, H-8), 1.96 (m, 
1H, H-7), 2.07 (dt, J = 16.5, 8.4 Hz, 1H, CH2), 2.35 (ddd, J 
= 18.6, 12.0, 6.6 Hz, 1H, H-6), 2.56 (m, 2H, H-6, CH2 ), 3.76 
(dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.48 (dd, J = 9.0, 8.1 Hz, 
1H, H-2), 4.71 (d, J = 8.4 Hz, 1H, H-8a), 5.13 (m, 2H, CH2), 
5.25 (t, J = 7.8 Hz, 1H, H-3), 5.83 (dddd, J = 16.5, 10.2, 
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8.1, 6.0 Hz, 1H, CH), 7.257.34 (m, 5H, ArH); 13C NMR (CDCl3, 
75.4 MHz, HETCOR):  = 22.8 (CH2), 31.4 (CH2), 35.9 (CH2), 
39.6 (CH), 58.3 (CH), 72.4 (CH2), 92.0 (CH), 117.4 (CH2), 
126.0 (CH), 128.6 (CH), 127.5 (CH), 134.6 (CH), 139.4 (C), 
168.6 (C); IR (film):  = 1658 cm-1; elemental analysis calcd 
(%) for C16H19NO2·1/4 H2O: C, 73.40, H, 7.51, N, 5.35; found: 
C, 73.27; H, 7.25; N, 5.51. 
(3R,8S,8aR)- and (3R,8R,8aR)-8-Ethyl-5-oxo-3,8a-diphenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (8a-epi-7g 
and 8g). Operating as in the general procedure, from 4-
benzoylhexanoic acid (1g; 1 g, 4.5 mmol) and (R)-
phenylglycinol (623 mg, 4.5 mmol) in toluene (9 mL) for 72 h, 
lactams 8g (580 mg, 41%) and 8a-epi-7g (125 mg, 9%) were 
obtained after flash chromatography (gradient 4:6 Et2Ohexane 
to Et2O). 8a-epi-7g: m.p. 115117
o
C (THFhexane); []22D +22.9 
(c 0.63, MeOH); 
1
H NMR (CDCl
3
, 300 MHz, COSY, HETCOR):  = 
0.95 (t, J = 8.1 Hz, 3H, CH3), 1.11 (m, 1H, CH2), 1.67 (m, 2H, 
H-7), 1.962.05 (m, 2H, H-8, CH2), 2.39 (ddd, J = 11.4, 6.3, 
4.5 Hz, 1H, H-6), 2.48 (ddd, J = 11.4, 4.5, 1.2 Hz, 1H, H-6), 
3.54 (t, J = 5.4 Hz, H-2), 4.34 (dd, J = 5.4, 4.8 Hz, 1H, H-
2), 5.13 (dd, J = 5.4, 4.8 Hz, 1H, H-3), 7.127.18 (m, 4H, 
ArH), 7.327.37 (m, 4H, ArH), 7.467.48 (m, 2H, ArH); 13C NMR 
(CDCl
3
, 75.4 MHz):  = 11.7 (CH3), 17.9 (CH2), 18.4 (CH2), 
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27.2 (CH2), 44.7 (CH), 61.2 (CH), 69.6 (CH2), 99.2 (C), 126.9 
(CH), 127.7 (CH), 127.3 (CH), 128.2 (CH), 127.9 (CH), 128.0 
(CH), 138.0 (C), 143.0 (C), 170.9 (C); IR (film):  = 1659 
cm
-1
; elemental analysis calcd (%) for C21H23NO·1/4H2O: C, 
77.39; H, 7.27; N, 4.30; found: C, 77.55; H, 7.18; N, 4.16. 
HMRS calcd for C21H23NO 321.1716, found: 321.1728. 8g: []
22
D 
+30.0 (c 0.47, MeOH); 
1
H NMR (CDCl
3
, 300 MHz, COSY, HETCOR):  
= 0.58 (m, 1H, CH2), 0.90 (t, J = 4.5 Hz, 3H, CH3), 1.40 (m, 
1H, H-7), 1.731.87 (m, 3H, H-7, H-8, CH2), 2.53 (ddd, J = 
11.4, 6.0, 5.1 Hz, 1H, H-6), 2.74 (dd, J = 11.4, 5.1 Hz, 1H, 
H-6), 3.63 (t, J = 5.4 Hz, H-2), 4.40 (dd, J = 5.4, 4.8 Hz, 
1H, H-2), 5.22 (t, J = 5.4 Hz, 1H, H-3), 6.91 (m, 2H, ArH), 
7.10 (m, 2H, ArH), 7.337.40 (m, 6H, ArH); 13C NMR (CDCl
3
, 
75.4 MHz):  = 11.5 (CH3), 20.4 (CH2), 22.9 (CH2), 31.1 (CH2), 
46.8 (CH), 61.0 (CH), 70.0 (CH2), 98.8 (C), 127.4 (CH), 127.7 
(CH), 127.2 (CH), 128.3 (CH), 127.9 (CH), 128.0 (CH), 137.9 
(C), 138.1 (C), 170.2 (C); IR (film):  = 1658 cm-1; HMRS 
calcd for C21H23NO2 321.1717, found 321.1728. 
(3R,8S,8aR)- and (3R,8R,8aS)-8-Ethyl-8a-methyl-5-oxo-3-
phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (7h 
and 8h). Operating as in the general procedure, from 4-ethyl-
5-oxohexanoic acid
[4]
 (1h, 2.9 g, 18.5 mmol) and (R)-
phenylglycinol (2.5 g, 18.5 mmol) in toluene (37 mL) for 24 
h, lactams 7h (622 mg, 13%) and 8h (2.2 g, 47%) were obtained 
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after flash chromatography (SiO2 previously washed with 
hexaneEt3N; gradient 9:1 hexaneEtOAc to EtOAc). 7h: m.p. 
9092 oC (THFhexane); []22D –1.82 (c 0.86, MeOH); 
1
H NMR 
(CDCl3, 300 MHz):  = 1.04 (t, J = 7.0 Hz, 3H), 1.25 (m, 1H), 
1.31 (s, 3H), 1.46 (m, 1H), 1.83 (m, 2H), 2.06 (m, 1H), 2.33 
(ddd, J = 18.0, 9.0, 9.0 Hz, 1H), 2.40 (ddd, J = 18.5, 9.0, 
3.0 Hz, 1H), 3.88 (dd, J = 9.0, 1.8 Hz, 1H), 4.42 (dd, J = 
9.0, 7.2 Hz, 1H), 4.92 (dd, J = 7.2, 1.8 Hz, 1H), 7.177.32 
(m, 5H); 
13
C NMR (CDCl3, 75.4 MHz):  11.8 (CH =3), 17.9 (CH3), 
22.7 (CH2), 23.4 (CH2), 30.0 (CH2), 45.6 (CH), 58.9 (CH), 71.1 
(CH2), 95.2 (C), 126.0 (CH), 127.0 (CH), 128.2 (CH), 141.5 
(C), 166.9 (C); IR (KBr):  = 1650 cm-1; elemental analysis 
calcd (%) for C16H21NO2: C, 74.10, H, 8.16; N, 5.40; found: C, 
74.24; H, 8.24; N, 5.41. 8h: []22D –160.5 (c 0.89, MeOH); 
1
H 
NMR (CDCl3, 300 MHz):  = 1.01 (t, J = 7.2 Hz, 3H), 1.24 (m, 
1H), 1.30 (s, 3H), 1.51 (m, 2H), 1.75 (m, 1H), 2.02 (m, 1H), 
2.44 (dd, J = 18.0, 9.3 Hz, 1H), 2.61 (ddd, J = 18.0, 9.3, 
2.1 Hz, 1H), 3.92 (dd, J = 9.0, 8.1 Hz, 1H), 4.46 (dd, J = 
9.0, 8.1 Hz, 1H), 5.33 (t, J = 8.1 Hz, 1H), 7.197.35 (m, 
5H); 
13
C NMR (CDCl3, 75.4 MHz):  = 11.7 (CH3), 18.5 (CH3), 
21.8 (CH2), 23.0 (CH2), 30.5 (CH2), 46.2 (CH), 58.6 (CH), 69.3 
(CH2), 95.8 (C), 125.1 (CH), 126.7 (CH), 128.2 (CH), 139.6 
(C), 168.9 (C); IR (film):  = 1653 cm-1; elemental analysis 
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calcd (%) for C16H21NO2: C, 74.10; H, 8.16; N, 5.41; found: C, 
74.39; H, 8.23; N, 5.57. 
(3R,7aS,11aR)- and (3R,7aR,11aS)-5-Oxo-3-phenyl-
2,3,5,6,7,7a,8,9,10,11-decahydrooxazolo[3,2-j]quinoline (7i 
and 8i). Operating as in the general procedure, from 3-(2-
oxocyclohexyl)propanoic acid
[4]
 (1i; 326 mg, 1.9 mmol) and 
(R)-phenylglycinol (526 mg, 3.8 mmol) in toluene (4 mL) for 
36 h, lactams 7i (61 mg, 12%) and 8i (300 mg, 58%) were 
obtained after flash chromatography (SiO2 previously washed 
with hexaneEt3N; gradient 4:6 hexaneEt2O to Et2O). 7i (lower 
Rf): []
22
D –21.9 (c 1.12, MeOH);
 1
H NMR (CDCl3, 300 MHz):  
1.41 =1.79 (m, 7H), 1.952.22 (m, 4H), 2.32 (dd, J = 18.0, 
8.5 Hz, 1H), 2.42 (ddd, J = 18.0, 8.5, 3.0 Hz, 1H), 3.91 (dd, 
J = 9.2, 1.7 Hz, 1H), 4.39 (dd, J = 9.2, 7.2 Hz, 1H), 4.94 
(dd, J = 7.2, 1.7 Hz, 1H), 7.267.30 (m, 5H); 13C NMR (CDCl3, 
75.4 MHz):  = 19.2 (CH2), 22.2 (CH2), 22.6 (CH2), 27.5 (CH2), 
29.5 (CH2), 30.5 (CH2), 38.6 (CH), 59.4 (CH), 71.0 (CH2), 94.2 
(C), 126.3 (CH), 127.3 (CH), 128.5 (CH), 142.0 (C), 167.4 
(C); IR (film):  = 1655 cm-1; HMRS calcd for C17H21NO2 
271.1578, found: 271.1572. 8i (higher Rf): m.p. 9092 
o
C 
(Et2Ohexane); []
22
D –129.0 (c 1.5, MeOH); 
1
H NMR (CDCl3, 300 
MHz):  = 1.401.74 (m, 8H), 1.85 (dm, J = 14.0 Hz, 1H), 1.93 
(m, 1H), 2.14 (m, 1H), 2.48 (ddd, J = 18.5, 10.4, 8.0 Hz, 
1H), 2.65 (dd, J = 18.5, 7.6 Hz, 1H), 3.87 (dd, J = 8.8, 8.0 
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Hz, 1H), 4.50 (t, J = 8.8 Hz, 1H), 5.34 (t, J = 8.0 Hz, 1H), 
7.167.31 (m, 5H); 13C NMR (CDCl3, 75.4 MHz):  = 19.5 (CH2), 
22.3 (CH2), 22.4 (CH2), 27.8 (CH2), 30.1 (CH2), 31.0 (CH2), 
39.5 (CH), 58.6 (CH), 69.5 (CH2), 94.6 (C), 125.2 (CH), 127.0 
(CH), 128.4 (CH), 140.0 (C), 169.3 (C); IR (film):  = 1655 
cm
-1
; X-ray crystal structure: see reference 5; elemental 
analysis calcd (%) for C17H21NO2: C, 75.25; H, 7.80, N, 5.16; 
found: C, 75.11; H, 7.91; N, 5.19. 
(3R,8S,8aR)- and (3R,8R,8aR)-8-(tert-Butylsilyloxy)-5-oxo-3-
phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (7j 
and 8-epi-7j). Operating as in the general procedure, from 
methyl 4-(tert-butyldimethylsilyloxy)-5-oxopentanoate
[6]
 (1j; 
1.08 g, 4.15 mmol) and (R)-phenylglycinol (0.64 g, 4.57 mmol) 
in toluene (15 mL) at reflux for 16 h, lactam 7j (420 mg, 
30%), its C8-epimer (285 mg, 20%), and minor amounts of 8j 
(undetermined stereochemistry at C8) were obtained after 
flash chromatography (SiO2 previously washed with hexaneEt3N; 
gradient 1:1 hexaneEtOAc to EtOAc as eluent). 7j: []22D 
+43.6 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 300 MHz, COSY, HETCOR):  
= 0.17 (s, 3H, CH3), 0.18 (s, 3H, CH3), 0.93 (s, 9H, CH3), 
1.82 (dddd, J = 13.8, 10.2, 10.2, 7.2 Hz, 1H, H-7), 2.03 (m, 
1H, H-7), 2.34 (ddd, J = 17.5, 10.2, 6.6 Hz, 1H, H-6), 2.45 
(ddd, J = 17.5, 7.2, 4.0 Hz, 1H, H-6), 3.96 (ddd, J = 10.2, 
7.2, 5.4 Hz, 1H, H-8), 4.04 (dd, J = 9.0, 1.2 Hz, 1H, H-2), 
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4.14 (dd, J = 9.0, 6.6 Hz, 1H, H-2), 4.64 (d, J = 7.2 Hz, 1H, 
H-8a), 4.04 (dd, J = 9.0, 1.2 Hz, 1H, H-2), 4.14 (dd, J = 
9.0, 6.6 Hz, 1H, H-2), 4.64 (d, J = 7.2 Hz, 1H, H-8a), 4.90 
(dd, J = 6.6, 1.2 Hz, 1H, H-3), 7.27 (m, 5H, ArH); 
13
C NMR 
(CDCl3, 75.4 MHz, HETCOR):  = 4.8 (CH3), 4.5 (CH3), 18.1 
(CH3), 25.7 (CH3), 28.3 (CH2), 30.2 (CH2), 58.8 (CH), 70.3 
(CH), 73.7 (CH2), 92.1 (CH), 126.3 (CH), 127,4 (CH), 128.4 
(CH), 141.1 (CH), 168.8 (C); IR (film):  = 1665 cm-1; 
elemental analysis calcd (%) for C19H19NO3Si: C, 65.67, H, 
8.41, N, 4.03; found: C, 65.67; H, 8.56; N, 4.02. 8-epi-7j: 
[]22D 6.8 (c 1.1, CHCl3);
 1
H NMR (CDCl3, 300 MHz, COSY, 
HETCOR):  =  0.7 (s, 3H, CH3), 0.17 (s, 3H, CH3), 0.97 (s, 
9H, CH3), 1.88 (m, 1H, H-7), 2.00 (m, 1H, H-7), 2.28 (ddd, J 
= 18.0, 6.3, 1.2 Hz, 1H, H-6), 2.58 (ddd, J = 18.0, 12.6, 7.0 
Hz, 1H, H-6), 3.98 (dd, J = 8.5, 1.2 Hz, 1H, H-2), 4.15 (dd, 
J = 8.5, 7.2 Hz, 1H, H-2), 4.42 (m, 1H, H-8), 4.78 (d, J = 
1.8 Hz, 1H, H-8a), 4.89 (dd, J = 7.2, 1.2 Hz, 1H, H-3), 7.19
7.45 (m, 5H, ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 5,2 
(CH3), 4,4 (CH3), 18.4 (CH3), 25.8 (CH3), 26.4 (CH2), 26.9 
(CH2), 58.2 (CH), 64.5 (CH), 73,8 (CH2), 89.7 (CH), 126.3 
(CH), 127.1 (CH), 128.1 (CH), 141.5 (C), 167.1 (C); IR 
(film):  = 1661 cm-1; elemental analysis calcd (%) for 
C19H19NO3Si: C, 65.67, H, 8.41, N, 4.03; found: C, 65.39; H, 
8.45; N, 4.15.  
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(3R,8S,8aR)- and (3R,8S,8aS)-8-Acetoxy-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (7k and 8a-
epi-8k). Operating as in the general procedure, from (R)-
phenylglycinol (344 mg, 2.42 mmol) and methyl 4-acetoxy-5-
oxopentanoate
[6] 
(1k, 380 mg, 2.02 mmol) in toluene (6 mL) for 
24 h, a mixture of lactams 7k, 8a-epi-7k and 8a-epi-8k in 
5:2:2 ratio (248 mg, 45%) was obtained. Flash chromatography 
(SiO2 previously washed with hexaneEt3N; gradient 1:1 hexane
EtOAc to EtOAc as eluent) afforded pure 7k and 8a-epi-8k. 7k: 
1
H NMR (CDCl3, 300 MHz, COSY, HETCOR):  = 2.15 (s, 3H, CH3), 
3.85 (dd, J = 8.1, 2.7 Hz, 1H, H-3), 4.08 (dd, J = 9.0, 1.5 
Hz, 1H, H-2), 4.19 (dd, J = 9.0, 6.6 Hz, 1H, H-2), 4.92 (d, J 
= 7.5 Hz, 1H, H-8a), 5.15 (ddd, J = 9.6, 7.5, 5.1 Hz, 1H, H-
8); 
13
C NMR (CDCl3, 75.4 MHz):  = 20.9 (CH3), 24.4 (CH2), 29.8 
(CH2), 58.6 (CH), 70.8 (CH), 74.0 (CH2), 89.0 (CH), 170.0 (C), 
174.5 (C); IR (film):  = 1655, 1738 cm-1. 8a-epi-8k: 1H NMR 
(CDCl3, 600 MHz, COSY, HETCOR):  = 1.82 (s, 3H, CH3), 3.86 
(dd, J = 7.8, 1.8 Hz, 1H, H-2), 4.52 (dd, J = 8.4, 6.6 Hz, 
1H, H-2), 4.91 (dd, J = 6.6, 1.8 Hz, 1H, H-3), 5.31 (dd, J = 
8.4, 5.4 Hz, 1H, H-8), 5.58 (bs, 1H, H-8a), 7.177.36 (m, 5H, 
ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 23.0 (CH2), 23.6 
(CH3), 27.8 (CH2), 61.0 (CH), 76.3 (CH2), 78.0 (CH), 91.2 
(CH), 169.6 (C), 177.3 (C); IR (film):  = 1655, 1774 cm-1. 
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 (3R,8R,8aS)- and (3R,8S,8aS)-8a-(Benzyloxymethyl)-8-[(2-
methoxyethoxy)methoxy]-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-
5H-oxazolo[3,2-a]pyridine (8l and 8-epi-8l). Operating as in 
the general procedure, from 6-(benzyloxy)-4-[(2-
methoxyethoxy)methoxy]-5-oxohexanoic acid
[6] 
(1l; 6 g, 17.6 
mmol) and (R)-phenylglycinol (2.9 g, 21.2 mmol) in toluene 
(180 mL) for 12 h, a mixture of lactams 8l and its C8 epimer 
(5.6 g, 72%, 3:2 ratio), and lactam 7l (191 mg, 2%) were 
obtained after flash chromatography (6:4 hexaneEtOAc to 
EtOAc). 8l: 1H NMR (CDCl3, 200 MHz, selected resonances)  = 
3.38 (s, 3H), 3.57 (m, 2H), 3.73 (m, 2H), 3.96 (dd, J = 8.8, 
6.8 Hz, 1H), 4.50 (d, J = 9.5 Hz, 1H); 4.53 (dd, J = 8.8, 6.8 
Hz, 1H), 4.56 (s, 2H), 4.83 (d, J = 6.6 Hz, 1H), 4.97 (dd, J 
= 8.0, 3.5 Hz, 1H), 5.03 (d, J =  6.6 Hz, 1H); 
13
C NMR (CDCl3, 
50.3 MHz):  = 22.5 (CH2), 29.2 (CH2), 58.9 (CH3), 59.1 (CH), 
67.0 (CH2), 68.1 (CH2), 70.9 (CH2), 71.5 (CH2), 73.3 (CH2), 
76.0 (CH), 93.7 (C), 94.5 (CH2), 125.8 (CH), 127.1 (CH), 
127.6 (CH), 128.2 (CH), 125.3 (CH), 127.7 (CH), 137.1 (C), 
139.6 (C), 169.2 (C). 8-epi-8l: 1H NMR (CDCl3, 300 MHz):  = 
2.20 (m, 2H), 2.47 (m, 2H), 3.38 (d, J =10.4 Hz, 1H), 3.40 
(s, 3H), 3.48 (d, J =10.4 Hz, 1H), 3.58 (m, 2H), 3.73 (m, 
2H), 4.09 (dd, J = 8.8, 5.8 Hz, 1H), 4.38 (d, J = 12.2 Hz, 
1H), 4.40 (dd, J = 8.8, 7.4 Hz, 1H), 4.45 (masked, 1H), 4.68 
(d, J = 12.2 Hz, 1H), 4.80 (d, J = 7.0 Hz, 1H), 4.92 (d, J = 
7.0 Hz, 1H), 5.43 (dd, J = 7.4, 5.8 Hz, 1H), 7.30 (m, 10H); 
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13
C NMR (CDCl3, 75.4 MHz):  = 21.8 (CH2), 26.4 (CH2), 58.8 
(CH), 58.9 (CH3), 66.9 (CH2), 70.3 (CH2), 70.7 (CH), 71.5 
(CH2), 71.6 (CH2), 73.3 (CH2), 95.0 (C), 95.6 (CH2), 127.1 
(CH), 127.6 (CH), 128.3 (CH), 128.5 (CH), 127.3 (CH), 127.8 
(CH), 137.5 (C), 139.7 (C), 170.2 (C). 7l: 22D –32.8 (c 1.0, 
CHCl3); 
1
H NMR (CDCl3, 300 MHz, COSY, HETCOR):  = 1.96 (m, 
1H, H-7), 2.11 (m, 1H, H-7), 2.36 (m, 2H, H-6), 3.39 (s, 3H, 
CH3), 3.59 (m, 2H, CH2), 3.62 (d, J = 10.0 Hz, 1H, CH2), 3.73 
(m, 2H, CH2), 3.89 (dd, J = 8.7, 2.5 Hz, 1H, H-2), 3.91 (d, J 
= 10.0 Hz, 1H, CH2), 4.15 (dd, J = 11.1, 6.7 Hz, 1H, H-8), 
4.50 (dd, J = 8.7, 7.8 Hz, H-2), 4.54 (s, 2H, CH2), 4.81 (d, 
J = 6.9 Hz, 1H, CH2), 4.97 (dd, J = 7.8, 2.5 Hz, 1H, H-3), 
5.02 (d, J = 6.9 Hz, 1H, CH2), 7.29 (m, 10H, ArH); 
13
C NMR 
(CDCl3, 75.4 MHz):  = 23.9 (CH2), 29.7 (CH2), 58.8 (CH3), 
59.8 (CH), 66.9 (CH2), 69.2 (CH2), 71.5 (CH2), 73.4 (CH2), 
73.5 (CH2), 76.2 (CH), 93.8 (C), 94.7 (CH2), 126.1 (CH), 127.2 
(CH), 128.2 (CH), 128.3 (CH), 127.3 (CH), 127.5 (CH), 137.3 
(C), 141.1 (C), 167.3 (C). 
Methyl (3R,7S,8aR)- and (3R,7R,8aS)-5-Oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine-7-acetate 
(9m and 10m). Operating as in the general procedure, from 
(R)-phenylglycinol (39.6 mg, 0.29 mmol) and dimethyl 3-(2-
oxoethyl)glutarate
[7]
 (1m, 70 mg, 0.35 mmol) in toluene (15 
mL) for 8 h, lactams 9m (19.6 mg, 20%) and 10m (60.2 mg, 75%) 
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were obtained after flash chromatography (Et2O). 10m (higher 
Rf): []
22
D –77.2 (c, 0.55, MeOH); 
1
H NMR (CDCl3, 500 MHz):  = 
1.36 (td, J = 12.5, 9.5 Hz, 1H), 2.04 (dd, J = 17.5, 7.5 Hz, 
1H), 2.352.46 (m, 4H), 2.66 (ddd, J = 17.5, 5.0, 1.5 Hz, 
1H), 3.67 (s, 3H), 3.75 (dd, J = 9.0, 8.0 Hz, 1H), 4.48 (dd, 
J = 9.0, 8.0 Hz, 1H), 5.00 (dd, J = 9.5, 6.0 Hz, 1H), 5.20 
(t, J = 8.0 Hz, 1H), 7.237.33 (m, 5H); 13C NMR (CDCl3, 75.4 
MHz):  = 26.6 (CH), 34.4 (CH2), 37.6 (CH2), 39.6 (CH2), 51,7 
(CH3), 57.9 (CH), 72.6 (CH2), 87.9 (CH), 126.0 (CH), 127.6 
(CH), 128.7 (CH), 139.2 (C), 167.6 (C), 171.7 (C); IR (film): 
 = 1732, 1677 cm-1; elemental analysis calcd (%) for 
C16H19NO4: C, 65.60; H, 6.83; N, 4.43; found: C, 65.42; H, 
6.62; N, 4.84. 9m (lower Rf): []
22
D –56.0 (c, 0.74, MeOH); 
1
H 
NMR (CDCl3, 500 MHz):  1.55 (td, = J = 12.0, 9.0 Hz, 1H), 
1.96 (dd, J = 17.5, 10.5 Hz, 1H), 2.382.45 (m, 3H), 2.46 
(dm, J = 12.0 Hz, 1H), 2.51 (ddd, J = 17.5, 5.0, 1.0 Hz, 1H), 
3.67 (s, 3H), 3.99 (dd, J = 9.0, 1.0 Hz, 1H), 4.14 (dd, J = 
9.0, 7.0 Hz, 1H), 4.86 (m, 2H), 7.247.32 (m, 5H); 13C NMR 
(CDCl3, 75.4 MHz):  = 27.4 (CH), 34.2 (CH2), 37.5 (CH2), 39.9 
(CH2), 51.7 (CH3), 58.6 (CH), 73.9 (CH2), 88.1 (CH), 126.3 
(CH), 127.5 (CH), 128.5 (CH), 141,2 (C), 165.8 (C), 171.7 
(C); IR (film):  = 1732, 1677 cm-1; HMRS calcd for C16H19NO4 
289.1319, found 289,1314. 
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Ethyl (3R,7S,8aR)- and (3R,7R,8aS)-8a-Methyl-5-oxo-3-
phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine-7-
acetate (9n and 10n). Operating as in the general procedure, 
a mixture of (R)-phenylglycinol (2.7 g, 19.6 mmol), diethyl 
3-acetonylglutarate
[8]
 (1n; 4 g, 16.4 mmol), and a few drops 
of p-TsOH in toluene (33 mL) was stirred at reflux for 18 h. 
The solvent was eliminated under reduced pressure, and the 
residue was dissolved in EtOAc and washed with 5% aqueous 
NaHCO3. The aqueous layer was extracted with EtOAc, and the 
combined organic extracts were washed with brine, dried, and 
evaporated. Flash chromatography (1:9 hexane–EtOAc) of the 
residue afforded lactams 9n (912 mg, 16%) and 10n (3.4 g, 
61%). 9n: []22D –19.6 (c 0.35, MeOH); 
1
H NMR (CDCl
3
, 300 MHz): 
 = 1.26 (t, J = 7.2 Hz, 3H), 1.51 (s, 3H), 1.73 (t, J = 12.3 
Hz, 1H), 1.95 (dd, J = 20.0, 12.0 Hz, 1H), 2.36 (dd, J = 
12.3, 4.8 Hz, 1H), 2.39 (d, J = 6.3 Hz, 2H), 2.502.68 (m, 
2H), 3.96 (dd, J = 9.5, 2.0 Hz, 1H), 4.14 (m, 2H), 4.49 (dd, 
J = 9.5, 7.2 Hz, 1H), 4.92 (dd, J = 7.2, 2.0 Hz, 1H), 7.20
7.33 (m, 5H); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 14.1 (CH3), 23.5 
(CH3), 27.2 (CH), 36.9 (CH2), 40.6 (CH2), 40.9 (CH2), 58.8 
(CH), 60.6 (CH2), 71.4 (CH2), 93.0 (C), 126.2 (CH), 127.4 
(CH), 128.5 (CH), 141.4 (C), 165.9 (C), 171.4 (C); IR (film): 
 = 1666, 1739 cm-1; HMRS calcd for C18H23NO4 317.1627, found 
317.1627. 10n: m.p. 4951 oC (THFhexane); []22D –188.0 (c 
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1.05, MeOH); 
1
H NMR (CDCl
3
, 300 MHz):  = 1.27 (t, J = 7.2 Hz, 
3H), 1.47 (s, 3H), 1.53 (t, J = 12.6 Hz, 1H), 2.10 (dd, J = 
18.0, 10.2 Hz, 1H), 2.26 (ddd, J = 12.6, 2.7, 1.8 Hz, 1H), 
2.40 (d, J = 7.2 Hz, 2H), 2.60 (m, 1H), 2.83 (dd, J = 18.0, 
6.3 Hz, 1H), 3.96 (dd, J = 10.8, 8.1 Hz, 1H), 4.15 (m, 2H), 
4.52 (t, J = 9.0, 1H), 5.35 (t, J = 8.4 Hz, 1H), 7.177.35 
(m, 5H); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 14.1 (CH3), 24.0 (CH3), 
26.7 (CH), 37.3 (CH2), 40.4 (CH2), 41.3 (CH2), 58.4 (CH), 60.6 
(CH2), 69.7 (CH2), 93.5 (C), 125.4 (CH), 127.2 (CH), 128.6 
(CH), 139.7 (C), 168.6 (C), 171.3 (C); IR (film):  = 1665, 
1739 cm
-1
; X-ray crystal structure: see reference 5; elemental 
analysis calcd (%) for C18H23NO4: C, 68.12; H, 7.30; N, 4.41; 
found: C, 68.07; H, 7.35; N, 4.36. 
Ethyl (3R,7S,8S,8aR)- and (3R,7R,8R,8aS)-8-Ethyl-5-oxo-3-
phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine-7-
acetate (9o and 10o). Operating as in the general procedure, 
from (R)-phenylglycinol (21 mg, 0.15 mmol) and diethyl 3-(1-
formylpropyl)glutarate
[7]
 (1o; 40 mg, 0.15 mmol) in toluene (1 
mL) for 14 h, lactams 9o (30 mg, 61%) and 10o (9 mg, 16%) 
were obtained after flash chromatography (hexane). 9o: []22D 
25.3 (c 1.0, EtOH); 1H NMR (CDCl3, 500 MHz, COSY):  = 1.01 
(t, J = 7.2 Hz, 3H, CH3), 1.22 (t, J = 7.0 Hz, 3H, CH3), 1.65
1.77 (m, 3H, CH2, H-8), 2.12 (dd, J = 10.2, 5.2 Hz, 1H, H-6), 
2.18 (dd, J = 9.3, 5.2 Hz, 1H, CH2), 2.27 (m, 1H, H-7), 2.51 
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(dd, J = 9.3, 2.7 Hz, 1H, CH2), 2.53 (dd, J = 10.2, 3.6 Hz, 
H-6), 4.01 (dd, J = 8.5, 1.5 Hz, 1H, H-2), 4.10 (q, J = 7.0 
Hz, 2H, CH3), 4.15 (dd, J = 8.5, 7.0 Hz, 1H, H-2), 4.65 (d, J 
= 8.5 Hz, H-8a), 4.91 (dd, J = 6.5, 1.5 Hz, 1H, H-3), 7.21
7.33 (m, 5H, ArH); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 9.8 (CH3), 
14.2 (CH3), 21.6 (CH2), 31.2 (CH), 37.4 (CH2), 38.2 (CH2), 
44.1 (CH), 58.7 (CH), 60.7 (CH2), 70.4 (CH2), 90.7 (CH), 126.3 
(CH), 127.5 (CH), 128.5 (CH), 141.1 (C), 166.2 (C), 171.6 
(C); IR (film):  = 1731, 1665 cm-1; elemental analysis calcd 
(%) for C20H27NO4·1/4 H2O: C, 67.67; H, 7.94; N, 4.22; found: 
C, 67.94; H, 7.65; N, 4.17. 10o: []22D 46.1 (c 3.27, CHCl3); 
1
H NMR (CDCl
3
, 300 MHz):  = 1.02 (t, J = 7.5 Hz, 3H), 1.27 
(t, J = 7.8 Hz), 1.511.85 (m, 3H), 2.102.25 (m, 2H), 2.33 
(m, 1H), 2.60 (dd, J = 14.7, 3.6 Hz, 1H), 2.73 (dd, J = 17.0, 
4.8 Hz, 1H), 3.76 (dd, J = 8.7, 8.0 Hz, 1H), 4.114.19 (m, 
2H), 4.48 (dd, J = 8.0, 8.7 Hz, 1H), 4.81 (d, J = 8.7 Hz, 
1H), 5.26 (t, J = 8.0 Hz, 1H), 7.247.37 (m, 5H); 13C NMR 
(CDCl
3
, 75.4 MHz):  = 9.8 (CH3), 14.1 (CH3), 20.9 (CH2), 29.9 
(CH), 37.1 (CH2), 37.6 (CH2), 43.7 (CH), 58.2 (CH), 60.8 
(CH2), 72.5 (CH2), 90.8 (CH), 126.0 (CH), 127.6 (CH), 128.8 
(CH), 139.3 (C), 167.7 (C), 171.7 (C); IR (film):  = 1731, 
1665 cm
-1
. 
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Ethyl (3R,7S,8S,8aR)- and (3R,7R,8R,8aS)-8a-Methyl-5-oxo-3-
phenyl-8-propyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2a] 
pyridine-7-acetate (9p and 10p). Operating as in the general 
procedure, from (R)-phenylglycinol (384 mg, 2.8 mmol), ethyl 
3-(ethoxycarbonylmethyl)-4-propyl-5-oxohexanoate
[4]
 (1p; 670 
mg, 2.34 mmol), and AcOH (0.63 mL, 1.17 mmol) in toluene (5 
mL) for 24 h, lactams 9p (50 mg, 5%) and 10p (410 mg, 49%) 
were obtained after flash chromatography (hexane). 9p: []22D 
–17.5 (c 1.0, MeOH); 1H NMR (CDCl
3
, 300 MHz):  = 0.97 (t, J = 
6.9 Hz, 3H, CH3), 1.23 (t, J = 7.2 Hz, 3H), 1.40 (s, 3H), 
1.431.79 (m, 5H), 2.13 (dd, J = 17.7, 5.4 Hz, 1H), 2.182.28 
(m, 2H), 2.57 (m, 1H), 2.64 (dd, J = 17.7, 7.2 Hz, 1H), 3.97 
(dd, J = 9.3, 2.1 Hz, 1H), 4.09 (qd, J = 7.2, 2.4 Hz, 2H), 
4.44 (dd, J = 9.3, 6.9 Hz, 1H), 4.95 (d, J = 6.9 Hz, 1H), 
7.267.30 (m, 5H); 13C NMR (CDCl
3
, 75.4 MHz):  = 14.2 (CH3), 
14.5 (CH3), 18.8 (CH3), 22.2 (CH2), 32.9 (CH2), 33.1 (CH), 
36.7 (CH2), 40.0 (CH2), 48.8 (CH), 58.9 (CH), 60.7 (CH2), 71.3 
(CH2), 95.7 (C), 126.3 (CH), 127.3 (CH), 128.4 (CH), 141.3 
(C), 166.2 (C), 171.9 (C); IR (film):  = 1663, 1732 cm-1; 
HMRS calcd for C21H29NO4 359.2093, found 359.2096. 10p: []
22
D –
57.7 (c 0.88, MeOH); 
1
H NMR (CDCl
3
, 300 MHz, COSY, HETCOR):  
= 0.92 (t, J = 7.2 Hz, 3H, CH3), 1.28 (t, J = 6.9 Hz, 3H, 
CH3), 1.39 (s, 3H, CH3), 1.401.58 (m, 5H, CH2CH2, H-8), 2.18 
(dd, J = 17.5, 7.0 Hz, 1H, H-6), 2.22 (dd, J = 14.7, 9.6 Hz, 
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1H, CH2), 2.50 (m, 1H, H-7), 2.64 (dd, J = 14.7, 2.7 Hz, 1H, 
CH2), 2.82 (dd, J = 17.5, 6.6 Hz, 1H, H-6), 3.96 (dd, J = 
9.3, 7.2 Hz, 1H, H-2), 4.17 (q, J = 6.9 Hz, 2H, CH2), 4.41 
(dd, J = 9.3, 8.4 Hz, 1H, H-2), 5.31 (t, J = 7.2 Hz, 1H, H-
3), 7.217.36 (m, 5H, ArH); 13C NMR (CDCl
3
, 75.4 MHz):  = 
14.2 (CH3), 14.5 (CH3), 19.6 (CH3), 22.3 (CH2), 31.8 (CH2), 
31.9 (CH), 37.4 (CH2), 39.0 (CH2), 48.4 (CH), 58.7 (CH), 60.7 
(CH2), 69.6 (CH2), 96.4 (C), 125.6 (CH), 127.2 (CH), 128.5 
(CH), 139.5 (C), 168.1 (C), 171.9 (C); IR (film):  = 1738 
cm
-1
; HMRS calcd for C21H29NO4 359.2093, found 359.2096; 
elemental analysis calcd (%) for C21H29NO4: C, 70.17; H, 8.13; 
N, 3.90; found: C, 70.56; H, 8.06; N, 4.25. 
Methyl (3R,7S,8S,8aR)- and (3R,7R,8R,8aS)-8-Ethyl-8a-
methyl-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-
a]pyridine-7-acetate (9q and 10q). Operating as in the 
general procedure, a mixture of (R)-phenylglycinol (1.45 g, 
10 mmol), dimethyl 3-(1-ethyl-2-oxopropyl)pentadionate
[7]
 (1q; 
2.16 g, 8.85 mmol), and AcOH (0.25 mL, 4.4 mmol) in toluene 
(25 mL) was stirred at reflux for 66 h. The solvent was 
eliminated under reduced pressure, and the residue was 
dissolved in EtOAc and washed with 5% aqueous NaHCO3. The 
aqueous layer was extracted with EtOAc, and the combined 
organic extracts were washed with brine, dried, and 
evaporated. Flash chromatography (gradient 5:1 to 1:1 hexane
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EtOAc) afforded lactams 9q (530 mg, 18%) and 10q (1.83 g, 
63%). 10q : []22D +71.5 (c 0.63, CHCl3);
 1
H NMR (CDCl3, 400 
MHz, COSY, HETCOR):  = 1.06 (t, J = 7.2 Hz, 3H, CH3), 1.39 
(s, 3H, CH3), 1.421.55 (m, 2H, H-8, CH2), 1.591.67 (m, 1H, 
CH2), 2.20 (dd, J = 17.2, 7.2 Hz, 1H, H-6), 2.222.35 (m, 2H, 
H-7, CH2), 2.65 (dd, J = 14.8, 2.8 Hz, 1H, CH2), 2.80 (dd, J = 
17.2, 6.8 Hz, H-6), 3.71 (s, 3H, CH3O), 3.98 (dd, J = 8.8, 
6.8 Hz, 1H, H-2), 4.42 (dd, J = 8.8, 8.0 Hz, 1H, H-2), 5.32 
(dd, J = 8.0, 6.8 Hz, 1H, H-3), 7.237.27 (m, 3H, ArH), 7.31
7.35 (m, 2H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 13.6 
(CH3), 19.4 (CH3), 22.2 (CH2), 31.6 (CH), 37.2 (CH2), 38.5 
(CH2), 50.0 (CH), 51.6 (CH3), 58.4 (CH), 69.4 (CH2), 96.3 (C), 
125.4 (CH), 127.0 (CH), 128.3 (CH), 139.4 (C), 167.8 (C), 
172.1 (C); IR (film):  = 1658, 1735 cm-1; HMRS calcd for 
C19H25NO4 331.1784, found 331.1773; elemental analysis calcd 
(%) for C19H25NO4: C, 68.80; H, 7.60; N, 4.23; found: C, 68.04; 
H, 8.06; N, 4.15. 
Methyl (3R,8R,8aR)- and (3R,8S,8aS)-5-Oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine-8-propionate 
(9r and 10r). Operating as in the general procedure, from 
dimethyl 4-formylpimelate
[4]
 (1r; 500 mg, 2.3 mmol) and (R)-
phenylglycinol (317 mg, 2.3 mmol) in toluene (4.6 mL) for 20 
h, a mixture of lactams 9r (434.8 mg, 65%), and 10r (12 mg, 
2%, 9:1 ratio) were obtained after flash chromatography (SiO2 
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previously washed with 7:3 hexaneEt3N; 9:1 hexaneEtOAc as 
eluent). 9r: []22D –60.9 (c 0.8, MeOH); 
1
H NMR (CDCl
3
, 300 
MHz, COSY):  = 1.52 (dddd, J = 13.5, 11.5, 11.5, 6.5 Hz, 1H, 
H-7), 1.77 (m, 1H, H-1’), 1.91 (m, 1H, H-8), 1.99 (m, 1H, H-
7), 2.05 (m, 1H, H-1’), 2.32 (ddd, J = 18.0, 11.5, 6.5 Hz, 
1H, H-6), 2.42 (ddd, J = 18.0, 6.5, 2.5 Hz, 1H, H-6), 2.57 
(td, J = 9.0, 6.5 Hz, 2H, 2H-2’), 3.70 (s, 3H, CH3), 4.02 
(dd, J = 5.7, 2.0 Hz, 1H, H-2), 4.11 (dd, J = 9.5, 5.7 Hz, 
1H, H-2), 4.54 (d, J = 9.0 Hz, 1H, H-8a), 4.91 (d, J = 5.7 
Hz, 1H, H-3), 7.237.31 (m, 5H, ArH); 13C NMR (CDCl
3
, 75.4 
MHz):  = 24.4 (CH2), 26.8 (CH2), 30.9 (CH2), 31.2 (CH2), 38.6 
(CH), 51.4 (CH3), 58.5 (CH), 73.5 (CH2), 92.4 (CH), 126.0 
(CH), 127.2 (CH), 128.2 (CH), 141.1 (C), 166.8 (C), 173.4 
(C); IR (film)  = 1663, 1735 cm-1; elemental analysis calcd 
(%) for C17H21NO4: C, 65.61; H, 6.98; N, 4.62; found: C, 65.66; 
H, 7.01; N, 4.64. 10r: []22D –64.5 (c 0.4, MeOH); 
1
H NMR 
(CDCl
3
, 300 MHz, COSY):  = 1.501.82 (m, 3H, H-7, H-8, CH2), 
1.842.08 (m, 2H, H-7, CH2), 2.302.62 (m, 4H, H-6, CH2), 3.69 
(s, 3H, CH3), 3.73 (t, J = 8.1 Hz, 1H, H-2), 4.47 (t, J = 8.1 
Hz, 1H, H-2), 4.70 (d, J = 7.8 Hz, 1H, H-8a), 5.22 (t, J = 
8.1 Hz, 1H, H-3), 7.247.36 (m, 5H, ArH); 13C NMR (CDCl
3
, 75.4 
MHz):  = 23.8 (CH2), 27.5 (CH2), 31.2 (CH2), 31.4 (CH2), 39.1 
(CH), 51.6 (CH3), 58.0 (CH), 72.4 (CH), 92.8 (CH), 125.9 
(CH), 127.5 (CH), 128.6 (CH), 139.3 (C), 168.3 (C), 173.5 
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(C); IR (film):  = 1651, 1735 cm-1; HMRS calcd for C17H21NO4 
303.1468, found: 303.1470. 
Method B. A mixture of dimethyl 4-formylpimelate
[4]
 (1r; 640 
mg, 2.9 mmol), (R)-phenylglycinol (398 mg, 2.9 mmol), and 
anhydrous Na2SO4 (800 mg) in Et2O (10 mL) was stirred at 0 ºC 
for 2 h. The resulting suspension was filtered, and the 
filtrate was concentrated under reduced pressure. The residue 
was heated at 100 ºC for 4 h under vacuum (10-15 mm Hg). 
Column chromatography (SiO2 previously washed with 7:3 
hexaneEt3N; 9:1 hexaneEtOAc as eluent) of the residue 
afforded lactams 9r (497 mg, 58%) and 10r (50 mg, 6%). 
 Methyl (3R,8R,8aR)- and (3R,8S,8aS)-8-Ethyl-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine-8-propionate 
(9s and 10s). Operating as in the general procedure, from 
dimethyl 4-ethyl-4-formylpimelate
[9]
 (1s; 450 mg, 2.3 mmol) 
and (R)-phenylglycinol (272 mg, 1.9 mmol) in toluene (4 mL) 
for 24 h, a 1:1 mixture of lactam 10s and its C8-epimer 10s’ 
(higher Rf, 25 mg, 4%) and a 1:1 mixture of lactam 9s and its 
C8-epimer 9s’ (lower Rf, 225 mg, 37%) were obtained after 
flash chromatography (SiO2 previously washed with 7:3 hexane
Et3N; gradient 7:3 hexaneEtOAc to EtOAc as eluent). 9s: 
1
H 
NMR (CDCl
3
, 300 MHz, from a mixture of 9s and 9s’)  = 0.89 
(t, J = 7.5 Hz, 3H), 1.48 (ddd, J = 14.4, 8.1, 3.0 Hz, 1H), 
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1.561.64 (m, 3H), 1.73 (m, 1H), 1.81 (ddd, J = 14.4, 5.7, 
3.0 Hz, 1H), 2.15 (dd, J = 4.5, 2.1 Hz, 1H), 2.222.31 (m, 
2H), 2.57 (dd, J = 4.5, 3.0 Hz, 1H), 3.69 (s, 3H), 4.11 
(masked, 2H), 4.63 (s, 1H), 4.82 (t, J = 4.8 Hz, 1H), 7.21
7.41 (m, 5H); 
13
C NMR (CDCl
3
, 75.4 MHz, from a mixture of 9s 
and 9s’)  = 6.7 (CH3), 17.5 (CH2), 28.0 (CH2), 28.5 (CH2), 
28.6 (CH2), 28.9 (CH2), 37.9 (C), 51.5 (CH3), 57.7 (CH), 73.6 
(CH2), 94.9 (CH), 127.2 (CH), 127.3 (CH), 128.1 (CH), 140.8 
(C), 166.9 (C), 173.9 (C). 9s’: 1H NMR (CDCl
3
, 300 MHz, from a 
mixture of 9s and 9s’)  = 1.00 (t, J= 7.8 Hz, 3H), 1.51 
(masked, 1H), 1.561.64 (m, 3H), 1.73 (m, 1H), 1.92 (td, J= 
11.1, 5.4 Hz, 1H), 2.222.31 (m, 2H), 2.42 (ddd, J= 16.5, 
11.1, 5.4 Hz, 1H), 2.68 (ddd, J= 16.5, 11.1, 5.4 Hz, 1H), 
3.69 (s, 3H, CH3), 4.11 (dd, J= 6.9, 5.4 Hz, 2H), 4.63 (s, 
1H), 4.88 (dd, J= 5.4, 3.6 Hz, 1H), 7.217.41 (m, 5H); 13C NMR 
(CDCl
3
, 75.4 MHz, from a mixture of 9s and 9s’)  = 7.8 (CH3), 
22.5 (CH2), 28.4 (CH2), 28.5 (CH2), 28.6 (CH2), 31.2 (CH2), 
37.6 (C), 51.6 (CH3), 57.9 (CH), 73.6 (CH2), 94.8 (CH), 127.2 
(CH), 127.4 (CH), 128.2 (CH), 140.7 (C), 166.9 (C), 173.7 
(C); HMRS calcd for C19H25NO4 (a mixture of 9s and 9s’) 
331.1783, found 331,1774. 10s: 1H NMR (CDCl
3
, 300 MHz, from a 
mixture of 10s and 10s’)  = 0.66 (t, J = 7.8 Hz, 3H), 1.29
1.60 (m, 4H), 1.68 (td, J = 11.1, 5.7 Hz, 1H), 1.74 (td, J = 
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5.4, 1.5 Hz, 1H), 1.982.27 (m, 3H), 2.42 (td, J = 11.1, 5.7 
Hz, 1H), 3.46 (masked, 1H), 3.49 (s, 3H), 4.22 (dd, J = 14.4, 
7.5 Hz, 1H), 4.67 (s, 1H), 4.97 (dd, J = 14.4, 7.5 Hz, 1H), 
7.047.17 (m, 5H); 13C NMR (CDCl
3
, 75.4 MHz, from a mixture of 
10s and 10s’)  = 6.5 (CH3), 16.9 (CH2), 26.8 (CH2), 27.9 
(CH2), 28.9 (CH2), 31.4 (CH2), 38.0 (C), 51.6 (CH3), 58.0 
(CH), 72.3 (CH2), 94.6 (CH), 126.0 (CH), 127.5 (CH), 128.6 
(CH), 139.2 (C), 168.1 (C), 174.0 (C). 10s’: 1H NMR (CDCl
3
, 
300 MHz, from a mixture of 10s and 10s’)  = 0.79 (t, J= 7.8 
Hz, 3H), 1.291.60 (m, 4H), 1.771.86 (m, 2H), 1.982.27 (m, 
3H), 2.41 (masked, 1H), 3.49 (s, 3H), 3.55 (td, J= 7.5, 2.4 
Hz, 1H), 4.26 (dd, J= 9.3, 7.5 Hz, 1H), 4.65 (s, 1H), 5.05 
(dd, J= 17.0, 9.3 Hz, 1H), 7.047.17 (m, 5H); 13C NMR (CDCl
3
, 
75.4 MHz, from a mixture of 10s and 10s’)  = 8.0 (CH3), 21.7 
(CH2), 26.9 (CH2), 27.9 (CH2), 28.2 (CH2), 29.2 (CH2), 37.7 
(C), 51.6 (CH3), 58.1 (CH), 72.2 (CH2), 94.1 (CH), 125.9 (CH), 
127.5 (CH), 128.6 (CH), 139.3 (C), 168.0 (C), 173.9 (C). 
(4RS,9aSR)- and (4RS,9aRS)-6-Oxo-4-phenylperhydropyrido 
[2,1-b][1,3]oxazine (rac-24a and rac-24b). Operating as in 
the general procedure, from methyl 5-oxopentanoate (1a; 1.02 
g, 7.57 mmol) and 3-amino-3-phenyl-1-propanol
[10]
 (rac-19; 
1.29 g, 8.3 mmol) in toluene (20 mL) for 36 h, lactams rac-
24a (831 mg, 47%) and rac-24b (363 mg, 21%, 2.3:1 ratio) were 
obtained after flash chromatography (SiO2 previously washed 
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with 1:1 hexaneEt2NH; gradient 2:1 to 1:1 hexaneEtOAc as 
eluent). rac-24a: 1H NMR (CDCl3, 300 MHz, COSY, HETCOR):  = 
1.68 (m, 1H, H-8), 1.82 (m, 1H, H-9), 1.90 (m, 1H, H-9), 1.95 
(m, 1H, H-8), 2.242.25 (m, 2H, H-3), 2.49 (m, 2H, H-7), 3.82 
(td, J = 11.4, 4.2 Hz, 1H, H-2), 3.93 (ddd, J = 11.4, 4.8, 
2.4 Hz, 1H, H-2), 4.76 (t, J = 4.2 Hz, 1H, H-9a), 6.11 (bs, 
1H, H-4), 7.207.36 (m, 5H, ArH); 13C NMR (CDCl3, 75.4 MHz, 
HETCOR):  = 16.7 (CH2), 27.0 (CH2), 28.8 (CH2), 32.7 (CH2), 
48.7 (CH), 63.5 (CH2), 81.4 (CH), 126.3 (CH), 128.4 (CH), 
126.5 (CH), 138.1 (C), 169.5 (C); IR (film):  = 1650 cm-1; 
HMRS calcd for C14H17NO2 231.1259, found 231.1259. rac-24b: 
m.p. 8082 ºC (hexane); 1H NMR (CDCl3, 300 MHz, COSY, HETCOR): 
 = 1.701.83 (m, 2H, H-8, H-9), 1.95 (m, 1H, H-8), 1.98 
(dddd, J = 14.4, 6.4, 2.7, 1.2 Hz, 1H, H-3), 2.20 (m, 1H, H-
9), 2.41 (m, 2H, H-7), 2.58 (dddd, J = 14.4, 12.0, 7.5, 4.8 
Hz, 1H, H-3), 3.67 (ddd, J = 12.0, 10.2, 6.3 Hz, 1H, H-2), 
3.95 (m, 1H, H-2), 5.15 (dd, J = 9.0, 4.3 Hz, 1H, H-9a), 5.38 
(dd, J = 4.8, 2.7 Hz, 1H, H-4), 7.187.38 (m, 5H, ArH); 13C 
NMR (CDCl3, 75.4 MHz, HETCOR):  = 17.4 (CH2), 27.8 (CH2), 
29.6 (CH2), 31.9 (CH2), 53.2 (CH), 60.7 (CH2), 81.0 (CH), 
125.9 (CH), 128.0 (CH), 126.5 (CH), 141.5 (C), 168.6 (C); IR 
(KBr):  = 1642 cm-1; elemental analysis calcd (%) for 
C14H17NO2: C, 72.70; H, 7.41; N, 6.06; found: C, 72.58; H, 
7.29; N, 6.19. 
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9-Ethyl-6-oxo-4-phenylperhydropyrido[2,1-b][1,3]oxazine 
(rac-25). Operating as in the general procedure, from methyl 
4-formylhexanoate
[1]
 (1d; 725 mg, 4.59 mmol) and aminoalcohol 
rac-19[10] (769 mg, 5.05 mmol) in toluene (20 mL) for 36 h, 
lactams rac-25a (1:1 mixture of C9 epimers; 466 mg, 39%) and 
rac-25b (368 mg, 31%) were obtained after flash 
chromatography (3:1 to 1:2 hexaneEtOAc). rac-25a (9-H / 9a-H 
trans): m.p. 4950 ºC (hexane); 1H NMR (CDCl3, 300 MHz, COSY, 
HETCOR):  = 0.91 (t, J = 7.5 Hz, 3H, CH3), 1.27 (m, 1H, CH2), 
1.48 (m, 1H, H-9), 1.55 (m, 1H, H-8), 1.65 (m, 1H, CH2), 1.99 
(dddd, J = 14.4, 5.7, 5.7, 3.6 Hz, 1H, H-8), 2.232.37 (m, 
2H, H-3), 2.45 (ddd, J = 17.4, 9.5, 5.4 Hz, 1H, H-7), 2.61 
(ddd, J = 17.4, 5.4, 4.8 Hz, 1H, H-7), 3.77 (td, J = 11.4, 
4.2 Hz, 1H, H-2), 3.94 (dm, J = 11.4 Hz, 1H, H-2), 4.41 (d, J 
= 5.7 Hz, 1H, H-9a), 6.11 (bs, 1H, H-4), 7.187.39 (m, 5H, 
ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 11.2 (CH3), 21.5 
(CH2), 24.0 (CH2), 27.3 (CH2), 31.0 (CH2), 40.7 (CH), 48.5 
(CH), 63.5 (CH2), 86.6 (CH), 126.4 (CH), 128.7 (CH), 126.7 
(CH), 138.2 (C), 170.0 (C); IR (KBr):  = 1654 cm-1; elemental 
analysis calcd (%) for C16H21NO2 ·1/4 Et2O: C, 73.48; H, 8.52; 
N, 5.04; found: C, 73.45; H, 8.26; N, 5.24. rac-25a (9-H / 
9a-H cis): 
1
H NMR (CDCl3, 300 MHz, COSY, HETCOR):  = 0.86 (t, 
J =7.5 Hz, 3H, CH3), 1.32 (m, 1H, CH2), 1.42 (m, 1H, CH2), 
1.61 (m, 1H, H-9), 1.68 (m, 1H, H-8), 1.81 (qd, J = 13.0, 5.1 
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Hz, 1H, H-8), 2.22 (m, 1H, H-3), 2.32 (m, 1H, H-3), 2.45 
(ddd, J = 17.7, 12.3, 6.3 Hz, 1H, H-7), 2.63 (ddd, J = 17.7, 
4.8, 2.1 Hz, 1H, H-7), 3.87 (td, J = 11.5, 3.6 Hz, 1H, H-2), 
4.01 (ddd, J = 11.5, 4.2, 2.4 Hz, 1H, H-2), 4.56 (d, J = 3.3 
Hz, 1H, H-9a), 6.12 (d, J =4.2 Hz, 1H, H-4), 7.247.40 (m, 
5H, ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 11.4 (CH3), 
22.0 (CH2), 23.4 (CH2), 27.3 (CH2), 32.7 (CH2), 39.8 (CH), 
50.1 (CH), 64.5 (CH2), 83.2 (CH), 126.6 (CH), 128.6 (CH), 
126.7 (CH), 138.6 (C), 170.3 (C); IR (film):  = 1654 cm-1; 
elemental analysis calcd (%) for C16H21NO2: C, 74.10; H, 8.16; 
N, 5.40; found: C, 73.70; H, 8.29; N, 5.27. rac-25b: 1H NMR 
(CDCl3, 300 MHz, COSY, HETCOR):  = 0.99 (t, J =7.5 Hz, 3H, 
CH3), 1.22 (m, 1H, CH2), 1.43 (m, 1H, H-8), 1.68 (m, 1H, H-9), 
1.86 (m, 1H, CH2), 1.97 (m, 2H, H-3, H-8), 2.44 (m, 2H, H-7), 
2.56 (m, 1H, H-3), 3.64 (ddd, J = 12.3, 10.2, 6.6 Hz, 1H, H-
2), 3.92 (dd, J = 10.2, 8.1 Hz, 1H, H-2), 4.75 (d, J = 8.7 
Hz, 1H, H-9a), 5.40 (dd, J = 4.8, 2.4 Hz, 1H, H-4), 7.187.34 
(m, 5H, ArH); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 10.8 
(CH3), 22.6 (CH2), 23.6 (CH2), 27.6 (CH2), 31.6 (CH2), 41.0 
(CH), 53.1 (CH), 60.8 (CH2), 84.8 (CH), 125.9 (CH), 128.0 
(CH), 126.4 (CH), 141.6 (C), 168.5 (C); IR (film):  = 1650 
cm
-1
; HMRS calcd for C16H21NO2 259.1572, found 259.1572. 
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(6RS,11aSR)-6-Methyl-4-oxo-1,2,3,4,6,11a-hexahydropyrido 
[2,1-b]-1,3-benzoxazine (rac-26). Operating as in the 
general procedure, from methyl 5-oxopentanoate (1a; 500 mg, 
3.85 mmol) and 2-(1-aminoethyl)phenol
[11]
 (rac-20; 594 mg, 
4.33 mmol) in toluene (15 mL) for 24 h, lactam rac-26 (725 
mg, 88%) was obtained after flash chromatography (SiO2 
previously washed with 1:1 hexane-Et3N; 10:1 hexaneEtOAc as 
eluent): m.p. 99101 ºC (hexane); 1H NMR (CDCl3, 600 MHz, 
COSY, HETCOR):  = 1.52 (d, J = 6.6 Hz, 3H, CH3), 1.79 (m, 
1H, H-2), 2.04 (m, 2H, H-1, H-2), 2.27 (m, 1H, H-1), 2.39 
(ddd, J =18.0, 10.8, 5.4 Hz, 1H, H-3), 2.52 (dddd, J = 18.0, 
4.8, 4.2, 1.8 Hz, 1H, H-3), 5.23 (t, J = 3.6 Hz, 1H, H-9a), 
5.65 (q, J = 6.6 Hz, 1H, H-10), 6.84 (dd, J = 7.8, 1.2 Hz, 
1H, H-8), 6.95 (td, J = 7.8, 1.2 Hz, 1H, H-6), 7.10 (dt, J = 
7.8, 0.6 Hz, 1H, H-5), 7.13 (tdd, J = 7.8, 1.2, 0.6 Hz, 1H, 
H-7); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 16.3 (CH2), 21.7 
(CH3), 28.0 (CH2), 32.7 (CH2), 46.5 (CH), 78.3 (CH), 116.9 
(CH), 121.5 (CH), 125.1 (C), 127.5 (CH), 127.8 (CH), 153.2 
(C), 168.7 (C); IR (KBr):  = 1638 cm-1; X-ray crystal 
structure: see reference 5; elemental analysis calcd (%) for 
C13H15NO2: C, 71.87; H, 6.96; N, 6.45; found: C, 71.95; H, 
6.91; N, 6.47. 
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(1RS,6SR,11aRS)- and (1RS,6RS,11aSR)-1-Ethyl-6-methyl-4-
oxo-1,2,3,4,6,11a-hexahydropyrido[2,1-b]-1,3-benzoxazine 
(rac-27a and rac-27b). Operating as in the general procedure, 
from methyl 4-ethyl-5-oxopentanoate
[1]
 (1d; 250 mg, 1.58 mmol) 
and aminophenol rac-20[11] (286 mg, 1.74 mmol) in toluene (6 
mL) for 20 h, a 1:1 mixture of lactams rac-27a and rac-27b 
(313 mg, 76%) was obtained after flash chromatography (SiO2 
previously washed with 1:1 hexaneEt3N; 95:5 hexaneEtOAc as 
eluent). rac-27a: 1H NMR (CDCl3, 300 MHz):  = 1.05 (t, J = 
7.5 Hz, 3H), 1.50 (d, J = 6.9 Hz, 3H), 1.52 (m, 2H), 1.74 (m, 
1H), 2.08 (m, 2H), 2.39 (ddd, J = 17.7, 7.2, 5.1 Hz, 1H), 
2.50 (ddd, J = 17.7, 8.1, 5.4 Hz, 1H), 4.92 (d, J = 4.2 Hz, 
1H), 5.64 (q, J = 6.9 Hz, 1H), 6.85 (dd, J = 8.1, 1.2 Hz, 
1H), 6.96 (td, J = 7.8, 1.2 Hz, 1H), 7.12 (m, 2H); 
13
C NMR 
(CDCl3, 75.4 MHz):  = 11.5 (CH3), 21.0 (CH2), 21.6 (CH3), 
23.5 (CH2), 30.0 (CH2), 39.0 (CH), 46.3 (CH), 83.2 (CH), 116.8 
(CH), 121.5 (CH), 125.1 (C), 127.4 (CH), 127.6 (CH), 152.9 
(C), 168.8 (C); IR (film):  = 1661 cm-1; HMRS calcd for 
C15H19NO2 245.1416, found 245.1415. rac-27b: 
1
H NMR (CDCl3, 300 
MHz):  = 1.03 (t, J = 7.5 Hz, 3H), 1.53 (d, J = 6.9 Hz, 3H), 
1.502.00 (m, 5H), 2.43 (ddd, J = 18.0, 12.3, 6.3 Hz, 1H), 
2.56 (ddd, J = 18.0, 5.4, 1.8 Hz, 1H), 5.08 (bs, 1H), 5.69 
(q, J = 6.9 Hz, 1H), 6.85 (dd, J = 8.1, 1.2 Hz, 1H), 6.95 
(ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 7.09-716 (m, 2H); 13C NMR 
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(CDCl3, 75.4 MHz):  = 11.6 (CH3), 21.7 (CH2), 21.8 (CH3), 
23.7 (CH2), 32.6 (CH2), 39.5 (CH), 47.1 (CH), 79.9 (CH), 117.1 
(CH), 121.4 (CH), 125.5 (C), 127.5 (CH), 127.6 (CH), 153.6 
(C), 169.0 (C); IR (film):  = 1661 cm-1; elemental analysis 
calcd (%) for C15H19NO2: C, 73.44; H, 7.81; N, 5.71; found: C, 
73.31; H, 7.92; N, 5.59. 
(6RS,11aSR)-6,11a-Dimethyl-4-oxo-1,2,3,4,6,11a-hexahydro- 
pyrido[2,1-b]-1,3-benzoxazine (rac-28). Operating as in the 
general procedure, from 5-oxohexanoic acid (1t; 500 mg, 3.84 
mmol) and aminophenol rac-20[11] (562 mg, 4.11 mmol) in 
toluene (15 mL) for 24 h, lactam rac-28 (690 mg, 77%) was 
obtained after flash chromatography (SiO2 previously washed 
with 1:1 hexaneEt3N; 1:1 hexaneEtOAc as eluent): m.p. 8385 
o
C (hexane); 
1
H NMR (CDCl3, 600 MHz, COSY, HETCOR):  = 1.61 
(s, 3H, CH3), 1.64 (d, J = 7.2 Hz, 3H, CH3), 1.75 (m, 1H, H-
2), 1.95 (m, 1H, H-2), 2.11 (dddd, J = 13.2, 8.4, 4.2, 0.6 
Hz, 1H, H-1), 2.21 (ddd, J = 13.2, 8.4, 3.6 Hz, 1H, H-1), 
2.45 (ddd, J = 18.0, 7.2, 5.4 Hz, 1H, H-3), 2.50 (dddd, J = 
18.0, 7.2, 5.4, 0.6 Hz, 1H, H-3), 5.56 (q, J = 7.2 Hz, 1H, H-
10), 6.81 (dd, J = 7.8, 1.2 Hz, 1H, H-8), 6.98 (td, J = 7.8, 
1.8 Hz, 1H, H-6), 7.14 (tm, J = 7.8 Hz, 1H, H-7), 7.17 (dm, J 
= 7.8 Hz, 1H, H-5); 
13
C NMR (CDCl3, 100 MHz):  = 16.6 (CH2), 
21.3 (CH3), 26.1 (CH3), 33.2 (CH2), 37.3 (CH2), 46.1 (CH), 
86.5 (C), 117.3 (CH), 121.6 (CH), 124.7 (CH), 126.6 (CH), 
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127.7 (CH), 150.3 (C), 169.2 (C); IR (KBr):  = 1645 cm-1; 
HMRS calcd for C14H17NO2 231.1259, found 231.1259; X-ray 
crystal structure: see reference 5; elemental analysis calcd 
(%) for C14H17NO2: C, 72.70; H, 7.41; N, 6.06; found: C, 72.76; 
H, 7.68; N, 6.04. 
(1RS,6SR,11aRS)- and (1RS,6RS,11aSR)-1-Ethyl-6,11a-
dimethyl-4-oxo-1,2,3,4,6,11a-hexahydropyrido[2,1-b]-1,3-
benzoxazine (rac-29a and rac-29b). Operating as in the 
general procedure, from 4-ethyl-5-oxohexanoic acid 
[4]
 (1h; 
209 mg, 1.32 mmol) and aminophenol rac-20[11] (200 mg, 1.46 
mmol) in toluene (8 mL) for 20 h, a 9:1 mixture of lactams 
rac-29a and rac-29b (155.4 mg, 45%) was obtained after flash 
chromatography (SiO2 previously washed with 1:1 hexaneEt3N; 
gradient hexane to 19:1 hexaneEtOAc as eluent). rac-29a: 1H 
NMR (CDCl3, 300 MHz, COSY, HETCOR):  = 1.04 (t, J = 7.2 Hz, 
CH3), 1.48 (m, 2H, H-1, CH2), 1.61 (s, 3H, CH3), 1.68 (d, J = 
6.9 Hz, 3H, CH3), 1.69 (m, 1H, H-2), 1.74 (m, 1H, H-2), 1.91 
(m, 1H, CH2), 2.37 (ddd, J = 17.7, 9.8, 6.0 Hz, 1H, H-3), 
2.55 (td, J = 17.7, 5.0 Hz, 1H, H-3), 5.54 (q, J = 6.9 Hz, 
1H, H-10), 6.80 (dd, J = 8.1, 1.2 Hz, 1H, ArH), 6.97 (td, J = 
7.5, 1.2 Hz, 1H, ArH), 7.107.18 (m, 2H, ArH); 13C NMR (CDCl3, 
75.4 MHz, HETCOR):  = 12.4 (CH3), 20.1 (CH2), 21.0 (CH2), 
21.5 (CH3), 24.9 (CH3), 31.8 (CH2), 46.3 (CH), 46.8 (CH), 88.1 
(C), 117.3 (CH), 121.4 (CH), 124.8 (C), 126.4 (CH), 127.5 
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(CH), 150.4 (C), 169.4 (C); IR (KBr):  = 1647 film; HMRS 
calcd for C16H21NO2 259.1572, found 259.1571. 
(1RS,6RS,11aSR)- and (1RS,6SR,11aRS)-6,11a-Dimethyl-4-oxo-
1-phenyl-1,2,3,4,6,11a-hexahydropyrido[2,1-b]-1,3-benzoxazine 
(rac-30a and rac-30b). Operating as in the general procedure, 
from 5-oxo-4-phenylhexanoic acid
[12]
 (1u; 260 mg, 1.26 mmol) 
and aminophenol rac-20[11] (137 mg, 1.39 mmol) in toluene (2 
mL) for 26 h, a 9:1 mixture of lactams rac-30a and rac-30b 
(163 mg, 42%) was obtained after flash chromatography (Et2O). 
rac-30a (selected resonances): 1H NMR (CDCl3, 400 MHz, COSY, 
HETCOR):  = 1.53 (s, 3H, CH3), 1.72 (d, J = 7.2 Hz, 3H, CH3), 
1.84 (m, 1H, H-2), 2.422.60 (m, 2H, H-2, H-3), 2.65 (dm, J = 
17.8 Hz, 1H, H-3), 3.09 (dd, J = 12.0, 2.4 Hz, 1H, H-1), 5.71 
(q, J = 7.2 Hz, 1H, H-10), 6.70 (dd, J = 8.0, 0.8 Hz, 1H, 
ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 21.3 (CH3), 23.5 
(CH2), 24.7 (CH3), 33.7 (CH2), 47.6 (CH), 51.6 (CH), 86.9 (C), 
169.7 (C); IR (KBr):  = 1647 cm-1; HMRS calcd for C20H21NO2 
307.1572, found 307.1572. rac-30b (selected resonances): 1H 
NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 1.27 (s, 3H, CH3), 
1.65 (d, J = 6.8 Hz, 3H, CH3), 2.06 (m, 1H, H-2), 2.76 (ddd, 
J = 17.6, 5.2, 2.0 Hz, 1H, H-3), 3.37 (dd, J = 13.2, 2.4 Hz, 
1H, H-1), 5.57 (q, J = 6.8 Hz, 1H, H-10), 6.77 (dd, J = 8.0, 
0.8 Hz, 1H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 20.4 
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(CH3), 21.5 (CH3), 22.2 (CH2), 33.0 (CH2), 46.0 (CH), 50.1 
(CH), 89.2 (C), 168.1 (C); IR (KBr):  = 1647 cm-1. 
Ethyl (2RS,6SR,11aRS)- and (2RS,6RS,11aSR)-6,11a-Dimethyl-
4-oxo-1,2,3,4,6,11a-hexahydropyrido[2,1-b]-1,3-benzoxazine-2-
acetate (rac-31a and rac-31b). Operating as in the general 
procedure, aminophenol rac-20[11] (305 mg, 2.23 mmol) and a 
few drops of p-TsOH were added to a solution of diethyl 3-
acetonylglutarate
[8]
 (1n; 501 mg, 2.03 mmol) in toluene (5 
mL), and the mixture was stirred at reflux for 24 h. The 
solvent was eliminated under reduced pressure, and the 
residue was dissolved in EtOAc and washed with 5% aqueous 
NaHCO3. The aqueous layer was extracted with EtOAc and the 
combined organic extracts were washed with brine, dried, and 
evaporated. Flash chromatography (hexane to 10:1 hexane
EtOAc) of the residue afforded a 3:2 mixture of lactams rac-
31a and rac-31b (243 mg, 37%). rac-31 (selected resonances 
from the mixture of epimers): 1H NMR (CDCl3, 400 MHz):  = 
1.27 and 1.28 (2t, J = 7.2 Hz, 3H), 1.61 and 1.64 (2s, 3H), 
1.62 and 1.67 (2d, J = 6.8 Hz, 3H), 5.48 and 5.62 (q, J = 6.8 
Hz, 2H); 
13
C NMR (CDCl3, 100 MHz):  = 14.1 (CH3), 21.1 (CH3), 
21.2 (CH3), 26.9 (CH3), 38.7 (CH2), 38,9 (CH2), 39.4 (CH2), 
39.5 (CH2), 45,5 (CH), 46,9 (CH), 60.5 (CH2), 60.6 (CH2); 85,6  
86,5 (C), 167.3 (CH), 168.8 (CH), 171.1 (C), 171.3 (C); IR 
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(KBr):  = 1647 cm-1; HMRS calcd for C18H23NO4 (mixture of 
epimers) 317.1627, found 317.1627. 
(5aS,10aR,11aS)- and (5aS,10aR,11aR)-4-Oxo-1,2,3,4,5a, 
10,10a,11a-octahydroindeno[1’,2’:4,5]oxazolo[3,2-a]pyridine 
(32a and 32b). Operating as in the general procedure, from 
methyl 5-oxopentanoate (1a; 159 mg, 1.22 mmol) and (1S,2R)-
cis-1-amino-2-indanol (21; 201 mg, 1.35 mmol) in toluene (5 
mL) for 18 h, lactams 32a (148 mg, 54%) and 32b (45.5 mg, 
16%), were obtained after flash chromatography (SiO2 
previously washed with 1:1 hexaneEt3N; gradient 4:1 to 2:1 
hexaneEtOAc as eluent). 32a: []22D +265.6 (c 0.36, CHCl3); 
1
H 
NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 1.44 (m, 1H, H-1), 
1.71 (m, 1H, H-2), 1.94 (m, 1H, H-2), 2.17 (m, 1H, H-1), 2.34 
(ddd, J = 18.0, 11.0, 6.8 Hz, 1H, H-3), 2.43 (ddd, J = 18.0, 
6.8, 2.4 Hz, 1H, H-3), 3.20 (bs, 2H, H-9), 4.81 (ddd, J = 
5.6, 4.4, 2.4 Hz, 1H, H-9a), 4.85 (dd, J = 10.0, 3.2 Hz, 1H, 
H-10a), 5.50 (d, J = 5.6 Hz, 1H, H-4b), 7.187.27 (m, 3H, H-
6, H-7, H-8), 8.00 (d, J = 7.6 Hz, 1H, H-5); 
13
C NMR (CDCl3, 
100 MHz, HETCOR):  = 17.7 (CH2), 28.0 (CH2), 31.0 (CH2), 36.4 
(CH2), 64.3 (CH), 81.1 (CH), 88.5 (CH), 124.8 (CH), 127.3 
(CH), 128.5 (CH), 128.6 (CH), 140.1 (C), 141.4 (C), 168.3 
(C); IR (film):  = 1650 cm-1; HMRS calcd for C14H15NO2 
229.1103, found 229.1104. 32b: m.p. 9799 ºC (hexane); [α]22D 
+275.7 (c 0.26, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, HETCOR): 
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 = 1.52 (m, 1H, H-1), 1.61 (dddd, J = 16.0, 11.0, 6.0, 2.6 
Hz, 1H, H-2), 1.88 (m, 1H, H-2), 2.22 (m, 1H, H-1), 2.34 
(ddd, J = 17.4, 11.0, 6.0 Hz, 1H, H-3), 2.47 (dm, J = 17.6 
Hz, 1H, H-3), 3.14 (dd, J = 18.0, 2.4 Hz, 1H, H-9), 3.34 (dd, 
J = 18.0, 7.4 Hz, 1H, H-9), 4.70 (dd, J = 8.2, 4.2 Hz, 1H, H-
10a), 5.05 (ddd, J = 7.4, 6.8, 2.4 Hz, 1H, H-9a), 5.92 (d, J 
= 6.8 Hz, 1H, H-4b), 7.197.30 (m, 3H, H-6, H-7, H-8), 7.60 
(d, J = 6.8 Hz, 1H, H-5); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  
= 17.2 (CH2), 28.2 (CH2), 31.2 (CH2), 38.7 (CH2), 62.4 (CH), 
79.2 (CH), 84.9 (CH), 124.5 (CH), 126.6 (CH), 127.6 (CH), 
128.8 (CH), 139.6 (C), 141.5 (C), 167.6 (C); IR (KBr):  = 
1651 cm
-1
; elemental analysis calcd (%) for C14H15NO2: C, 
73.34; H, 6.59; N, 6.11; found: C, 73.66; H, 6.74; N, 5.78. 
(1R,5aS,10aR,11aS)- and (1S,5aS,10aR,11aR)-1-Ethyl-4-oxo-
1,2,3,4,5a,10,10a,11a-octahydroindeno[1’,2’:4,5]oxazolo[3,2-
a]pyridine (33a and 33b). Operating as in the general 
procedure, from methyl 4-formylhexanoate
[1]
 (1d; 191 mg, 1.21 
mmol) and aminoindanol 21 (200 mg, 1.33 mmol) in toluene (4 
mL) for 10 h, lactams 33a (132 mg, 42%), 11a-epi-33b (53.5, 
17%) and 33b (86 mg, 28%) were obtained after flash 
chromatography (Et2O). 33a: m.p. 6566 ºC (hexane); [α]
22
D 
+196.2 (c 0.54, CHCl3); 
1
H NMR (CDCl3, 600 MHz, COSY, HETCOR): 
 = 0.90 (t, J = 7.8 Hz, 3H, CH3), 1.21 (m, 1H, CH2), 1.35 (m, 
1H, H-2), 1.44 (m, 1H, H-1), 1.71 (m, 1H, CH2), 1.94 (dddd, J 
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= 13.6, 7.2. 3.6, 2.4 Hz, 1H, H-2), 2.37 (ddd, J = 18.0, 
11.4, 7.2 Hz, 1H, H-3), 2.45 (ddd, J = 18.0, 6.6, 2.4 Hz, 1H, 
H-3), 3.18 (d, J = 3.5 Hz, 2H, H-9), 4.50 (d, J = 9.0 Hz, 1H, 
H-10a), 4.76 (ddd, J = 6.0, 3.5, 3.5 Hz, 1H, H-9a), 5.48 (d, 
J = 6.0 Hz, 1H, H-4b), 7.167.24 (m, 3H, H-6, H-7, H-8), 7.97 
(d, J = 5.2 Hz, 1H, H-5); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  
= 10.7 (CH3), 23.7 (CH2), 23.8 (CH2), 31.4 (CH2), 36.4 (CH2), 
40.4 (CH), 64.5 (CH), 81.0 (CH), 92.2 (CH), 124.8 (CH), 127.3 
(CH), 128.5 (CH), 128.7 (CH), 140.2 (C), 141.5 (C), 168.3 
(C); IR (KBr):  = 1647 cm-1; elemental analysis calcd (%) for 
C16H19NO2: C, 74.68; H, 7.44; N, 5.44; found: C, 74.73; H, 
7.48; N, 5.41. 11a-epi-33b: [α]22D +260.3 (c 0.69, CHCl3); 
1
H 
NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 0.75 (m, 4H, CH3, 
CH2), 1.18 (m, 1H, CH2), 1.74 (m, 1H, H-2), 1.89 (m, 1H, H-2), 
2.01 (m, 1H, H-1), 2.33 (m, 2H, H-3), 3.18 (bs, 2H, H-9), 
4.80 (ddd, J = 5.6, 3.6, 2.0 Hz, 1H, H-9a), 5.02 (d, J = 3.6 
Hz, 1H, H-10a), 5.52 (d, J = 5.6 Hz, 1H, H-4b), 7.177.27 (m, 
3H, H-6, H-7, H-8), 7.92 (d, J = 7.2 Hz, 1H, H-5); 
13
C NMR 
(CDCl3, 100 MHz, HETCOR):  = 11.2 (CH3), 15.6 (CH2), 21.1 
(CH2), 27.4 (CH2), 36.4 (CH2), 36.4 (CH), 64.2 (CH), 81.0 
(CH), 90.4 (CH), 124.6 (CH), 127.3 (CH), 128.2 (CH), 128.3 
(CH), 140.1 (C), 141.2 (C), 168.3 (C); IR (film) 1651 cm
-1
; 
HMRS calcd for C16H19NO2 257.1416, found 257.1416. 33b: m.p. 
8081 ºC (hexane); [α]22D +242.8 (c 0.51, CHCl3); 
1
H NMR 
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(CDCl3, 600 MHz, COSY, HETCOR):  = 0.95 (t, J = 7.5 Hz, 3H, 
CH3), 1.26 (m, 2H, H-2, CH2), 1.44 (m, 1H, H-1), 1.69 (m, 1H, 
CH2), 1.85 (dddd, J = 13.8, 6.6, 3.0, 1.8 Hz, 1H, H-2), 2.35 
(ddd, J = 18.0, 12.0, 6.0 Hz, 1H, H-3), 2.50 (ddd, J = 18.0, 
5.4, 1.8 Hz, 1H, H-3), 3.12 (dd, J = 18.0, 2.4 Hz, 1H, H-9), 
3.31 (dd, J = 18.0, 7.5 Hz, 1H, H-9), 4.32 (d, J = 7.8 Hz, 
1H, H-10a), 5.02 (ddd, J = 7.5, 6.6, 2.4 Hz, 1H, H-9a), 5.87 
(d, J = 6.6 Hz, 1H, H-4b), 7.17 (d, J = 7.2 Hz, 1H, H-8), 
7.217.27 (m, 2H, H-6, H-7), 7.58 (dt, J = 7.2, 0.6 Hz, 1H, 
H-5); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 11.0 (CH3), 22.9 
(CH2), 24,7 (CH2), 31,4 (CH2), 38.8 (CH2), 41.2 (CH), 62.5 
(CH), 79.1 (CH), 89.0 (CH), 124.5 (CH), 126.7 (CH), 127.6 
(CH), 128.8 (CH), 139.7 (C), 141.5 (C), 167.5 (C); IR (KBr): 
 = 1645 cm-1; elemental analysis calcd (%) for C16H19NO2: C, 
74.68; H, 7.44; N, 5.44; found: C, 74.46; H, 7.42; N, 5.42. 
Methyl (2R,5aS,10aR,11aS)- and (2S,5aS,10aR,11aR)-4-Oxo-
1,2,3,4,5a,10,10a,11a-octahydroindeno[1’,2’:4,5]oxazolo[3,2-
a]pyridine-2-acetate (34a and 34b). Operating as in the 
general procedure, from dimethyl 3-(2-oxoethyl)pentadionate
[7] 
(1m, 256 mg, 1.27 mmol) and aminoindanol 21 (208 mg, 1.39 
mmol) in toluene (5 mL) for 6 h, lactams 34a (256 mg, 61%), 
and 34b (71 mg, 17%) were obtained after flash chromatography 
(Et2O). 34a: [α]
22
D +149.9 (c 0.71, CHCl3); 
1
H NMR (CDCl3, 400 
MHz, COSY, HETCOR):  = 1.28 (td, J = 12.0, 10.0 Hz, 1H, H-
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1), 2.07 (dd, J = 17.2, 10.4 Hz, 1H, H-3), 2.25 (dm, J = 12.0 
Hz, 1H, H-1), 2.34 (m, 2H, CH2), 2.40 (m, 1H, H-2), 2.60 
(ddd, J = 17.2, 6.0, 1.2 Hz, 1H, H-3), 3.20 (bs, 2H, H-9), 
3.68 (s, 3H, CH3), 4.84 (ddd, J = 6.0, 4.0, 2.0 Hz, 1H, H-
9a), 4.91 (dd, J = 10.0, 3.2 Hz, 1H, H-10a), 5.49 (d, J = 6.0 
Hz, 1H, H-4b), 7.187.28 (m, 3H, H-6, H-7, H-8), 8.00 (d, J = 
7.2 Hz, 1H, H-5); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 27.4 
(CH), 34.1 (CH2), 36.5 (CH2), 37.5 (CH2), 40.0 (CH2), 51.7 
(CH3), 64.3 (CH), 81.5 (CH), 87.8 (CH), 124.8 (CH), 127.4 
(CH), 128.6 (CH), 128.7 (CH), 140.2 (C), 141.1 (C), 166.8 
(C), 171.8 (C); IR (film):  = 1650, 1731 cm-1; HMRS calcd for 
C17H19NO4 301.1314, found 301.1314. 34b: 
1
H NMR (CDCl3, 400 
MHz, COSY, HETCOR):  = 1.32 (td, J = 12.4, 9.2 Hz, 1H, H-1), 
2.07 (dd, J = 17.6, 11.6 Hz, 1H, H-3), 2.28 (m, 2H, H-1, H-
2), 2.35 (m, 2H, CH2), 2.62 (ddd, J = 17.6, 4.8, 2.0 Hz, 1H, 
H-3), 3.16 (dd, J = 18.0, 2.0 Hz, 1H, H-9), 3.33 (dd, J = 
18.0, 7.2 Hz, 1H, H-9), 3.67 (s, 3H, CH3), 4.75 (dd, J = 9.2, 
4.4 Hz, 1H, H-10a), 5.07 (ddd, J = 7.2, 7.2, 2.0 Hz, 1H, H-
9a), 5.89 (d, J = 7.2 Hz, 1H, H-4b), 7.197.29 (m, 3H, H-6, 
H-7, H-8), 7.58 (d, J = 6.8 Hz, 1H, H-5); 
13
C NMR (CDCl3, 100 
MHz, HETCOR):  = 26.6 (CH), 34.2 (CH2), 37.4 (CH2), 38.7 
(CH2), 39.6 (CH2), 51.7 (CH3), 62.3 (CH), 79.5 (CH), 84.3 (C), 
124.5 (CH), 126.6 (CH), 127.7 (CH), 128.9 (CH), 139.4 (C), 
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141.4 (C), 166.3 (C), 171.7 (C); IR (film):  = 1650, 1735 
cm
-1
; HMRS calcd for C17H19NO4 301.1314, found 301.1314.  
(5aS,10aR,11aS)- and (5aS,10aR,11aR)-11a-Methyl-4-oxo-
1,2,3,4,5a,10,10a,11a-octahydroindeno[1’,2’:4,5]oxazolo[3,2-
a]pyridine (35a and 35b). Operating as in the general 
procedure, from 5-oxohexanoic acid (1t; 162 mg, 1.20 mmol) 
and aminoindanol 21 (200 mg, 1.33 mmol) in toluene (4 mL) for 
15 h, lactams 35a (29 mg, 9%) and 35b (white solid, 288 mg, 
90%) were obtained after flash chromatography (SiO2 
previously washed with 1:1 hexaneEt3N; EtOAc as eluent). 
35a: 
1
H NMR (CDCl3, 300 MHz):  = 1.46 (s, 3H), 5.06 (td, J = 
5.4, 0.6 Hz, 1H), 5.58 (d, J = 5.4 Hz, 1H), 7.197.28 (m, 
3H), 8.03 (d, J = 7.5 Hz, 1H); 
13
C NMR (CDCl3, 75.4 MHz):  = 
16.8 (CH 2), 23.5 (CH3), 29.6 (CH2), 34.2 (CH2), 36.8 (CH2), 
64.3 (CH), 78.3 (CH), 93.3 (C), 124.7 (CH), 125.8 (CH), 127.1 
(CH), 128.8 (CH), 140.3(C), 141.2 (C), 168.3 (C); IR (film): 
 = 1650 cm-1. 35b: m.p. 6768 oC (hexane); [α]22D +283.1 (c 
0.51, CHCl3); 
1
H NMR (CDCl3, 300 MHz):  = 0.98 (s, 3H), 1.62 
(m, 1H), 1.75 (m, 1H), 1.92 (m, 1H), 2.04 (m, 1H), 2.41 (ddd, 
J = 18.0, 9.6, 7.8 Hz, 1H), 2.54 (ddd, J = 18.0, 7.8, 3.0 Hz, 
1H), 3.19 (dd, J = 17.7, 1.8 Hz, 1H), 3.32 (dd, J = 17.7, 6.6 
Hz, 1H), 4.93 (td, J = 6.6, 1.8 Hz, 1H), 6.02 (d, J = 6.6 Hz, 
1H), 7.207.30 (m, 3H), 7.53 (dm, J = 7.5 Hz, 1H); 13C NMR 
(CDCl3, 75.4 MHz):  = 17.1 (CH2), 26.9 (CH3), 30.0 (CH2), 
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35.7 (CH2), 40.0 (CH2), 63.8 (C), 79.1 (CH), 94.0 (C), 124.9 
(CH), 125.9 (CH), 127.4 (CH), 128.5 (CH), 140.7(C), 141.8 
(C), 167.8 (C); IR (film) 1648 cm
-1
; HMRS calcd for C15H17NO2 
243.1259, found 243.1259. 
(1S,5aS,10aR,11aR)-1-Ethyl-11a-methyl-4-oxo-1,2,3,4,5a, 
10,10a,11a-octahydroindeno[1’,2’:4,5]oxazolo[3,2-a]pyridine 
(36b). Operating as in the general procedure, from 4-ethyl-5-
oxohexanoic acid
[4]
 (1h; 139 mg, 0.88 mmol) and aminoindanol 
21 (144 mg, 0.97 mmol) in toluene (4 mL) for 8 h, lactams 36a 
(19 mg, 8%) and 36b (145 mg, 61%) were obtained after flash 
chromatography (SiO2 previously washed with 1:1 hexaneEt3N; 
5:4 hexaneEtOAc as eluent). 36b: m.p. 114115 oC (hexane); 
[α]22D +259.9 (c 0.53, CHCl3); 
1
H NMR (CDCl3, 300 MHz, COSY, 
HETCOR):  = 0.84 (s, 3H, CH3), 0.98 (t, J = 7.5 Hz, 3H, CH3), 
1.11 (m,1H, CH2), 1.31 (dddd, J = 14.0, 13.0, 9.6, 8.4 Hz, 
1H, H-2), 1.48 (m, 1H, H-1), 1.73 (m, 1H, CH2), 1.97 (dddd, J 
= 14.0, 8.1, 4.2, 2.4. 1H, H-2), 2.46 (ddd, J = 18.6, 9.6, 
8.4 Hz, 1H, H-3), 2.57 (ddd, J = 18.6, 8.4, 2.4 Hz, 1H, H-3), 
3.17 (dm, J = 17.0 Hz, 1H, H-9), 3.29 (dd, J = 17.7, 6.3 Hz, 
1H, H-9), 4.88 (td, J = 6.3, 1.5 Hz, 1H, H-9a), 5.98 (d, J = 
6.3 Hz, 1H, H-4b), 7.197.30 (m, 3H, H-6, H-7, H-8), 7.55 (m, 
1H, H-5); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  = 11.9 (CH3), 
21.9 (CH2), 22.0 (CH3), 23.1 (CH2), 30.2 (CH2), 39.8 (CH2), 
46.6 (CH), 64.1 (CH), 78.9 (CH), 96.1 (C), 124.9 (CH), 125.9 
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(CH), 127.4 (CH), 128.4 (CH), 140.6 (C), 142.0 (C), 167.8 
(C); IR (film):  = 1647 cm-1; elemental analysis calcd (%) 
for C17H21NO2: C, 75.25; H, 7.80; N, 5.16; found: C, 75.12; H, 
7.70; N, 5.13 
 (1S,5aS,10aR,11aS)- and (1R,5aS,10aR,11aR)-11a-Methyl-1-
phenyl-4-oxo-1,2,3,4,5a,10,10a,11a–octahydroindeno[1’,2’:4,5] 
oxazolo[3,2-a]pyridine (37a and 37b). Operating as in the 
general procedure, from 4-phenyl-5-oxohexanoic acid
[12]
 (1u; 
255 mg, 1.24 mmol) and aminoindanol 21 (203 mg, 1.36 mmol) in 
toluene (4 mL) for 24 h, lactams 37a (25 mg, 6%) and 37b (308 
mg, 77%) were obtained after flash chromatography (EtOAc). 
37a: m.p. 177179 ºC (hexaneacetone); [α]22D +8.5 (c 0.31, 
CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 1.29 (s, 
3H, CH3), 2.002.07 (m, 1H, H-2), 2.242.36 (m, 1H, H-2), 
2.58 (ddd, J = 18.0, 8.8, 8.8 Hz, 1H, H-3), 2.66 (ddd, J = 
18.0, 8.8, 2.4 Hz, 1H, H-3), 2.95 (dd, J = 13.2, 4.4 Hz, 1H, 
H-1), 3.213.22 (m, 2H, H-9), 4.985.00 (m, 1H, H-9a), 5.63 
(d, J = 6.0 Hz, 1H, H-4b), 7.217.33 (m, 8H, ArH), 8.09 (d, J 
= 7.6 Hz, 1H, H-5); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 19.1 
(CH3), 22.5 (CH2), 30.6 (CH2), 37.1 (CH2), 49.4 (CH), 64.8 
(CH), 75.5 (CH), 95.1 (C), 124.9 (CH), 127.3 (CH), 127.4 
(CH), 128.1 (CH), 128.7 (CH), 128.9 (CH), 129.1 (CH), 138.5 
(C), 140.8 (C), 141.3 (C), 168.0 (C); IR (KBr):  = 1640 cm-1; 
elemental analysis calcd (%) for C21H21NO2: C, 78.97; H, 6.63; 
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N, 4.39; found: C, 78.98; H, 6.54; N, 4.25. 37b: m.p. 113114 
o
C (hexane); [α]22D +65.7 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 400 
MHz, COSY, HETCOR):  = 0.76 (s, 3H, CH3), 2.04 (dddd, J = 
13.5, 8.1, 3.6, 1.8 Hz, 1H, H-2), 2.20 (dddd, J = 13.5, 13.5, 
10.2, 7.8 Hz, 1H, H-2), 2.61 (ddd, J = 18.6, 10.2, 8.1 Hz, 
1H, H-3), 2.76 (ddd, J = 18.6, 7.8, 1.8 Hz, 1H, H-3), 2.99 
(dd, J = 13.5, 3.6 Hz, 1H, H-1), 3.11 (d, J = 17.7 Hz, 1H, H-
9), 3.28 (dd, J = 17.7, 6.6 Hz, 1H, H-9), 5.04 (td, J = 6.6, 
1.5 Hz, 1H, H-9a), 6.07 (d, J = 6.6 Hz, 1H, H-4b), 7.147.35 
(m, 8H, ArH), 7.58 (m, 1H, H-5); 
13
C NMR (CDCl3, 75.4 MHz, 
HETCOR):  = 22.4 (CH2), 22.5 (CH3), 30.7 (CH2), 39.9 (CH2), 
50.1 (CH), 64.3 (CH), 79.1 (CH), 95.6 (C), 124.8 (CH), 125.9 
(CH), 127.1 (CH), 127.4 (CH), 127.9 (CH), 128.5 (CH), 128.8 
(CH), 138.8 (C), 140.7 (C), 141.8 (C), 167.4 (C); IR (KBr):  
= 1650 cm
-1
; X-ray crystal structure: see reference 5; 
elemental analysis calcd (%) for C21H21NO2: C, 78.97; H, 6.63; 
N, 4.39; found: C, 78.82; H, 6.65; N, 4.39. 
Ethyl (2R,5aS,10aR,11aS)- and (2S,5aS,10aR,11aR)-11a-
Methyl-4-oxo-1,2,3,4,5a,10,10a,11a-octahydroindeno[1’,2’:4,5] 
oxazolo[3,2-a]pyridine-2-acetate (38a and 38b). Operating as 
in the general procedure, from diethyl 3-acetonylglutarate
[8]
 
(1n; 200 mg, 0.82 mmol) and aminoindanol 21 (134 mg, 0.90 
mmol) in toluene (4 mL) for 24 h, lactams 38a (63 mg, 23%) 
and 38b (112 mg, 41%) were obtained after flash 
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chromatography (5:1 hexaneEtOAc to EtOAc). 38a: [α]22D +9.7 
(c 0.71, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 
1.23 (t, J = 7.2 Hz, 3H, CH3), 1.32 (t, J = 12.0 Hz, 1H, H-
1), 1.50 (s, 3H, CH3), 2.06 (dd, J = 18.0, 9.0 Hz, 1H), 2.14 
(dd, J = 12.0, 4.4 Hz, 1H, H-1), 2.28 (m, 2H, H-9), 2.512.55 
(m, 1H, H-2), 2.66 (dd, J = 18.0, 7.4 Hz, 1H, CH2), 3.13 (d, 
J = 17.6 Hz, 1H, CH2), 3.23 (dd, J = 17.6, 6.6 Hz, 1H, CH2), 
4.12 (q, J = 7.2 Hz, 2H, CH2), 5.08 (t, J = 5.6 Hz, 1H, H-
9a), 5.56 (d, J = 5.6 Hz, 1H, H-4b), 7.177.28 (m, 3H, ArH), 
8.03 (d, J = 7.6 Hz, 1H, ArH); 
13
C NMR (CDCl3, 100 MHz, 
HETCOR):  = 14.1 (CH3), 24.0 (CH3), 26.9 (CH), 36.7 (CH2), 
36.9 (CH2), 40.6 (CH2), 41.0 (CH2), 60.6 (CH2), 64.3 (CH), 
78.6 (CH), 93.1 (C), 124.8 (CH), 127.2 (CH), 128.6 (CH), 
129.0 (CH), 140.6 (C), 140.9 (C), 167.0 (C), 171.5 (C); IR 
(film):  = 1650, 1731 cm-1; HMRS calcd for C19H23NO4 329.1627, 
found 329.1629. 38b: [α]22D +158.7 (c 0.63, CHCl3); 
1
H NMR 
(CDCl3, 400 MHz, COSY, HETCOR):  = 1.01 (s, 3H, CH3), 1.26 
(t, J = 6.8 Hz, 3H, CH3), 1.44 (t, J = 12.4 Hz, 1H, H-1), 
2.062.13 (m, 2H, CH2), 2.332.35 (m, 2H, H-9), 2.342.40 (m, 
1H, H-2), 2.75 (dd, J = 18.0, 5.6 Hz, 1H, CH2), 3.19 (d, J = 
17.6 Hz, 1H, CH2), 3.32 (dd, J = 17.6, 6.6 Hz, 1H, CH2), 4.15 
(q, J = 6.8 Hz, 2H, CH2), 4.94 (t, J = 6.8 Hz, 1H, H-9a), 
6.01 (d, J = 6.8 Hz, 1H, H-4b), 7.217.30 (m, 3H, ArH), 7.52 
(d, J = 6.8 Hz, 1H, ArH); 13C NMR (CDCl3, 100 MHz, HETCOR):  
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= 14.2 (CH3), 26.7 (CH), 27.4 (CH3), 36,8 (CH2), 40.0 (CH2), 
40.6 (CH2), 42.0 (CH2), 60.6 (CH2), 63.8 (CH), 79.5 (CH), 93.7 
(C), 125.0 (CH), 125.9 (CH), 127.6 (CH), 128.7 (CH), 140.8 
(C), 141.7 (C), 167.1 (C), 171.4 (C); IR (film):  = 1650, 
1731 cm
-1
; HMRS calcd for C19H23NO4 329.1627, found 329.1620. 
Methyl (1R,2R,5aS,10aR,11aS)- and (1S,2S,5aS,10aR,11aR)-1-
Ethyl-11a-methyl-4-oxo-1,2,3,4,5a,10,10a,11a-octahydroindeno 
[1’,2’:4,5]oxazolo[3,2-a]pyridine-2-acetate (39a and 39b). 
Operating as in the general procedure, from dimethyl 3-(1-
ethyl-2-oxopropyl)pentadionate
[7] 
(1q; 500 mg, 2.05 mmol) and 
aminoindanol 21 (336 mg, 2.25 mmol) in toluene (7 mL) for 24 
h, lactams 39a (190 mg, 27%) and 39b (203 mg, 29%) were 
obtained after flash chromatography (8:1 hexaneEtOAc to 
EtOAc). 39a: [α]22D +131.7 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 400 
MHz, COSY, HETCOR):  = 0.95 (t, J = 7.6 Hz, 3H, CH3), 1.16
1.22 (m, 1H, H-1), 1.331.45 (m, 1H, CH2), 1.40 (s, 3H, CH3), 
1.501.63 (m, 1H, CH2), 2.102.20 (m, 2H, CH2), 2.24 (dd, J = 
17.6, 4.0 Hz, 1H, CH2), 2.402.47 (m, 1H, CH2), 2.68 (dd, J = 
17.6, 8.4 Hz, 1H, CH2), 3.12 (d, J = 17.6 Hz, 1H, H-9), 3.21 
(dd, J = 17.6, 5.6 Hz, 1H, H-9), 3.65 (s, 3H, CH3), 5.01 (dd, 
J = 5.6, 5.2 Hz, 1H, H-9a), 5.56 (d, J = 5.6 Hz, 1H, H-4b), 
7.187.28 (m, 3H, ArH), 7.97 (d, J = 8.4 Hz, 1H, ArH); 13C NMR 
(CDCl3, 100 MHz, HETCOR):  = 13.2 (CH3), 19.5 (CH3), 23.6 
(CH2), 32.7 (CH), 36.5 (CH2), 37.0 (CH2), 40.3 (CH2), 50.1 
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(CH),  51.7 (CH3), 64.2 (CH), 78.9 (CH), 95.8 (C), 124.8 
(CH), 127.3 (CH), 128.4 (CH), 128.5 (CH), 140.5 (C), 141.6 
(C), 167.4 (C), 172.5 (C); IR (film):  = 1656, 1736 cm-1; 
HMRS calcd for C20H25NO4 343.1784, found 343.1782. 39b: m.p. 
6668 ºC (hexaneacetone); [α]22D +247.4 (c 0.14, CHCl3);  
1
H 
NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 0.93 (s, 3H, CH3), 
1.04 (t, J = 7.2 Hz, 3H, CH3), 1.341.45 (m, 2H, CH2, H-1), 
1.551.64 (m, 1H, CH2), 2.082.17 (m, 1H, H-2), 2.202.28 (m, 
2H, H-3, CH2), 2.60 (dd, J = 15.2, 3.6 Hz, 1H), 2.72 (dd, J = 
17.6, 7.6 Hz, 1H, CH2), 3.16 (d, J = 17.6 Hz, 1H, H-9), 3.26 
(dd, J = 17.6, 6.0 Hz, 1H, H-9), 3.70 (s, 3H, CH3), 4.86 (td, 
J = 6.0, 1.6 Hz, 1H, H-9a), 5.92 (d, J = 6.0 Hz, 1H, H-4b), 
7.217.27 (m, 3H, ArH), 7.53 (d, J = 7.6 Hz, 1H, ArH); 13C NMR 
(CDCl3, 100 MHz, HETCOR):  = 13.9 (CH3), 22.5 (CH2), 22.6 
(CH3), 31.8 (CH), 36.7 (CH2), 39.1 (CH2), 39.4 (CH2), 50.1 
(CH), 51.7 (CH3), 64.0 (CH), 79.0 (CH), 96.3 (C), 125.0 (CH), 
126.0 (CH), 127.5 (CH), 128.5 (CH), 140.6 (C), 141.8 (C), 
166.8 (C), 172.4 (C); IR (film):  = 1654, 1736 cm-1; 
elemental analysis calcd (%) for C20H25NO4: C, 69.95; H, 7.34; 
N, 4.08; found: C, 69.82; H, 7.62; N, 4.15. 
(2R,3R,8R,8aS)- and (2R,3R,8S,8aR)-2-[(Benzhydryloxy) 
methyl]-8-ethyl-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-
oxazolo[3,2-a]pyridine (40a and 40b). Operating as in the 
general procedure, from methyl 4-formylhexanoate
[1]
 (1d; 68.5 
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mg, 0.43 mmol) and (1R,2R)-1-amino-1-phenyl-3-
(benzhydryloxy)-2-propanol
[13]
 (22; 146.7 mg, 0.44 mmol) in 
toluene (1 mL) for 24 h, lactams 40a (21 mg, 8%) and 40b (128 
mg, 70%) were obtained after flash chromatography (SiO2 
previously washed with hexane–Et3N; gradient hexane to 95:5 
hexane–EtOAc). 40a: [α]22D –37.9 (c 1.06, CHCl3); 
1
H NMR 
(CDCl3, 300 MHz )  = 1.04 (t, J = 7.5 Hz, 3H), 1.251.50 (m, 
3H), 1.86 (m, 1H), 1.96 (m, 1H), 2.38 (ddd, J = 18.0, 11.1, 
7.2 Hz, 1H), 2.54 (ddd, J = 18.0, 6.5, 1.8 Hz, 1H), 3.11 (dd, 
J = 10.2, 5.4 Hz, 1H), 3.31 (dd, J = 10.2, 6.3 Hz, 1H), 4.60 
(ddd, J = 7.5, 6.3, 5.4 Hz, 1H), 4.91 (d, J = 7.8 Hz, 1H), 
5.02 (s, 1H), 5.52 (d, J = 7.5 Hz, 1H), 7.10–7.30 (m, 15H, 
ArH); 
13
C NMR (CDCl3, 75.4 MHz):  = 11.0 (CH3), 22.4 (CH2), 
24.5 (CH2), 31.1 (CH2), 41.6 (CH), 60.1 (CH), 67.7 (CH2), 77.8 
(CH), 84.0 (CH), 91.6 (CH), 126.7 (CH), 127.1 (CH), 127.3 
(CH), 127.5 (CH), 128.2 (CH), 128.2 (CH), 128.3 (CH), 136.5 
(C), 141.7 (C), 168.2 (C); IR (film):  = 1651 cm-1; HMRS 
calcd for C29H31NO3 441.2304, found 441.2304. 40b: [α]
22
D +29.9 
(c 1.21, CHCl3); 
1
H NMR (CDCl3, 300 MHz, COSY, HETCOR):  = 
1.06 (t, J = 7.5 Hz, 3H, CH3), 1.23–1.50 (m, 2H, CH2, H-7), 
1.73–1.94 (m, 2H, CH2, H-8), 2.02 (m, 1H, H-7), 2.27 (ddd, J 
= 18.0, 11.1, 5.1 Hz, 1H, H-6), 2.40 (ddd, J = 18.0, 6.9, 2.1 
Hz, 1H, H-6), 3.06 (dd, J = 10.2, 6.3 Hz, 1H, CH2), 3.23 (dd, 
J = 10.2, 6.3 Hz, 1H, CH2), 4.38 (q, J = 6.3 Hz, 1H, H-2), 
4.58 (d, J = 9.0 Hz, 1H, H-8a), 5.00 (d, J = 6.3 Hz, 1H, H-
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3), 5.04 (s, 1H, CH), 7.10–7.25 (m, 15H, ArH); 13C NMR (CDCl3, 
75.4 MHz, HETCOR):  = 11.0 (CH3), 23.6 (CH2), 24.2 (CH2), 
31.3 (CH2), 40.6 (CH), 61.1 (CH), 67.3 (CH2), 79.9 (CH), 84.0 
(CH), 92.0 (CH), 126.7 (CH), 127.3 (CH), 127.5 (CH), 128.0 
(CH), 128.1 (CH), 128.2 (CH), 137.0 (C), 141.4 (C), 141.5 
(C), 167.0 (C); IR (film):  = 1651 cm-1; HMRS calcd for 
C29H31NO3 441.2304, found 441.2304. 
Methyl (2R,3R,7R,8aS)- and (2R,3R,7S,8aR)-2-
[(Benzhydryloxy)methyl]-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro 
-5H-oxazolo[3,2-a]pyridine-7-acetate (41a and 41b). Operating 
as in the general procedure, from dimethyl 3-(2-
oxoethyl)pentadionate
[7]
 (1m; 120 mg, 0.59 mmol) and 
aminoalcohol 22[13] (220 mg, 0.66 mmol) in toluene (4 mL) for 
9 h, lactams 41a (17.8 mg, 6%) and 41b (231 mg, 80%) were 
obtained after flash chromatography (gradient 1:1 to 1:3 
hexane–EtOAc). 41a: [α]22D –49.4 (c 0.42, CHCl3); 
1
H NMR 
(CDCl3, 600 MHz, COSY, HETCOR):  = 1.28 (ddd, J = 12.5, 
12.5, 9.6 Hz, 1H, H-8), 2.00 (dd, J = 18.0, 10.8 Hz, 1H, H-
6), 2.29–2.40 (m, 4H, CH2, H-7, H-8), 2.60 (dd, J = 17.4, 3.0 
Hz, 1H, H-6), 3.05 (dd, J = 10.8, 4.8 Hz, 1H, CH2), 3.22 (dd, 
J = 10.8, 6.6 Hz, 1H, CH2), 3.63 (s, 3H, CH3), 4.55 (ddd, J = 
7.8, 6.0, 4.8 Hz, 1H, H-2), 4.91 (s, 1H, CH), 5.26 (dd, J = 
9.6, 4.2 Hz, 1H, H-8a), 5.44 (d, J = 7.8 Hz, 1H, H-3), 7.04–
7.21 (m, 15H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 26.7 
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(CH), 35.2 (CH2), 37.3 (CH2), 39.8 (CH2), 51.8 (CH3), 59.9 
(CH), 67.8 (CH2), 78.2 (CH), 84.2 (CH), 87.1 (CH), 126.7 
(CH), 126.8 (CH), 127.0 (CH), 127.3 (CH), 127.4 (CH), 127.6 
(CH), 128.2 (CH), 136.3 (C), 141.6 (C), 167.2 (C), 171.8 (C); 
IR (film):  = 1658, 1732 cm-1; HMRS calcd for C30H31NO5 
485.2202, found 485.2202; elemental analysis calcd (%) for 
C30H31NO5·1/2 H2O: C, 72.86; H, 6.52; N, 2.83; found: C, 72.82; 
H, 6.53; N, 2.80. 41b: [α]22D +13.9 (c 1.30, CHCl3); 
1
H NMR 
(CDCl3, 600 MHz, COSY, HETCOR):  = 1.60 (q, J = 12.0 Hz, 1H, 
H-8), 1.95 (dd, J = 18.0, 10.8 Hz, 1H, H-6), 2.40–2.48 (m, 
4H, CH2, H-7, H-8), 2.53 (ddd, J = 18.0, 5.4, 1.8 Hz, 1H, H-
6), 3.04 (dd, J = 10.8, 5.4 Hz, 1H, CH2), 3.18 (dd, J = 10.8, 
6.6 Hz, 1H, CH2), 3.67 (s, 3H, CH3), 4.43 (ddd, J = 6.6, 6.6, 
5.4 Hz, 1H, H-2), 4.97 (d, J = 6.6 Hz, 1H, H-3), 4.98 (dd, J 
= 10.2, 3.0 Hz, 1H, H-8a), 5.03 (s, 1H, CH), 7.11–7.21 (m, 
15H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 27.3 (CH), 
34.0 (CH2), 37.6 (CH2), 40.0 (CH2), 51.7 (CH3), 60.9 (CH), 
67.4 (CH2), 80.3 (CH), 84.1 (CH), 87.8 (CH), 126.8 (CH), 
126.8 (CH), 127.4 (CH), 127.7 (CH), 128.1 (CH), 128.2 (CH), 
136.7 (C), 141.4 (C), 141.5 (C), 165.7 (C), 171.7 (C); IR 
(film):  = 1658, 1732 cm-1; HMRS calcd for C30H31NO5 485.2202, 
found 485.2202; elemental analysis calcd (%) for C30H31NO5·1/2 
H2O: C, 72.86; H, 6.52; N, 2.83; found: C, 72.78; H, 6.33; N, 
2.87. 
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Methyl (2R,3R,8R,8aS)- and (2R,3R,8S,8aR)-2-
[(Benzhydryloxy)methyl]-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro 
-5H-oxazolo[3,2-a]pyridine-8-propionate (42a and 42b). 
Operating as in the general procedure, from dimethyl 4-
formylpimelate
[4]
 (1r; 76.1 mg, 0.35 mmol) and aminoalcohol 
22[13] (128.9 mg, 0.39 mmol) in toluene (3 mL) for 9 h, 
lactams 42a (6.6 mg, 4%) and 42b (133.4 mg, 76%) were 
obtained after flash chromatography (SiO2 previously washed 
with hexane-Et3N; gradient 1:1 to 1:3 hexane–EtOAc). 42a: 
[α]22D –52.0 (c 0.55, CHCl3); 
1
H NMR (CDCl3, 300 MHz, COSY, 
HETCOR):  = 1.58 (m, 2H, H-7, H-8), 1.74 (m, 1H, H-1’), 1.92 
(m, 1H, H-7), 2.03 (m, 1H, H-1’), 2.40 and 2.55 (m, 4H, H-6, 
H-2’), 3.12 (dd, J = 10.2, 5.4 Hz, 1H, CH2), 3.31 (dd, J = 
10.2, 6.0 Hz, 1H, CH2), 3.69 (s, 3H, CH3), 4.58 (ddd, J = 7.2, 
6.0, 5.4 Hz, 1H, H-2), 4.93 (d, J = 8.1 Hz, 1H, H-8a), 5.00 
(s, 1H, CH), 5.50 (d, J = 7.2 Hz, 1H, H-3), 7.20 (m, 15H, 
ArH); 
13
C NMR (CDCl3, 100 MHz):  = 23.3 (CH2), 27.4 (CH2), 
30.9 (CH2), 31.5 (CH2), 39.5 (CH), 51.6 (CH3), 60.1 (CH), 67.7 
(CH2), 77.9 (CH), 84.1 (CH), 91.9 (CH), 126.7 (CH), 126.8 
(CH), 127.2 (CH), 127.4 (CH), 127.6 (CH), 128.2 (CH), 128.3 
(CH), 128.4 (CH), 136.5 (C), 141.6 (C), 141.7 (C), 167.9 (C), 
173.7 (C); IR (film):  = 1661, 1735 cm-1; HMRS calcd for 
C31H35NO5 (M
+
 +H) m/z 499.2359, found 500.2433. 42b: [α]22D 
+36.2 (c 1.08, CHCl3); 
1
H NMR (CDCl3, 300 MHz, COSY, HETCOR): 
 = 1.54 (m, 1H, H-7), 1.79 (m, 1H, H-1’), 1.99 (m, 3H, H-7, 
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H-8, H-1’), 2.35 (m, 2H, H-6, H-2’), 2.37 (dd, J = 18.6, 6.0 
Hz, 1H, H-6), 2.45 (dd, J = 16.2, 2.4 Hz, 1H, CH2), 2.59 (m, 
2H, H-6, H-2’), 3.07 (dd, J = 13.2, 7.6 Hz, 1H, CH2), 3.22 
(dd, J = 13.2, 8.4 Hz, 1H, CH2), 3.69 (s, 3H, CH3),  4.39 
(ddd, J = 8.4, 8.4, 7.6 Hz, 1H, H-2), 4.61 (d, J = 11.6 Hz, 
1H, H-8a), 4.99 (d, J = 8.4 Hz, 1H, H-3), 5.03 (s, 1H, CH), 
7.20 (m, 15H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 24.6 
(CH2), 27.1 (CH2), 31.2 (CH2), 31.5 (CH2), 38.7 (CH), 51.6 
(CH3), 61.0 (CH), 67.4 (CH2), 80.1 (CH), 84.0 (CH), 92.2 (CH), 
126.8 (CH), 126.9 (CH), 127.4 (CH), 127.6 (CH), 128.1 (CH), 
128.2 (CH), 128.3 (CH), 137.0 (C), 141.4 (C), 141.5 (C), 
166.8 (C), 173.7 (C); IR (film):  = 1661, 1735 cm-1; HMRS 
calcd for C31H35NO5 (M
+
 +H) m/z 499.2359, found 500.2433. 
Methyl (2R,3R,7R,8R,8aS)- and (2R,3R,7S,8S,8aR)-2-
[(Benzhydryloxy)methyl]-8-ethyl-5-oxo-3-phenyl-2,3,6,7,8,8a-
hexahydro-5H-oxazolo[3,2-a]pyridine-7-acetate (43a and 43b). 
Operating as in the general procedure, from dimethyl 3-(1-
formylpropyl)glutarate
[7]
 (1v; 80.4 mg, 0.35 mmol) and 
aminoalcohol 22[13] (128 mg, 0.38 mmol) in toluene (3 mL) for 
9 h, lactams 43a (11 mg, 6%) and 43b (122 mg, 66%) and minor 
amounts of C8 epimer of 43b were obtained after flash 
chromatography (gradient 2:1 to 1:1 hexane–EtOAc). 43a: [α]22D 
–42.3 (c 0.91, CHCl3); 
1
H NMR (CDCl3, 600 MHz, COSY, HETCOR): 
 = 0.94 (t, J = 7.2 Hz, 3H, CH3), 1.43 (m, 1H, H-8), 1.57 
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(m, 1H, CH2), 1.71 (m, 1H, CH2), 2.11 (dd, J = 17.4, 9.0 Hz, 
1H, H-6), 2.15 (dd, J = 15.0, 9.0 Hz, 1H, CH2), 2.53 (dd, J = 
15.0, 3.6 Hz, 1H, CH2), 2.61 (dd, J = 17.4, 6.0 Hz, 1H, H-6), 
3.07 (dd, J = 10.8, 6.6 Hz, 1H, CH2), 3.24 (dd, J = 10.8, 5.4 
Hz, 1H, CH2), 3.62 (s, 3H, CH3), 4.52 (ddd, J = 7.2, 6.6, 6.0 
Hz, 1H, H-2), 4.92 (s, 1H, CH), 5.04 (d, J = 8.4 Hz, 1H, H-
8a), 5.43 (d, J = 7.2 Hz, 1H, H-3), 7.13 (m, 15H, ArH); 
13
C 
NMR (CDCl3, 100 MHz):  = 9.8 (CH3), 21.3 (CH2), 29.7 (CH), 
37.3 (CH2), 37.4 (CH2), 44.3 (CH), 51.8 (CH3), 60.1 (CH), 67.6 
(CH2), 78.0 (CH), 84.2 (CH), 89.9 (CH), 126.7 (CH), 126.8 
(CH), 127.1 (CH), 127.3 (CH), 127.4 (CH), 127.6 (CH), 128.2 
(CH), 128.3 (CH), 128.4 (CH), 128.5 (CH), 136.5 (C), 141.6 
(C), 141.7 (C), 167.2 (C), 172.2 (C); IR (film).  = 1651, 
1738 cm
-1
; HMRS calcd for C32H35NO5 (M
+
 +H) m/z 513.2515, found 
514.2593. 43b: [α]22D +17.6 (c 0.54, CHCl3); 
1
H NMR (CDCl3, 600 
MHz, COSY, HETCOR):  = 0.98 (t, J = 7.8 Hz, 3H, CH3), 1.63 
(m, 1H, CH2), 1.71 (m, 2H, CH2, H-8), 2.06 (dd, J = 17.4, 8.4 
Hz, 1H, CH2), 2.16 (dd, J = 15.0, 9.0 Hz, 1H, CH2), 2.47 (dd, 
J = 17.4, 6.0 Hz, 1H, CH2), 2.50 (dd, J = 15.0, 4.8 Hz, 1H, 
CH2), 3.01 (dd, J = 10.2, 6.0 Hz, 1H, CH2), 3.19 (dd, J = 
10.2, 6.6 Hz, 1H, CH2), 3.60 (s, 3H, CH3), 4.37 (ddd, J = 6.6, 
6.6, 6.0 Hz, 1H, H-2), 4.68 (d, J = 9.0 Hz, 1H, H-8a), 4.94 
(d, J = 6.6 Hz, 1H, H-3), 5.00 (s, 1H, CH), 7.01–7.21 (m, 
15H, ArH); 
13
C NMR (CDCl3, 100 MHz):  = 10.0 (CH3), 21.9 
(CH2), 31.2 (CH), 37.4 (CH2), 38.1 (CH2), 44.1 (CH), 51.7 
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(CH3), 60.9 (CH), 67.4 (CH2), 80.9 (CH), 84.1 (CH), 90.4 (CH), 
126.8 (CH), 126.9 (CH), 127.3 (CH), 127.4 (CH), 127.6 (CH), 
127.7 (CH), 128.1 (CH), 128.2 (CH), 128.3 (CH), 137.0 (C), 
141.5 (C), 141.6 (C), 166.1 (C), 172.1 (C); IR (film):  = 
1651, 1738 cm
-1
; HMRS calcd for C32H35NO5 (M
+
 +H) m/z 513.2515, 
found 514.2616. 8-epi-43b: [α]22D +33.7 (c 0.70, CHCl3); 
1
H NMR 
(CDCl3, 600 MHz, COSY, HETCOR):  = 1.01 (t, J = 7.8 Hz, 3H, 
CH3), 1.35 (m, 1H, CH2), 1.82 (m, 1H, CH2), 2.12 (dd, J = 
16.2, 12.4 Hz, 1H, CH2), 2.29 (dd, J = 18.6, 1.8 Hz, 1H, H-
6), 2.37 (dd, J = 18.6, 6.0 Hz, 1H, H-6), 2.45 (dd, J = 16.2, 
2.4 Hz, 1H, CH2), 2.64 (m, 1H, H-7), 2.99 (dd, J = 10.8, 6.0 
Hz, 1H, CH2), 3.14 (dd, J = 10.8, 6.6 Hz, 1H, CH2), 3.63 (s, 
3H, CH3), 4.39 (ddd, J = 6.6, 6.6, 6.0 Hz, 1H, H-2), 4.54 (d, 
J = 9.0 Hz, 1H, H-8a), 4.91 (d, J = 6.6 Hz, 1H, H-3), 4.96 
(s, 1H, CH), 7.04–7.21 (m, 15H, ArH); 13C NMR (CDCl3, 100 MHz, 
HETCOR):  = 11.3 (CH3), 21.0 (CH2), 29.5 (CH), 33.1 (CH2), 
37.8 (CH2), 43.2 (CH), 51.9 (CH3), 61.5 (CH), 67.4 (CH2), 80.2 
(CH), 84.1 (CH), 89.5 (CH), 126.8 (CH), 126.9 (CH), 127.4 
(CH), 127.7 (CH), 127.8 (CH), 128.2 (CH), 128.3 (CH), 128.6 
(CH), 136.7 (C), 141.5 (C), 141.6 (C), 166.2 (C), 172.6 (C); 
IR (film):  = 1667, 1738 cm-1; HMRS calcd for C32H35NO5 (M
+
 
+H) m/z 513.2515, found 514.2573. 
(2R,3R,8R,8aS) and (2R,3R,8S,8aR)-2-[(Benzhydryloxy) 
methyl]-8-ethyl-8a-methyl-5-oxo-3-phenyl-2,3,6,7,8,8a-
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hexahydro-5H-oxazolo[3,2-a]pyridine (44a and 44b). Operating 
as in the general procedure, from 4-ethyl-5-oxohexanoic 
acid
[4]
 (1h; 35 mg, 0.22 mmol) and aminoalcohol 22[13] (81 mg, 
0.24 mmol) in toluene (5 mL) for 22 h, lactams 44a (49 mg, 
49%) and 44b (32 mg, 32%) were obtained after flash 
chromatography (gradient hexane to 1:2 hexane–EtOAc). 44a: 
[α]22D –38.9 (c 0.44, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, 
HETCOR):  = 0.99 (t, J = 7.6 Hz, 3H, CH3), 1.15–1.22 (m, 1H, 
CH2), 1.33–1.41 (m, 1H, H-7), 1.47 (s, 3H, CH3), 1.61–1.70 (m, 
1H, H-8), 1.78–1.87 (m, 1H, CH2), 2.02–2.11 (m, 1H, H-7), 
2.47 (t, J = 7.6 Hz, 2H, H-6), 3.30 (dd, J = 10.0, 6.8 Hz, 
1H, CH2), 3.47 (dd, J = 10.0, 6.0 Hz, 1H, CH2), 4.52 (ddd, J = 
6.8, 6.8, 6.0 Hz, 1H, H-2), 5.09 (s, 1H, CH), 5.47 (d, J = 
6.8 Hz, 1H, H-3), 7.09–7.36 (m, 15H, ArH); 13C NMR (CDCl3, 100 
MHz, HETCOR):  = 12.1 (CH3), 20.8 (CH3), 21.4 (CH2), 24.0 
(CH2), 29.1 (CH2), 44.4 (CH), 61.9 (CH), 67.9 (CH2), 76.9 
(CH), 84.1 (CH), 96.1 (C), 126.7 (CH), 126.8 (CH), 127.3 
(CH), 127.4 (CH), 127.5 (CH), 128.2 (CH), 128.3 (CH), 137.0 
(C), 141.6 (C), 141.8 (C), 169.8 (C);  IR (film):  = 1645 
cm
-1
; HMRS calcd for C30H33NO3 455.2460, found 455.2443. 44b: 
[α]22D +16.6 (c 0.43, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, 
HETCOR):  = 1.05 (t, J = 7.2 Hz, 3H, CH3), 1.18–1.28 (m, 1H, 
CH2), 1.36 (s, 3H, CH3), 1.41–1.48 (m, 1H, H-7), 1.79–1.93 (m, 
2H, H-8, CH2), 2.03–2.12 (m, 1H, H-7), 2.29 (dd, J = 18.4, 
8.8 Hz, 1H, H-6), 2.41 (ddd, J = 18.4, 9.2, 2.8 Hz, 1H, H-6), 
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3.01 (dd, J = 10.0, 6.4 Hz, 1H, CH2), 3.26 (dd, J = 10.0, 5.6 
Hz, 1H, CH2), 4.74 (q, J = 6.4 Hz, 1H, H-2), 5.09 (d, J = 7.2 
Hz, 1H, H-3), 7.06–7.08 (m, 2H, ArH), 7.18–7.28 (m, 13H, 
ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 11.9 (CH3), 18.7 
(CH3), 22.8 (CH2), 23.6 (CH2), 30.1 (CH2), 45.6 (CH), 61.7 
(CH), 68.0 (CH2), 76.6 (CH), 84.1 (CH), 94.7 (C), 126.7 (CH), 
126.8 (CH), 127.2 (CH), 127.3 (CH), 127.4 (CH), 128.0 (CH), 
128.1 (CH), 128.2 (CH), 137.1 (C), 141.6 (C), 141.7 (C), 
167.1 (C); IR (film):  = 1655 cm-1. 
Methyl (2R,3R,7R,8R,8aS)- and (2R,3R,7S,8S,8aR)-2-
[(Benzhydryloxy)methyl]-8-ethyl-8a-methyl-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine-7-acetate 
(45a and 45b). Operating as in the general procedure, 
aminoalcohol 22[13] (115 mg, 0.34 mmol) was added to a 
solution of dimethyl 3-(1-ethyl-2-oxopropyl)pentadionate
[7]
 
(1q; 75.6 mg, 0.31 mmol) and AcOH (9 mg, 0.15 mmol) in 
toluene (4 mL), and the mixture was stirred at reflux for 31 
h. The solvent was eliminated under reduced pressure, and the 
residue was dissolved in EtOAc and washed with 5% aqueous 
NaHCO3. The aqueous layer was extracted with EtOAc, and the 
combined organic extracts were washed with brine, dried, and 
evaporated. Flash chromatography (1:1 hexane–EtOAc to EtOAc) 
afforded lactams 45a (29 mg, 18%), 45b (9 mg, 6%), minor 
amounts of a third diastereomer, and starting material (1q; 
45 mg). 45a: [α]22D –1.6 (c 2.74, CHCl3); 
1
H NMR (CDCl3, 400 
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MHz, COSY, HETCOR):  = 1.10 (t, J = 7.6 Hz, 3H, CH3), 1.46–
1.52 (m, 2H, CH2, H-8), 1.58 (s, 3H, CH3), 1.66–1.73 (m, 1H, 
CH2), 2.15–2.19 (m, 1H, H-7), 2.20 (dd, J = 16.4, 1.6 Hz, 1H, 
CH2), 2.35 (dd, J = 16.0, 10.0 Hz, 1H, CH2), 2.54 (dd, J = 
16.0, 3.2 Hz, 1H, CH2), 2.67 (dd, J = 16.4, 9.6 Hz, 1H, CH2), 
3.27 (dd, J = 10.0, 6.4 Hz, 1H, CH2), 3.44 (dd, J = 10.0, 6.0 
Hz, 1H, CH2), 3.69 (s, 3H, CH3), 4.50 (ddd, J = 6.4, 6.4, 6.0 
Hz, 1H, H-2), 5.09 (s, 1H, CH), 5.38 (d, J = 6.4 Hz, 1H, H-
3), 7.07–7.09 (dd, J = 8.0, 2.0 Hz, 2H, ArH), 7.18–7.35 (m, 
13H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 13.7 (CH3), 
21.4 (CH3), 24.3 (CH2), 31.7 (CH), 36.0 (CH2), 40.0 (CH2), 
48.7 (CH), 51.7 (CH3), 61.7 (CH), 67.4 ( CH2), 76.8 (CH), 84.0 
(CH), 96.3 (C), 126.6 (CH), 126.7 (CH), 126.8 (CH), 127.4 
(CH), 127.6 (CH), 127.6 (CH), 128.0 (CH), 128.2 (CH), 128.3 
(CH), 128.4 (CH), 137.0 (C), 141.6 (C), 141.8 (C), 168.7 (C), 
172.4 (C); IR (film):  = 1665, 1733 cm-1. 45b: [α]22D –10.3 (c 
0.78, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 1.13 
(t, J = 7.6 Hz, 3H, CH3), 1.45 (s, 3H, CH3), 1.53-1.78 (m, 3H, 
CH2, H-8), 2.11 (dd, J = 18.0, 4.8 Hz, 1H, CH2), 2.17-2.31 (m, 
2H, CH2), 2.57-2.65 (m, 2H, H-6), 3.05 (dd, J = 10.0, 6.0 Hz, 
1H, CH2), 3.25 (dd, J = 10.0, 6.0 Hz, 1H, CH2), 3.63 (s, 3H, 
CH3), 4.74 (ddd, J = 6.8, 6.0, 6.0 Hz, 1H, H-2), 4.98 (s, 1H, 
CH), 5.06 (d, J = 6.8 Hz, 1H, H-3), 7.06 (dd, J = 8.0, 2.0 
Hz, 2H, ArH), 7.15–7.32 (m, 13H, ArH); 13C NMR (CDCl3, 100 
MHz, HETCOR):  = 13.5 (CH3), 19.3 (CH3), 23.7 (CH2), 32.8 
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(CH2), 36.6 (CH2), 40.1 (CH2), 50.6 (CH), 51.7 (CH3), 61.3 
(CH), 68.0 (CH2), 76.8 (CH), 84.1 (CH), 95.0 (C), 126.8 (CH), 
126.9 (CH), 127.4 (CH), 127.6 (CH), 127.8 (CH), 128.2 (CH), 
128.3 (CH), 128.4 (CH), 128.5 (CH), 128.6 (CH), 137.0 (C), 
141.6 (C), 141.7 (C), 166.1 (C), 172.3 (C); IR (film):  = 
1665, 1735 cm
-1
. 
Methyl (2R,3S,7R,8R,8aS)- and (2R,3S,7S,8S,8aR)-8-Ethyl-3-
(methoxymethyl)-5-oxo-2-phenyl 2,3,6,7,8,8a-hexahydro-5H-
oxazolo[3,2-a]pyridine-7-acetate (46a and 46b). Operating as 
in the general procedure, from dimethyl 3-(1-
formylpropyl)glutarate
[7]
 (1v; 250 mg, 1.09 mmol) and (1S,2S)-
2-amino-3-methoxy-1-phenyl-1-propanol
[14]
 (23; 235 mg, 1.19 
mmol) in toluene (5 mL) for 22 h, lactams 46a (214 mg, 47%) 
and 46b (73 mg, 17%) and a mixture of other stereoisomers (71 
mg, 15%) were obtained after flash chromatography (SiO2 
previously washed with hexane–Et3N; gradient hexane–EtOAc as 
eluent). 46a: [α]22D –81.4 (c 2.57, CHCl3); 
1
H NMR (CDCl3, 500 
MHz, COSY, HETCOR):  = 1.01 (t, J = 7.5 Hz, 3H, CH3), 1.55 
(m, 1H, H-8), 1.67 (m, 2H, CH2), 2.22 (m, 3H, H-6, H-7, CH2), 
2.45 (dd, J = 19.0, 8.0 Hz, 1H, CH2), 2.52 (dd, J = 15.0, 4.0 
Hz, 1H, CH2), 3.43 (s, 3H, CH3), 3.54 (t, J = 8.5 Hz, 1H, 
CH2), 3.68 (s, 3H, CH3), 3.97 (dd, J = 8.5, 3.0 Hz, 1H, CH2), 
4.37 (m, 1H, H-3), 4.71 (d, J = 8.5 Hz, 1H, H-8a), 5.35 (bs, 
1H, H-2), 7.34 (m, 5H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR): 
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 = 10.2 (CH3), 22.7 (CH2), 31.4 (CH), 37.2 (CH2), 38.8 (CH2), 
45.1 (CH), 51.7 (CH3), 60.5 (CH), 70.2 (CH2), 80.9 (CH), 88.9 
(CH), 125.7 (CH), 127.9 (CH), 128.7 (CH), 139.2 (C), 167.1 
(C), 172.2 (C); IR (film):  = 1651, 1732 cm-1; HMRS calcd for 
C20H27NO5 361.1889, found 361.1889. 46b: [α]
22
D +9.4 (c 1.08, 
CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, HETCOR):  = 0.99 (t, J 
= 7.2 Hz, 3H, CH3), 1.62 (m, 2H, CH2, H-8), 1.80 (m, 1H, CH2), 
2.17 (dd, J = 17.6, 11.2 Hz, 1H, H-6), 2.19 (dd, J = 15.6, 
4.0 Hz, 1H, CH2), 2.31 (m, 1H, H-7), 2.64 (dd, J = 15.6, 4.0 
Hz, 1H, CH2), 2.70 (dd, J = 17.6, 4.8 Hz, 1H, H-6), 3.38 (s, 
3H, CH3), 3.55 (dd, J = 10.0, 2.8 Hz, 1H, CH2), 3.70 (s, 3H, 
CH3), 3.83 (dd, J = 10.0, 2.8 Hz, 1H, CH2), 4.12 (ddd, J = 
7.2, 4.4, 2.8 Hz, 1H, H-3), 4.84 (d, J = 8.0 Hz, 1H, H-8a), 
5.07 (d, J = 7.2 Hz, 1H, H-2), 7.35 (m, 5H, ArH); 
13
C NMR 
(CDCl3, 100 MHz, HETCOR):  = 9.6 (CH3), 20.6 (CH2), 29.8 
(CH), 36.7 (CH2), 37.6 (CH2), 43.6 (CH), 51.7 (CH3), 59.2 
(CH3), 62.0 (CH), 70.3 (CH2), 79.9 (CH), 90.2 (CH), 126.4 
(CH), 128.2 (CH), 128.5 (CH), 138.9 (C), 167.2 (C), 172.1 
(C); IR (film):  = 1654, 1735 cm-1; HMRS calcd for C20H27NO5 
361.1889, found 361.1889. 
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Reduction Reactions 
(2S,3R)-3-Ethyl-1-[(1R)-2-hydroxy-1-phenylethyl]-2-
phenylpiperidine (cis-11a). Operating as in the Method B, 
from lactam 8g (500 mg, 1.7 mmol) and Red-Al (0.1M in THF, 
44.3 mL, 4.4 mmol) in THF (3 mL) for 8 h, piperidine cis-11a 
(270 mg, 56%) was obtained after flash chromatography 
(hexane): []22D –75.2 (c 1.09, MeOH); 
1
H NMR (CDCl
3
, 300 MHz, 
COSY):  = 0.64 (t, J =7.2 Hz, 3H, CH3), 1.23–1.38 (m, 2H, H-
4, CH2), 1.44–1.59 (m, 3H, H-3, H-5, CH2), 1.67–1.88 (m, 2H, 
H-4, H-5), 1.95 (td, J = 11.4, 3.0 Hz, 1H, H-6), 3.09 (dm, J 
= 11.4 Hz, 1H, H-6), 3.50 (dd, J = 10.5, 5.4 Hz, 1H, H-2’), 
3.58 (d, J = 2.4 Hz, 1H, H-2), 4.09 (t, J = 10.5 Hz, 1H, H-
2’), 4.30 (dd, J = 10.5, 5.4 Hz, 1H, H-1’), 6.87–6.90 (m, 2H, 
ArH), 7.24–7.39 (m, 8H, ArH); 13C NMR (CDCl
3
, 75.4 MHz):  = 
11.8 (CH3), 18.3 (CH2), 20.4 (CH2), 26.6 (CH2), 42.0 (CH), 
45.6 (CH2), 59.4 (CH2), 61.0 (CH), 68.7 (CH), 127.5 (CH), 
129.1 (CH), 126.4 (CH), 127.4 (CH), 127.8 (CH), 129.3 (CH), 
134.2 (C), 140.8 (C); IR (film)  = 3523 cm-1; HMRS calcd for 
C21H27NO 309.4501, found 309.4512. cis-11a hydrochloride: 
1
H 
NMR (CDCl
3
, 300 MHz):  = 0.68 (t, J = 7.2 Hz, 3H), 1.70 (dm, 
J = 14.1 Hz, 1H), 2.01 (dm, J = 13.5 Hz, 1H), 2.22 (m, 1H), 
2.50 (m, 1H), 2.61 (m, 1H), 3.68 (bs, 1H), 3.87 (bs, 1H), 
4.03 (m, 1H), 4.18 (m, 1H), 4.64 (m, 1H), 10.32 (bs, 1H); 
13
C 
NMR (CDCl
3
, 75.4 MHz):  = 12.0 (CH3), 17.8 (CH2), 18.1 (CH2), 
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24.8 (CH2), 41.8 (CH), 50.7 (CH2), 59.4 (CH2), 60.2 (CH2), 
69.8 (CH), 71.1 (CH), 128.4 (CH), 129.6 (CH), 128.5 (CH), 
130.2 (CH), 129.1 (CH), 130.4 (CH), 129.4 (C), 133.7 (C). 
(2R,3R)-3-Ethyl-1-[(1R)-2-hydroxy-1-phenylethyl]-2-
phenylpiperidine (trans-11a). Operating as in the Method A, 
from lactam 8g (100 mg, 0.31 mmol) and 9-BBN (0.5M in THF, 
6.22 mL, 3.11 mmol) in THF (5 mL) for 8 h, piperidine trans-
11a (83 mg, 86%) was obtained after flash chromatography 
(hexane to hexane–EtOAc 1:9): []22D –51.6 (c 1.06, MeOH); 
1
H 
NMR (CDCl
3
, 300 MHz):  = 0.68 (t, J =7.5 Hz, 3H), 0.84 (m, 
1H), 1.03 (m, 2H), 1.40–1.70 (m, 4H), 1.97 (m, 1H), 2.41 (td, 
J = 11.1, 3.0 Hz, 1H), 2.89 (bd, J = 11.1 Hz, 1H), 3.44 (d, J 
= 9.3 Hz, 1H), 3.68 (t, J = 6.3 Hz, 1H), 4.08 (d, J = 6.3 Hz, 
2H), 7.25–7.37 (m, 10H); 13C NMR (CDCl
3
, 75.4 MHz):  = 11.1 
(CH3), 25.8 (CH2), 26.1 (CH2), 30.0 (CH2), 45.4 (CH), 47.3 
(CH2), 59.3 (CH2), 62.2 (CH), 71.4 (CH), 126.5 (CH), 127.1 
(CH), 127.9 (CH), 128.0 (CH), 128.3 (CH), 128.6 (CH), 140.6 
(C), 143.0 (C); IR (film):  = 3523 cm-1; HMRS calcd for 
C21H27NO 309.4501, found 309.4513. 
(4aR,8aR)-1-[(1R)-2-Hydroxy-1-phenylethyl]perhydroquinoline 
(13a). Operating as in the Method C, from lactam 8i (300 mg, 
1.1 mmol), AlCl3 (558 mg, 4.4 mmol), and LiAlH4 (546 mg, 14.5 
mmol) in THF (44 mL), perhydroquinoline 13a (200 mg, 70%) was 
obtained after flash chromatography (Et2O): []
22
D –29.2 (c 
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1.59, MeOH); 
1
H NMR (CDCl3, 300 MHz, 55 
o
C)  = 1.24–1.91 (m, 
12H), 2.07 (bt, J = 8.7 Hz, 1H), 2.23 (m, 1H), 2.55 (m, 1H), 
2.85 (m, 1H), 3.17 (bs, 1H), 3.66 (dd, J = 10.5, 5.7 Hz, 1H), 
3.93 (dd, J = 10.5, 8.7 Hz, 1H), 4.10 (dd, J = 8.7, 5.1 Hz, 
1H), 7.20-7.32 (m, 5H); 
13
C NMR (CDCl3, 75.4 MHz, 55 
o
C):  = 
21.9 (CH2), 23.3 (CH2), 24.8 (CH2), 25.9 (CH2), 28.3 (CH2), 
28.7 (CH2), 37.3 (CH), 45.3 (CH2), 57.2 (CH), 61.1 (CH2), 64.0 
(CH), 127.3 (CH), 128.0 (CH), 128.6 (CH), 137.4 (C). 13a 
hydrochloride: m.p. 225–227 oC (THF-EtOH); []22D –32.2 (c 
0.8, MeOH); 
1
H NMR (CDCl3–CD3OD, 300 MHz):  0.75 (m, 1H), 
1.31–1.94 (m, 10H), 2.50 (m, 1H), 2.56 (m, 2H), 3.05 (m, 2H), 
3.96 (dd, J = 13.0, 3.0 Hz, 1H), 4.20 (dd, J = 7.0, 3.0 Hz, 
1H), 4.24 (dd, J = 13.0, 3.0 Hz, 1H), 4.59 (dd, J = 13.0, 7.0 
Hz, 1H), 7.42–7.70 (m, 5H), 10.5 (bs, 1H); 13C NMR (CDCl3–
CD3OD, 75.4 MHz):  = 17.8 (CH2), 19.4 (CH2), 21.2 (CH2), 22.3 
(CH2), 24.4 (CH2), 30.2 (CH2), 37.3 (CH), 47.4 (CH2), 60.8 
(CH), 63.1 (CH2), 70.1 (CH), 128.6 (CH), 129.3 (CH), 129.5 
(CH), 132.3 (C); IR (KBr):  = 3253 cm-1; elemental analysis 
calcd (%) for C17H26ClNO: C, 69.02; H, 8.86; N, 4.73; found: 
C, 69.15; H, 9.00; N, 4.59. 
Methyl (3R)-1-[(1R)-2-Hydroxy-1-phenylethyl]piperidine-3-
propionate (16a). Operating as in the Method D, from lactam 
9r (500 mg, 1.65 mmol) and BH3 (1M in THF, 4.95 mL, 4.95 
mmol) in THF (8.2 mL), piperidine 16a was obtained (293 mg, 
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61%) after flash chromatography (EtOAc): []22D –11.8 (c 0.7, 
MeOH); 
1
H NMR (CDCl
3
, 300 MHz, COSY):  = 0.79 (m, 1H, H-4), 
1.44–1.73 (m, 7H, H-6, H-5, H-4, H-3, 2H-1’), 1.98 (t, J = 
9.3 Hz, 1H, H-2), 2.32 (t, J = 7.5 Hz, 2H, H-2’), 2.74–2.81 
(m, 2H, H-6, H-2), 3.61 (dd, J = 10.0, 5.1 Hz, 1H, CH2), 3.67 
(s, 3H, CH3), 3.70 (dd, J = 10.0, 5.1 Hz, 1H, CH2), 3.98 (t, J 
= 10.0 Hz, 1H, CH), 7.14–7.37 (m, 5H, ArH); 13C NMR (CDCl
3
, 
75.4 MHz):  = 25.4 (CH2), 29.2 (CH2), 30.5 (CH2), 31.6 (CH2), 
36.3 (CH), 46.8 (CH2), 51.6 (CH3), 58.5 (CH2), 59.9 (CH2), 
70.2 (CH), 127.8 (CH), 128.0 (CH), 128.8 (CH), 135.2 (C), 
174.0 (C); IR (film):  = 1786, 3440 cm-1; HMRS calcd for 
C17H25NO3 291.3902, found 291.3910. 
Ethyl (2R,4S)-1-[(1R)-2-Hydroxy-1-phenylethyl]-2-
methylpiperidine-4-acetate (17a). Operating as in the Method 
D (reaction conditions: – 78 ºC for 2 h, 0 ºC for 2 h, and 25 
ºC for 2 h), from lactam 10n (1.1 g, 3.6 mmol) and BH3 (1M in 
THF, 10.8 mL, 10.8 mmol) in THF (18 mL), piperidines 17a (608 
mg, 55%) and 2-epi-17a (209 mg, 19%) were obtained  after 
flash chromatography (Et2O). 17a: []
22
D –35.4 (c 0.64, MeOH); 
1
H NMR (CDCl
3
, 300 MHz):  = 1.04 (d, J = 6.6 Hz, 3H), 1.22 
(t, J = 7.2 Hz, 3H), 1.38 (m, 1H), 1.48 (m, 2H), 1.74 (m, 
1H), 2.17 (m, 3H), 2.44 (ddd, J = 11.5, 7.2, 3.6 Hz, 1H), 
2.67 (ddd, J = 11.5, 7.2, 3.6 Hz, 1H), 2.82 (m, 1H), 3.71 
(dd, J = 10.5, 5.5 Hz, 1H), 3.82 (dd, J = 10.5, 7.0 Hz, 1H), 
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3.91 (dd, J = 7.0, 5.5 Hz, 1H), 4.10 (q, J = 7.2 Hz, 2H), 
7.25–7.33 (m, 5H); 13C NMR (CDCl
3
, 75.4 MHz):  = 14.1 (CH3), 
15.2 (CH3), 27.4 (CH), 31.3 (CH2), 38.9 (CH2), 39.2 (CH2), 
41.2 (CH2), 48.4 (CH), 60.1 (CH2), 61.4 (CH2), 64.0 (CH), 
127.5 (CH), 128.2 (CH), 128.4 (CH), 138.2 (C), 172.7 (C); IR 
(film):  = 1733, 3410 cm-1; HMRS calcd for C18H27NO3 305.4215, 
found 305.4213. 2-epi-17a: []22D +32.1 (c, 1.16, MeOH); 
1
H 
NMR (CDCl
3
, 500 MHz):  = 1.03 (q, J = 12.5 Hz, 1H), 1.06 
(qd, J = 12.0, 3.5 Hz, 1H), 1.18 (d, J = 6.0 Hz, 3H), 1.24 
(t, J = 7.5 Hz, 3H), 1.59 (dm, J = 12.0 Hz, 1H), 1.65 (ddd, J 
= 12.5, 6.5, 2.5 Hz, 1H), 1.82 (m, 1H), 2.16 (d, J = 7.0 Hz, 
2H), 2.20 (bs, 1H), 2.54 (td, J = 12.0, 2.0 Hz, 1H), 2.70 (m, 
1H), 2.86 (dt, J = 12.0, 3.5 Hz, 1H), 4.02 (dd, J = 10.5, 7.5 
Hz, 1H), 4.07 (dd, J = 10.5, 7.5 Hz, 1H), 4.11 (q, J = 7.5 
Hz, 2H), 4.18 (t, J = 7.5 Hz, 1H), 7.26 (tm, J = 7.5 Hz, 1H), 
7.34 (tm, J = 7.5 Hz, 2H), 7.39 (dm, J = 7.5 Hz, 2H); 
13
C NMR 
(CDCl
3
, 75.4 MHz):  = 14.3 (CH3), 21.3 (CH3), 32.8 (CH2), 
33.4 (CH), 41.4 (CH2), 42.2 (CH2), 49.6 (CH2), 54.0 (CH), 60.1 
(CH2), 60.2 (CH2), 63.6 (CH), 127.1 (CH), 128.3 (CH), 128.4 
(CH), 139.5 (C), 172.7 (C); IR (film):  = 1733, 3645 cm-1; 2-
epi-17a hydrochloride: m.p. 155–157 ºC (acetone–Et2O); 
elemental analysis calcd (%) for C18H27NO3
.
1/4 H2O: C, 63.24; 
H, 8.25; N, 4.10; found: C, 63.42; H, 8.22; N, 4.04. 
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Ethyl (2S,4R)-1-[(1R)-2-Hydroxy-1-phenylethyl]-2-
methylpiperidine-4-acetate (1’-epi-ent-17a). Operating as in 
the Method D (reaction conditions: – 78 ºC for 2 h, 0 ºC for 
2 h, and 25 ºC for 2 h), from lactam 9n (556 mg, 1.75 mmol) 
and BH3 (1M in THF, 5.26 mL, 5.26 mmol) in THF (9 mL), 
piperidine 1’-epi-ent-17a (280 mg, 53%) was obtained after 
flash chromatography (Et2O): []
22
D –10.8 (c 0.85, MeOH); 
1
H 
NMR (CDCl
3
, 300 MHz):  = 0.98 (d, J= 6.6 Hz, 3H), 1.16 (qd, 
J= 12.5, 4.2 Hz, 1H), 1.23 (t, J= 7.2 Hz, 3H), 1.50–1.57 (m, 
2H), 1.63 (dm, J= 12.5 Hz, 1H), 2.05 (m, 1H), 2.15 (m, 2H), 
2.45 (td, J= 12.5, 2.5 Hz, 1H), 2.61 (ddd, J= 12.5, 4.0, 3.0 
Hz, 1H), 3.35 (m, 1H), 3.60–3.80 (m, 3H), 4.08 (m, 2H), 7.21–
7.31 (m, 5H); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 11.8 (CH3), 14.2 
(CH3), 27.5 (CH), 32.5 (CH2), 38.7 (CH2), 41.1 (CH2), 41.6 
(CH2), 52.1 (CH), 60.1 (CH2), 62.3 (CH2), 68.1 (CH), 127.5 
(CH), 128.3 (CH), 128.6 (CH), 140.2 (C), 172.6 (C); IR 
(film):  = 1732, 3402 cm-1; HMRS calcd for C18H27NO3, 305.4212 
found 305.4207. 
Methyl (2R,3R,4R)-3-Ethyl-1-[(1R)-2-hydroxy-1-phenylethyl]-
2-methylpiperidine-4-acetate (18a). Operating as described in 
the Method D (reaction conditions: – 78 ºC for 20 min and 25 
ºC for 2 h), from lactam 10q (504 g, 1.51 mmol) and BH3 (1M 
in THF, 4.6 mL, 4.6 mmol) in THF (10 mL), piperidine 18a (322 
mg, 66%) was obtained after flash chromatography (gradient 
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4:1 to 1:1 hexane–EtOAc): [α]22D +16.4 (c 1.1, CHCl3); 
1
H NMR 
(CDCl3, 400 MHz, COSY, HETCOR):  = 0.71 (t, J = 7.6 Hz, 3H, 
CH3), 0.84 (d, J = 6.4 Hz, 3H, CH3), 1.01–1.13 (m, 1H, CH2), 
1.24–1.38 (m, 2H, H-5, H-3), 1.39–1.50 (m, 1H, CH2), 1.71–
1.77 (m, 1H, H-5), 1.92–2.01 (m, 1H, H-4), 2.06 (dd, J = 
14.8, 8.4 Hz, 1H, CH2), 2.46 (dd, J = 14.8, 5.2 Hz, 1H, CH2), 
2.62–2.70 (m, 2H, H-6), 2.93–2.98 (m, 1H, H-2), 3.65 (s, 3H, 
CH3), 3.75–3.81 (m, 3H, CH2, CH), 7.27–7.33 (m, 5H, ArH); 
13
C 
NMR (CDCl3, 100 MHz, HETCOR):  = 8.7 (CH3), 11.5 (CH3), 21.3 
(CH2), 31.4 (CH2), 32.0 (CH), 38.3 (CH2), 42.1 (CH2), 46.5 
(CH), 50.5 (CH), 51.4 (CH3), 62.4 (CH2), 64.5 (CH), 127.6 
(CH), 128.3 (CH), 139.5 (C), 173.7 (C); IR (film):  = 1736, 
3000–3500 cm-1. 
(1S,2R)-1-[(2S,3S)-(2-Methyl-3-phenyl)-1-piperidyl)]-2-
indanol (47). Operating as described in the Method D 
(reaction conditions: – 78 ºC for 20 min and 25 ºC for 8 h), 
from lactam 37b (2 g, 6.26 mmol) and BH3 (1M in THF, 19 mL, 
19 mmol) in THF (30 mL), piperidine 47 (1.63 g, 89%) was 
obtained after flash chromatography (95:5 EtOAc–Et3N): [α]
22
D 
–57.1 (c 1.07, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, HETCOR): 
 = 1.55–1.66 (m, 1H, H-5), 1.71–1.81 (m, 2H, H-4, H-5), 
1.92–2.02 (m, 1H, H-4), 2.54–2.59 (m, 1H, H-6), 2.91 (dd, J = 
16.0, 6.8 Hz, 1H, CH2), 2.97 (ddd, J = 12.4, 11.2, 2.8 Hz, 
1H, H-6), 3.15 (dd, J = 16.0, 7.2 Hz, 1H, CH2), 3.16 (ddd, J 
 127 
= 11.2, 7.4, 4.4 Hz, 1H, H-3), 3.34–3.40 (m, 1H, H-2), 4.25 
(d, J = 6.4 Hz, 1H, H-1’), 4.45 (ddd, J = 7.2, 6.8, 6.4 Hz, 
1H, CH), 7.15–7.31 (m, 8H, ArH), 7.39 (d, J = 7.2 Hz, 1H, 
ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 10.7 (CH3), 23.7 
(CH2), 25.3 (CH2), 40.5 (CH2), 44.9 (CH2), 46.1 (CH), 57.9 
(CH), 69.7 (CH), 70.7 (CH), 125.5 (CH), 125.9 (CH), 126.2 
(CH), 127.0 (CH), 127.8 (CH), 128.0 (CH), 128.9 (CH), 139.7 
(C), 141.7 (C), 143.4 (C); IR (film):  = 3000–3500 cm-1. 
(3S,4S)-1-[(1R,2R)-3-(Benzhydryloxy)-2-hydroxy-1-
phenylpropyl]-3-ethyl-4-(2-hydroxyethyl)piperidine (49). 
Operating as described in the Method D (reaction conditions: 
– 78 ºC for 20 min and 25 ºC for 2 h) from lactam 43b (270 
mg, 0.53 mmol) and BH3 (1M in THF, 1.6 mL, 1.6 mmol) in THF 
(4 mL), piperidine 49 (203 mg, 78%) was obtained after flash 
chromatography (EtOAc): [α]22D –10.3 (c 0.97, CHCl3); 
1
H NMR 
(CDCl3, 400 MHz, COSY, HETCOR):  = 0.85 (t, J = 7.2 Hz, 3H, 
CH3), 0.99–1.31 (m, 5H, CH2, H-5, H-3, CH2, H-4), 1.48–1.63 
(m, 2H, H-5, CH2), 1.73–1.85 (m, 3H, CH2, H-6, H-2), 2.59–2.62 
(m, 1H, H-6), 2.97–3.00 (m, 1H, H-2), 3.40–3.48 (m, 3H, CH2, 
H-1’), 3.53–3.69 (m, 2H, CH2), 4.43–4.48 (m, 1H, CH), 5.30 
(s, 1H, CH), 7.28–7.31 (m, 15H, ArH); 13C NMR (CDCl3, 100 MHz, 
HETCOR):  = 11.1 (CH3), 23.7 (CH2), 31.2 (CH2), 35.7 (CH2), 
36.4 (CH), 42.3 (CH), 49.7 (CH2), 56.7 (CH2), 60.7 (CH2), 68.8 
(CH), 71.4 (CH2 and CH), 84.1 (CH), 126.9 (CH), 127.4 (CH), 
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127.9 (CH), 128.1 (CH), 128.2 (CH), 128.3 (CH), 129.5 (C), 
136.1 (C),  142.0 (C), 142.1 (C); IR (film):  = 3000–3500 
cm
-1
. 
Hydrogenolysis Reactions 
(R)-2-Phenylpiperidine (ent-6b). Operating as described in 
the general procedure, piperidine ent-6b (48 mg, 56 %) was 
obtained from 5b (150 mg, 0.53 mmol) and Pd-C (10%, 37.5 mg) 
after flash chromatography (CH2Cl2): []
22
D +25.2 (c 0.4, 
MeOH), (lit
[15]
 []24D +27.6 (c 1.0, MeOH)); HMRS calcd for 
C11H15N 161.1199, found 161.1202. 
(2S,3R)-3-Ethyl-2-phenylpiperidine (cis-11b). Following the 
general procedure, from piperidine cis-11a (400 mg, 1.3 mmol) 
and 10 % Pd(OH)2-C (100 mg) in MeOH (26 mL) was obtained 
piperidine cis-11b (140 mg, 70%) after flash chromatography 
(EtOAc): []22D –24.3 (c 1.48, MeOH); 
1
H NMR (CDCl
3
, 300 MHz, 
COSY):  = 0.66 (t, J =7.5 Hz, 3H, CH3), 1.02 (m, 1H, CH2), 
1.39–1.51 (m, 2H, H-5, CH2), 1.61–1.72 (m, 3H, H-3, H-4, H-
5), 1.96 (m, 1H, H-4), 2.78 (td, J =11.4, 3.0 Hz, 1H, H-6), 
3.22 (dd, J =11.4, 3.0 Hz, 1H, H-6), 3.93 (d, J = 2.7 Hz, 1H, 
H-2), 7.17–7.33 (m, 5H, ArH); 13C NMR (CDCl
3
, 75.4 MHz):  = 
12.3 (CH3), 17.2 (CH2), 20.6 (CH2), 27.7 (CH2), 41.5 (CH), 
48.0 (CH2), 64.7 (CH), 126.2 (CH), 126.4 (CH), 127.9 (CH), 
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144.1 (C); IR (film):  = 3321 cm-1; HMRS calcd for C13H19N 
189.1517, found 189.1512. 
(2R,3R)-3-Ethyl-2-phenylpiperidine (trans-11b). Following 
the general procedure, from compound trans-11a (400 mg, 1.3 
mmol) and 10% Pd-C (100 mg) in MeOH (26 mL) was obtained 
piperidine trans-11b (110 mg, 60%) after flash chromatography 
(EtOAc): []22D –23.1 (c 0.67, MeOH); 
1
H NMR (CDCl
3
, 300 MHz): 
 = 0.71 (t, J =7.5 Hz, 3H), 0.87 (m, 1H), 1.09 (m, 1H), 1.48 
(m, 1H), 1.60–1.72 (m, 2H), 1.72 (bs, 1H), 1.86 (m, 1H), 2.04 
(m, 1H), 2.74 (td, J = 11.7, 2.7 Hz, 1H), 3.14 (dm, J = 11.7 
Hz, 1H), 3.22 (d, J = 9.9 Hz, 1H), 7.26–7.32 (m, 5H); 13C NMR 
(CDCl
3
, 75.4 MHz):  = 10.9 (CH3), 25.3 (CH2), 26.4 (CH2), 
30.2 (CH2), 43.5 (CH), 47.6 (CH2), 68.3 (CH), 127.2 (CH), 
127.9 (CH), 128.2 (CH), 143.6 (C); IR (film):  = 3327 cm-1; 
HMRS calcd for C13H19N 189.1512, found 189.1518. 
(2R,3R)-1-(tert-Butoxycarbonyl)-3-ethyl-2-methylpiperidine 
(12c). Following the general procedure, from piperidine 12a 
(160 mg, 0.64 mmol), 20% Pd(OH)2-C (64 mg), and di-tert-butyl 
dicarbonate (282 mg, 1.29 mmol) in EtOAc (22 mL) was obtained 
carbamate 12c (121 mg, 82%) after flash chromatography 
(hexane): []22D –41.3 (c 0.75, MeOH); 
1
H NMR (CDCl3, 300 MHz, 
broad signals):  0.90 (t, = J = 7.2 Hz, 3H), 0.98 (d, J = 
7.2 Hz, 3H), 1.45 (s, 9H), 2.77 (bs, 1H), 3.80 (bs, 2H), 4.20 
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and 4.38 (2 bs, 2H); 
13
C NMR (CDCl3, 75.4 MHz):  = 10.3 
(CH3), 11.5 (CH3), 24.7 (CH2), 26.1 (CH2), 26.2 (CH2), 29.4 
(CH3), 39.0 (CH2), 41.2 (CH), 48.9 (CH), 78.9 (C), 146.6 (C); 
IR (film):  = 1811 cm-1; HMRS calcd for C13H25NO2 227.2080, 
found 227.2083. 
(4aR,8aR)-Decahydroquinoline (13b). Method A. Following the 
above general procedure, from 13a hydrochloride (350 mg, 1.35 
mmol) and 10% Pd-C (35 mg) in MeOH (17 mL) was obtained 
decahydroquinoline 13b hydrochloride (200 mg, 85%): m.p. 246–
248 ºC (EtOH–Et2O); []
22
D +7.4 (c 1.62, MeOH), [lit
[16]
 []20D 
+6.2 (c, 2.0, EtOH)]; 
1
H NMR (CDCl3, 300 MHz, 55
o
C):  = 1.31–
2.01 (m, 13H), 2.98 (m, 1H), 3.25 (m, 1H), 3.39 (m, 1H), 9.15 
(bs, 1H), 9.70 (bs, 1H); 
13
C NMR (CDCl3, 75.4 MHz):  = 19.7 
(CH2), 21.8 (CH2), 22.9 (CH2), 25.7 (CH2), 26.0 (CH2), 27.2 
(CH2), 33.2 (CH), 42.1 (CH2), 54.8 (CH); IR (KBr):  = 3415 
cm
-1
; elemental analysis calcd (%) for C9H18ClN: C, 61.52; H, 
10.33; N, 7.97; found: C, 61.49; H, 10.39; N, 7.80.  
Method B. Following the general procedure, from 
decahydroquinoline 13a (425 mg, 1.64 mmol), di-tert-butyl 
dicarbonate (715 mg, 3.28 mmol), and 20% Pd(OH)2-C (170 mg) 
in EtOAc (55 mL) was obtained (4aR,8aR)-1-(tert-
Butoxycarbonyl)decahydroquinoline (13c; 203 mg, 65%) after 
flash chromatography (98:2 CH2Cl2–Et2O): []
22
D –17.9 (c 0.73, 
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MeOH); 
1
H NMR (CDCl3, 200 MHz):  = 0.88 (m, 1H), 1.25–1.90 
(m, 12H), 1.45 (s, 9H), 2.75 (td, J = 12.6, 3.0 Hz, 1H), 3.93 
(dm, J = 12.0 Hz, 1H), 4.06 (dt, J = 12.6, 4.2 Hz, 1H); 
13
C 
NMR (CDCl3, 54.3 MHz):  = 20.4 (CH2), 23.9 (CH2), 24.0 (CH2), 
25.8 (CH2), 26.0 (CH2), 28.5 (CH3), 31.5 (CH2), 35.0 (CH), 
38.9 (CH2), 53.0 (CH), 79.0 (C), 155.0 (C). TFA (0.927 mL, 
12.1 mmol) was added to a solution of 13c (38.6 mg, 0.16 
mmol) in anhydrous CH2Cl2 (1 mL). The resulting solution was 
stirred at 25 ºC for 15 min. The crude mixture was cooled to 
0 ºC and brought to basic pH by careful addition to Ca2CO3. 
The aqueous layer was extracted with CH2Cl2, and the combined 
organic extracts were washed with brine, dried and 
concentrated. Flash chromatography (80:15:5 CH2Cl2–Et2O–Et2NH) 
gave decahydroquinoline 13b (19 mg, 85%): []22D –8.7 (c 0.37, 
MeOH); 
1
H NMR (CDCl3, 300 MHz):  = 0.70–1.90 (m, 12H), 2.03 
(bs, 1H), 2.65 (td, J = 12.0, 3.6 Hz, 1H), 2.84 (dd, J = 7.2, 
3.6 Hz, 1H), 3.04 (dt, J = 12.0, 3.6 Hz, 1H); 
13
C NMR (CDCl3, 
75.4 MHz):  = 21.7 (CH2), 22.6 (CH2), 26.0 (CH2), 26.3 (CH2), 
29.6 (CH2), 32.0 (CH2), 35.6 (CH), 46.8 (CH2), 54.9 (CH); IR 
(film):  = 3323 cm-1. 
 Ethyl (3S,4S)-3-Ethylpiperidine-4-acetate (14b). Following 
the general procedure, from piperidine 14a (70 mg, 0.22 mmol) 
and 10% Pd-C (17.5 mg) in MeOH (50 mL) was obtained 
piperidine 14b (30 mg, 70 %) after flash chromatography 
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(EtOAc to 95:5 EtOAc–Et2NH): []
22
D –43.1 (c 0.7, MeOH); 
1
H NMR 
(CDCl3, 500 MHz, COSY, HETCOR):  = 0.86 (t, J = 7.5 Hz, 3H, 
CH3), 1.29 (t, J = 7.5 Hz, 3H, CH3), 1.25 (s, 1H, CH2), 1.59 
(ddd, J = 14.5, 7.5, 3.5 Hz, 1H, CH2), 1.71 (td, J = 13.0, 
3.5 Hz, 1H, H-5), 1.75–1.81 (m, 2H, H-3, H-4), 1.95 (dd, J = 
13.0, 3.0 Hz, 1H, H-5), 2.08 (dd, J = 16.0, 8.6 Hz, 1H, CH2), 
2.55 (t, J = 12.0 Hz, 1H, H-2), 2.56 (dd, J = 16.0, 3.5 Hz, 
1H, CH2), 2.81 (td, J = 13.0, 3.0 Hz, 1H, H-6), 3.40 (bd, J = 
12.0 Hz, 1H, H-2), 3.42 (dd, J = 13.0, 3.5 Hz, 1H, H-6), 4.11 
(q, J = 7.5 Hz, 2H, CH2); 
13
C NMR (CDCl3, 75.4 MHz, HETCOR):  
= 9.8 (CH3), 14.2 (CH3), 22.9 (CH2), 28.2 (CH2), 35.2 (CH), 
37.5 (CH2), 38.5 (CH), 43.8 (CH2), 47.4 (CH2), 60.7 (CH2), 
172.1 (C); IR (film) 3419, 1731 cm
-1
; HMRS calcd for C11H21NO2 
199.1572, found 199.1577. 
Ethyl (4S,5S)-5-Ethyl-2-oxopiperidine-4-acetate (15b). Into 
a three-necked, 250 mL round-bottomed flask equipped with a 
coldfinger condenser charged with dry ice–acetone were 
condensed 15 mL of NH3 at –78 ºC, and calcium metal was added 
in small portions until the blue color persisted. Then, a 
solution of lactam 9o (100 mg, 0.30 mmol) in THF (2 mL) was 
added, and the mixture was stirred at –78 ºC for 3 h. The 
reaction was quenched by addition of solid NH4Cl until the 
blue color disappeared, and the mixture was stirred at room 
temperature for 2 h. The resulting residue was digested with 
EtOAc, and the resulting suspension was filtered and 
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concentrated to give an oil (80 mg), which was used in the 
next reaction without further purification. Et3SiH (100 L, 
0.06 mmol) and TFA (1.7 mL) were added to the above obtained 
oil (80 mg), and the resulting mixture was stirred at room 
temperature for 18 h and concentrated. The residue was 
dissolved in CH2Cl2, and the organic extract was washed with 
aqueous NaHCO3, dried, filtered, and concentrated to give a 
yellow oil (50 mg). Flash chromatography (4:6 hexane–EtOAc to 
EtOAc) afforded piperidone 15b (30 mg, 48%): []22D –70.9 (c 
0.26, EtOH); 
1
H NMR (CDCl3, 300 MHz):  = 0.93 (t, J = 7.5 Hz, 
1H), 1.26 (t, J = 6.9 Hz, 3H), 1.30 (m, 1H, CH2), 1.63 (m, 
1H, CH2), 1.83 (m, 1H), 2.17 (dd, J = 14.5, 4.0 Hz, 1H), 2.23 
(dd, J = 14.5, 8.4 Hz, 1H), 2.51 (m, 2H), 3.03 (ddd, J = 
12.0, 8.4, 1.6 Hz, 1H), 3.40 (ddd, J = 12.0, 4.6, 3.4 Hz, 
1H), 4.14 (q, J = 7.2 Hz, 2H), 6.25 (bs, 1H); 
13
C NMR (CDCl3, 
75.4 MHz):  = 11.0 (CH3), 14.2 (CH3), 23.5 (CH2), 33.5 (CH), 
35.7 (CH2), 38.1 (CH), 38.2 (CH2), 44.9 (CH2), 60.6 (CH2), 
171.5 (C), 171.8 (C); IR (film):  = 1728, 1660 cm-1; HMRS 
calcd for C11H19NO3 231.1364, found 213.1367. 
Methyl (3R)-3-Piperidine-3-propionate (16b). Following the 
general procedure, from piperidine 16a (140 mg, 0.48 mmol) 
and 20% Pd(OH)2-C (35 mg) in EtOAc (12 mL) was obtained 
piperidine 16b (90 mg, 91%) after flash chromatography (95:5 
EtOAc–Et2NH): []
22
D +6.1 (c 0.75, CH2Cl2); 
1
H NMR (CDCl
3
, 300 
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MHz):  = 1.05 (qd, J = 13.0, 4.2 Hz, 1H), 1.43 (m, 2H), 1.54 
(t, J = 7.8 Hz, 2H), 1.65 (dm, J = 13.0 Hz, 1H), 1.84 (dm, J 
= 13.0 Hz, 1H), 2.19 (m, 1H), 2.32 (t, J = 7.8 Hz, 2H), 2.52 
(td, J = 13.0, 2.4 Hz, 1H), 3.01 (m, 2H), 3.66 (s, 3H); 
13
C 
NMR (CDCl
3
, 75.4 MHz):  = 26.4 (CH2), 29.5 (CH2), 31.2 (CH2), 
31.4 (CH2), 36.6 (CH), 46.8 (CH2), 51.5 (CH3), 52.5 (CH2), 
174.1 (C); IR (film):  = 1734, 3326 cm-1; HMRS calcd for 
C9H17NO2 171.1259, found 171.1258. 
Ethyl (2R,4S)-2-Methylpiperidine-4-acetate (17b). Following 
the general procedure, from piperidine 17a hydrochloride (151 
mg, 0.5 mmol) and 10% Pd-C (15 mg) in MeOH (6 mL) was 
obtained piperidine 17b hydrochloride (102 mg, 93%): m.p. 
165–167 ºC (acetone–Et2O); []
22
D +5.4 (c 1.0, MeOH); 
1
H NMR 
(CDCl
3
, 300 MHz):  1.25 (t, = J= 6.9 Hz, 3H), 1.47 (d, J= 
6.9 Hz, 3H), 1.68 (m, 1H), 1.81 (m, 2H), 2.02 (m, 1H), 2.34 
(m, 3H), 3.15 (bs, 2H), 3.58 (bs, 1H), 4.14 (q, J= 6.9 Hz, 
2H); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 14.1 (CH3), 16.6 (CH3), 
26.2 (CH), 27.2 (CH2), 33.9 (CH2), 38.3 (CH2), 38.5 (CH2), 
47.8 (CH), 60.6 (CH2), 171.7 (C); IR (film):  = 1724, 3501 
cm
-1
; elemental analysis calcd (%) for C10H20ClNO2: C, 54.17; 
H, 9.09; N, 6.32; found: C, 53.99; H, 9.07; N, 6.11. 17b: 1H 
NMR (CDCl
3
, 300 MHz):  = 1.04 (d, J = 6.6 Hz, 3H), 1.23 (t, 
J = 7.2 Hz, 3H), 1.39 (m, 3H), 1.67 (ddd, J = 17.7, 9.0, 4.5 
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Hz, 1H), 1.81 (bs, 1H), 2.31 (m, 1H), 2.33 (dd, J = 11.7, 4.0 
Hz, 1H), 2.34 (t, J = 4.0 Hz, 1H), 2.84 (m, 2H), 2.94 (m, 
1H), 4.12 (q, J = 7.2 Hz, 2H); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 
14.2 (CH3), 21.4 (CH3), 28.5 (CH), 30.8 (CH2), 38.2 (CH2), 
38.3 (CH2), 40.9 (CH2), 46.5 (CH), 60.1 (CH2), 172.9 (C). 
Ethyl (2S,4R)-2-Methylpiperidine-4-acetate (ent-17b). 
Following the general procedure, from piperidine 1’-epi-ent-
17a was obtained ent-17b hydrochloride: 87% yield; []22D –5.4 
(c 1.0, MeOH). 
Ethyl (2R,4S)-1-(tert-Butoxycarbonyl)-2-methyl-4-
piperidineacetate (17c). Following the general procedure, 
from piperidine 17a (285 mg, 0.98 mmol), 20% Pd(OH)2-C (120 
mg), and di-tert-butyl dicarbonate (428 mg, 1.96 mmol) in 
EtOAc (30 mL) was obtained carbamate 17c (250 mg, 94%) after 
flash chromatography (2:8 hexane–Et2O): []
22
D –36.2 (c 0.48, 
MeOH); 
1
H NMR (CDCl
3
, 300 MHz):  = 1.08 (qd, J = 13.2, 4.5 
Hz), 1.13 (d, J = 7.2 Hz, 3H), 1.26 (t, J = 7.5 Hz, 3H), 1.35 
(td, J = 12.3, 5.7 Hz, 1H), 1.45 (s, 9H), 1.55 (dm, J = 12.3 
Hz, 1H), 1.60 (dm, J = 13.2 Hz, 1H), 2.12 (m, 1H), 2.18 (m, 
2H), 2.86 (bt, J = 13.2 Hz, 1H), 3.95 (bs, 1H), 4.11 (m, 2H), 
4.42 (bs, 1H); 
13
C NMR (CDCl
3
, 75.4 MHz):  = 14.2 (CH3), 16.1 
(CH3), 27.5 (CH), 28.4 (CH3), 31.9 (CH2), 36.6 (CH2), 38.2 
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(CH2), 41.4 (CH2), 46.4 (CH), 60.2 (CH2), 79.2 (C), 155.0 (C), 
172.4 (C); IR (film):  = 1690, 1736 cm-1. 
Ethyl (2S,4R)-1-(tert-Butoxycarbonyl)-2-methyl-4-
piperidineacetate (ent-17c). Following the above procedure, 
from 1’-epi-ent-17a was obtained ent-17c: 92% yield; []22D 
+36.0 (c 1.51, MeOH). 
Methyl (2R,3R,4R)-3-Ethyl-2-methylpiperidine-4-acetate 
(18b). Following the general procedure, from piperidine 18a 
(290 mg, 0.91 mmol) and 20% Pd(OH)2-C (140 mg) in MeOH (18 
mL) was obtained piperidine 18b (153 mg, 84%) after flash 
chromatography (7:2:1 EtOAc–MeOH–Et3N to 95:5 EtOAc–Et2NH): 
[α]22D +19.4 (c 1.01, CHCl3); 
1
H NMR (CDCl3, 400 MHz, COSY, 
HETCOR):  = 0.91 (d, J = 6.8 Hz, CH3), 1.19 (d, J = 6.8 Hz, 
3H, CH3), 1.20–1.28 (m, 1H, CH2), 1.39–1.58 (m, 2H, CH2), 
1.78–1.84 (m, 1H, H-5), 2.06–2.14 (m, 1H, H-4), 2.21 (dd, J = 
15.2, 8.8 Hz, 1H, CH2), 2.54 (dd, J = 15.2, 5.6 Hz, 1H, CH2), 
2.94–2.98 (m, 2H, H-6), 3.38–3.44 (m, 1H, H-2), 3.68 (s, 3H, 
CH3), 5.96 (bs, 1H, NH); 
13
C NMR (CDCl3, 100 MHz, HETCOR):  = 
11.3 (CH3), 12.7 (CH3), 20.5 (CH2), 28.5 (CH2), 31.0 (CH), 
37.6 (CH2), 38.7 (CH2), 43.5 (CH), 48.7 (CH), 51.4 (CH3), 
173.0 (C); IR (film):  = 1736 cm-1; HMRS calcd for C12H17N 
199.1572, found 199.1574. 
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(2S,3S)-cis-2-Methyl-3-phenylpiperidine (48). Following the 
general procedure, from piperidine 47 (250 mg, 0.81 mmol) and 
20% Pd(OH)2-C (100 mg) in MeOH (16 mL) was obtained 
piperidine 48 (121 mg, 68%) after flash chromatography (4:1:1 
EtOAc–MeOH–Et3N): [α]
22
D –2.9  (c 0.97, CHCl3); 
1
H NMR (CDCl3, 
400 MHz, COSY, HETCOR):  = 0.90 (d, J = 6.8 Hz, CH3), 1.54–
1.62 (m, 1H, H-5), 1.76–1.86 (m, 2H, H-5, H-4), 1.91–2.00 (m, 
1H, H-4), 2.81–2.86 (m, 1H, H-6), 2.93 (bs, 1H, NH), 2.96–
3.02 (m, 2H, H-6, H-3), 3.30–3.37 (m, 1H, H-2), 7.16–7.22 (m, 
1H, ArH), 7.28 (m, 4H, ArH); 
13
C NMR (CDCl3, 100 MHz, HETCOR): 
 = 14.2 (CH3), 25.1 (CH2), 25.5 (CH2), 41.1 (CH2), 45.6 (CH), 
53.5 (CH), 125.9 (CH), 128.0 (CH), 128.1 (CH), 143.8 (C); IR 
(film):  = 3059 cm-1; HMRS calcd for C12H17N 175.1361, found 
175.1367. 
(3S,4S)-3-Ethyl-4-hydroxyethylpiperidine (50). Following 
the general procedure, from piperidine 49 (51 mg, 0.16 mmol) 
and 20% Pd(OH)2-C (20 mg) in MeOH (5 mL) was obtained 
piperidine 50 (12 mg, 48%) after flash chromatography (10:2:1 
EtOAc–MeOH–Et3N): 
1
H NMR (CDCl3. 500 MHz, COSY, HETCOR):  = 
0.83 (t, J = 8.0 Hz, 3H, CH3), 1.11 (m, 1H, CH2), 1.16 (m, 1H, 
H-4), 1.21 (m, 1H, H-5), 1.28 (m, 1H, H-3), 1.31 (m, 1H, 
CH2), 1.57 (m, 1H, CH2), 1.74 (dq, J = 13.0, 3.0 Hz, 1H, H-5), 
1.83 (m, 1H, CH2), 2.25 (dd, J = 12.0, 10.5, 1H, H-2), 2.54 
(td, J = 12.0, 3.0 Hz, 1H, H-6), 3.03 (dt, J = 12.0, 2.5 Hz, 
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1H, H-6), 3.08 (ddd, J = 12.0, 4.0, 1.0 Hz, 1H, H-2), 3.64 
(m, 1H, CH2), 3.68 (m, 1H, CH2); 
13
C NMR (CDCl3, 75.4 MHz, 
HETCOR):  = 10.9 (CH3), 23.5 (CH2), 31.7 (CH2), 35.9 (CH2), 
36.8 (CH), 42.5 (CH), 46.4 (CH2), 50.7 (CH2), 60.2 (CH2); IR 
(film):  = 3000–3500 cm-1. 
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